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ENDOTHELIAL CELL FACTORS INVOLVED IN BARTONELLA BACILLIFORMIS
PATHOGENESIS

by
TANUSHREE SONI

Under the Direction of Dr. Barbara Baumstark, Ph.D.
ABSTRACT
The genus Bartonella comprises emerging pathogens that are causative agents of a wide
range of clinical manifestations such as cat scratch disease, bacillary angiomatosis, and Carrion’s
disease. All species are transmitted by blood-sucking arthropods and infect erythrocytes and
endothelial cells of hosts. Carrion’s disease is a bi-phasic infection caused by Bartonella
bacilliformis which is characterized by hemolysis of infected erythrocytes followed by invasion
of the vascular endothelium. This provokes pronounced cellular proliferation, angiogenesis and
skin eruptions called verruga peruana. Endothelial cells are thought to be the primary niche
wherein bacteria reside between inoculation and erythrocyte infection. This study aims to
elucidate some of the endothelial factors involved during the verruga peruana phase of Carrion’s
disease.
In order to adhere to and invade human microvascular endothelial cells (HMEC-1), B.
bacilliformis engages a family of cell receptors called integrins. We used anti-integrin antibodies
to show that the primary integrin involved is the fibronectin receptor α5β1, although the
vitronectin receptor αVβ3 also plays a minor role. We show B. bacilliformis invasion is also
dependent on integrin ligands, fibronectin and vitronectin as antibodies against these proteins

decreased invasion and attachment, whereas pre-treatment of the bacteria with these molecules
enhanced infection of endothelial cells. Bacterial uptake requires various host cytoplasmic
signaling pathways to work in tandem, and our study identified three mitogen activated protein
kinases involved. Apart from MAPKs, phosphotidylinositol 3 kinase plays a role during
invasion and cell survival. PI3K inhibitors blocked bacterial internalization and B. bacilliformis
infected cells showed accelerated apoptosis. Lastly, microarray analysis was performed to study
the gene expression profile of B. bacilliformis infected HMEC-1 cells. Numerous molecules of
the integrin signaling pathways are involved, suggesting integrins as the major receptor recruited
for the successful infection by B. bacilliformis.
In summary this is the first study to demonstrate the role of integrins as B. bacilliformis
receptors and integrin ligands as facilitators of infection. Gene expression analysis suggests the
possibility that integrin mediated signaling pathways are the key modulators of cellular
alterations during B. bacilliformis infection. This hypothesis is supported by the identification of
some members of the integrin signaling pathway necessary for B. bacilliformis entry into
endothelial cells.
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General Introduction
Bartonella (formerly Rochalimaea) is a genus of facultative intracellular parasites
that consists of 20 species (spps), eight of which are known human pathogens (Table.1.).
These bacteria employ an arthropod mode of transmission; the blood-sucking vectors
include sandflies, ticks, fleas, and mosquitoes. Bartonella spps cause a wide range of
diseases that can induce acute onset (e.g., Oroya phase of B. bacilliformis infection) or
chronic disease (e.g.,bacilliary angiomatosis during B. henselae infection). The invasion
and persistent colonization of erythrocytes in the mammalian reservoir is unique to the
Bartonella genus. Erythrocytic infection also can be asymptomatic, representing an
exception to Koch’s postulate, which states that “Bacteria do not occur in the blood or
tissues of healthy animals or humans” (Brock, 1999). In this chapter, we review some of
the virulent factors of the human pathogens B. bacilliformis, B. henselae, and B.
quintana, with a predominant focus on B. bacilliformis.
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Table 1. Bartonella species, their natural reservoir and vector, and the resulting human diseases
Bartonella species

Reservoir

Vector

Human disease(s)

Human-specific species
B. bacilliformis
B. quintana

Human
Human

Sandfly
Body louse

Carrión's disease: Oroya fever and verruga peruana
Trench fever, endocarditis, bacillary angiomatosis

Zoonotic species
B. clarridgeiae
B. elizabethae
B. grahamii

Cat
Rat
Mouse, vole

Cat flea
?
?
Cat flea
Ticks

B. washoensis

Cat
Mouse
Ground
squirrels

Cat-scratch disease
Endocarditis, neuroretinitis
Neuroretinitis
CSD, endocarditis, BA, BP, neuroretinitis, bacteremia with
fever
Bacteremia with fever

?

Myocarditis

Animal-specific species
B. alsatica
B. birtlesii
B. bovis (=B. weissii)
B. capreoli
B. chomelii
B. doshiae
B. koehlerae
B. peromysci
B. schoenbuchensis
B. talpae
B. taylorii
B. tribocorum
B. vinsonii subsp. berkhoffii
B. vinsonii subsp. vinsonii

Rabbit
Mouse
Cattle/cat
Roe deer
Cattle
Vole
Cat
Deer, mouse
Roe deer
Mole
Mouse, vole
Rat
Dog
Vole

?
?
?
?
?
?
?
?
Deer ked
?
?
?
Ticks
Vole ear mite

?
?
?
?
?
?
?
?
?
?
?
?
?
?

B. henselae
B. vinsonii subsp. arupensis

Source : Molecular and Cellular Basis of Bartonella Pathogensis. Christoph Dehio. Annual Review of Microbiology. 2004.
58: 365-90.
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History of Carrion’s disease
Carrion’s disease is a bi-phasic infection named after Daniel Carrion, a medical
student, who first linked the two phases of the disease, namely, Oroya fever and verruga
peruana. The first, acute-onset, phase of the disease was documented in 1870 when
thousands of rail workers succumbed to fever and anemia caused by unknown factors. A
railway was being built in the Andean region from Lima to La Oroya, and because the
disease was contained within this region, authorities called it “Oroya fever” in reference
to the final point of the rail (Cueto, 1996). The second phase of the disease is
characterized by nodular skin lesions. These lesions have been described for centuries,
and are represented on artifacts from pre-Incan civilizations. These lesions last anywhere
from a few weeks to months. Because these lesions were unique to the Peruvian region,
they were given the simple nomenclature Peruvian warts or verruga peruana. Cases of
Carrion’s disease also have been recorded in arid regions of Ecuador and Colombia
(Alexander, 1995). For many years, Oroya fever and verruga peruana were believed to
be manifestations of two separate infections. Daniel Carrion demonstrated their
relationship by inoculating himself with blood from an eruptive verruga lesion. Within
three weeks, he suffered from acute febrile anemia, a hallmark of the Oroya phase.
Unfortunately, Carrion died while in the acute phase of the disease, though his fatal selfexperimentation provided proof that the two stages had the same origin.
The causative agent of Carrion’s disease remained unidentified until the
establishment of local bacteriological institutes in the early 1900s. Alberto Barton, a
British immigrant, first described the causative agent in his thesis and then, after
extensive research, announced the discovery of a novel microbe in the blood of Oroya
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fever patients in 1909. He observed that the fever coincided with an increase in
bacteremia. This was followed by a decrease in the number of bacteria and ultimately
their complete absence from the blood stream; only later did the blood-filled warts
characteristic of verruga peruana make their appearance. Barton’s conclusions were not
accepted until 1913, when Richard P. Strong confirmed his findings and proposed the
new genus Bartonella bacilliformis (Strong et al., 1915). Subsequently, the genus
Bartonella was merged with Rochalimaea (B. quintana, B. henselae, B. elizabethae, and
B. vinsonii) and Grahamella (B. talpae, B. peromysci, B. grahamii, B. taylori, and B.
doshiae) (Birtles et al., 1995; Brenner et al., 1993), based on DNA hybridization and 16S
rRNA similarities to produce a genus currently containing 20 species.
All Bartonella species are transmitted by blood-sucking arthropods. Bueno and
colleagues first proposed sandflies as a common vector for the transmission of the
causative agent of Carrion’s disease and cutaneous leishmaniasis (Herrer et al., 1975).
Townsend then identified Phlebotomus verrucarum (now known as Lutzomyia
verrucarum), a nocturnal sandfly, as the vector of Oroya fever (Townsend, 1913). B.
bacilliformis also were isolated from the proboscis of the sandfly, which further
confirmed it as the arthropod vector (Hertig, 1942). The source for B. bacilliformis
colonization of Lutzomyia verrucarum remains unknown. So far, no mammalian
reservoirs have been discovered, though a mammalian reservoir cannot be ruled out
because of the phylogenetic relation to Grahamella, which are harbored by small
woodland animals. The primary reservoirs for the zoonotic pathogen B. henselae are
cats. B. henselae causes intraerythrocytic bacteremia in cats; the cat flea Ctenocephalides
felis is responsible for feline-to-feline transmission (Higgins et al., 1996; Kordick et al.,
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1995). Incidental transfer of the bacteria from cats to humans occurs through cat bites
and scratches and indirectly via cat fleas. The arthropod vector for B. quintana
transmission is the human body louse, Pediculus humanus. B. quintana can multiply
within the intestines of the lice and is present in their feces. Fecal transmission into the
skin occurs when a body louse bite induces pruritis and scratching of the host skin
(Raoult et al., 1999). Humans are thought to be the only reservoirs necessary for B.
quintana because infections can lead to prolonged, asymptomatic bacteremia. However,
since the bacteria have been detected in cat teeth, cat fleas, and monkey fleas, additional
reservoirs also have been proposed (Raoult et al., 1994).
Bacteriology
The genus Bartonella consists of small (0.3–0.5μm wide, 1–1.7 μm long), Gram
negative, pleomorphic, aerobic rods. Bartonella, along with Afipia, Agrobacterium, and
Brucella, constitute the alpha-2 subgroup of the class Proteobacteria. Biochemically,
they are catalase and oxidase negative. They also are fastidious and extremely slowgrowing organisms that can be recovered from primary isolates on blood agar only after
12–14 days. Subculture reduces the colony formation time to 3–5 days. B. bacilliformis
has an optimal growth temperature of approximately 26°C, which could explain why the
lesions are localized to bodily extremities, as well as its survival within an insect vector.
The other two widely studied Bartonellae, B. henselae and B. quintana, need 5% CO2 at
37°C to grow optimally. Fresh clinical isolates of B. henselae and B. quintana produce
dry colonies that are deeply embedded in agar. These strains also have increased
autoagglutination properties in suspension, which can be attributed to the presence of
surface, type-IV pili. Higher passaged strains produce smooth mucoid colonies without
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any agar indentations and do not agglutinate in liquid (Batterman et al., 1995). With the
exception of B. bacilliformis and B. clarridgeiae, the species are non-flagellated and nonmotile. B. heneselae and B. quintana have surface pili that represent important virulence
factors. The genome size of B. bacilliformis is relatively small at just 1600kbp, with a
GC content of 39–40% (Brenner et al., 1991). B. henselae and B. quintana genomes are
believed to have originated from Brucella melitensis. The genome of B. henselae has a
slightly larger genome (1.9Mb) than B. quintana. The B. quintana genome appears to
have been derived from that of B. henselae through the deletion of genomic islands
(Alsmark et al., 2004). The complete genomes of B. bacilliformis, B. henselae, and B.
quintana are now available.
Clinical manifestations of Bartonella infections
Oroya Fever and verruga peruana
Oroya fever, the first phase of Carrion’s disease, is characterized by the presence
of B. bacilliformis-infected erythrocytes and develops 3 to 12 weeks after inoculation
from the bite of the sandfly (Strong et al., 1915). Almost 80% of circulating red blood
cells (RBCs) can be parasitized with B. bacilliformis. B. bacilliformis is the only species
in its genus to have hemolytic properties, as a result of which the infected erythrocytes
undergo hemolysis in vivo, leading to severe hemolytic anemia. The fatality rate of
untreated cases is extremely high, and survivors of the acute infection have asymptomatic
persistent bacteremia. Patients recovering from the Oroya phase also suffer decreased
immuno-competency. The two most common infections occurring in such patients are
salmonellosis and toxoplasmosis (Cuadra, 1956; Garcia-Caceres et al., 1991). The
verruga peruana stage sets in within six weeks of an acute infection. During this phase,
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the bacteria show tropism for the vascular endothelial cells. Vasculature infection
provokes endothelial cell hyperplasia and neovascularization, resulting in the formation
of new blood capillaries, a process defined as angiogenesis. The proliferating endothelial
cells, along with inflammatory and growth factors induced by B. bacilliformis, culminate
in pyogenic granulomatous hemangiomas, referred to as verruga peruana. These nodular
lesions are primarily localized on limb extremities and the face and neck, though they can
be found on the mucosal lining and, rarely, internal organs. Histologically, they are very
similar to Kaposi’s sarcoma (KS) lesions associated with infection by human herpes virus
8 (HHV8) (Caceres-Rios et al., 1995). Most newly formed capillaries in the verrugas do
not have lumens, and those that do feature open lumens that allow blood to collect in the
papules. Dendrocytes and neutrohpils are also seen, along with the proliferating
endothelial cells, and bacteria are concentrated in extracellular and interstitial spaces
(Arias-Stella et al., 1986b; Arrese Estrada et al., 1992). Electron micrographs of cells
from the verruga lesions show membrane-bound B. bacilliformis in the process of being
phagocytosed, though intracellular bacteria were rare (Arias-Stella et al., 1986b).
Treatment with oral antibiotics can temporarily resolve the lesions; however, due to the
chronic infection of the host cells, relapse is common. Prolonged antibiotic therapy is
required to eliminate the infection completely.
Trench Fever
Trench fever was prevalent in World War I as a result of poor sanitary conditions
that allowed for the infestation of body lice, the vector for the causative pathogen, B.
quintana. Recently, this infection, which is characterized by recurrent, high-fever
episodes that last 1–3 days, has been reported among homeless people with poor
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unsanitary conditions across the globe. The condition, renamed “urban” trench fever, is
self-limiting and accompanied by pre-tibial pain, dizziness, and chronic bacteremia,
which then lead to bacillary angiomatosis (BA) and endocarditis.
Cat Scratch Disease (CSD)
The most common disease caused by B. henselae in all age groups and people
across the world, CSD is a benign, self-limiting condition transmitted by B. henselaeinfected cat scratches or bites or indirectly by cat fleas. Regional lymphadenopathy
(swollen, enlarged lymph nodes) and suppurative papules at the site of inoculation are
characteristic clinical manifestations of CSD. Symptoms can occur with a couple of
weeks or months and resolve spontaneously. Immunocompromised patients may present
more complications. Antibiotic therapy has been used successfully to treat CSD.
Bacillary angiomatosis and endocarditis
Bacillary angiomatosis and endocarditis are caused by various Bartonella species.
Verruga peruana–like lesions, which are manifestations of B. henselae or B. quintana
infections, are referred to as epitheloid angiomatosis or bacillary angiomatosis. In
appearance, they are blood filled, ulcerated, crusted, subcutaneous, or dermal nodules.
Unlike verruga peruana, BA occurs only in immunocompromised patients, particularly
those infected by human immunodeficiency virus (HIV). The other difference between
verruga lesions and BA is that a variety of internal organs, such as the liver, spleen, brain,
lungs, and bowel, can be affected (Cockerell et al., 1987). Finally, BA differs from
verruga because the bacteria are easily cultured and detected in BA lesions by PCR
amplification of the 16sRNA sequence, histochemical staining, and electron microscopy.
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The condition, in which the internal organs present with cystic lesions due to B. henselae
or B. quintana infection is called bacillary pelosis. The peliotic space is partially lined
with endothelium, which is separated from the parenchymal cells by a mixture of
inflammatory cells and clumps of bacilli (Relman et al., 1991).
The causative Bartonella species for endocarditis include B. henselae, B.
quintana, B. elizabethae, and B. vinsonii subsp berkhoffii and subsp. arupensis. Patients
with preexisting valvulopathies suffer increased risk of endocarditis through transmission
of B. henselae via cats and/or cat fleas. B. quintana-associated endocarditis does not
correlate with any preexisting conditions. The antibodies from people suffering from
Bartonella-induced endocarditis are cross-reactive with Chlamydia spps., often resulting
in the misdiagnosis of the pathogen (Maurin et al., 1997). Aminoglycoside treatment
results in full recovery from Bartonella endocarditis.
Virulent factors involved in adhesion and invasion
All Bartonella spps. can infect erythrocytes in the specific mammalian host and
therefore are spread easily by blood-sucking arthropods. The course of erythrocytic
infection has been described in great detail for B. tribocorum, an organism found in rats
(Schulein et al., 2001). Briefly, a synchronous wave of erythrocyte infection occurs five
days after the initial inoculation with the bacterium. Following invasion, eight rounds of
bacterial replication take place. The number of bacteria remains unchanged for the life
span of the erythrocytes. Because RBC infection is recurrent at five-day intervals, it
ensures the presence of erythrocytic bacteria for efficient vector transmission.
Erythrocytic infection subsides spontaneously, and at no point do the cells undergo
hemolysis. This model is extremely useful for explaining what might occur in B.
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quintana infections but not B. bacilliformis infections, because the latter condition is
marked by severe hemolysis. In vitro, hemolysis is contact dependent, and the hemolysis
factor is protease sensitive (Hendrix, 2000).
Erythrocyte infection by B. bacilliformis
B. bacilliformis infection of erythrocytes depends primarily on the presence of
multiple, unipolar flagella. Non-motile bacteria exhibit decreased binding capacity and
are unable to invade erythrocytes; B. bacilliformis pretreated with anti-flagellin
antibodies also are deficient in erythrocytic invasion (Scherer et al., 1993). The case in
support of the flagella requirement was further strengthened when site-directed
mutatagenesis of the flagellin gene reduced bacterial binding by 75% (Battisti et al.,
1999). The mechanism of flagella-mediated invasion is not well understood, but motility
may enhance B. bacilliformis–erythrocyte interactions, in which case the twirling motion
of the flagella would help the bacteria force their way into the erythrocytes. This idea is
supported by the observation that binding is reduced in the presence of proton motive
force and respiration inhibitors (Benson et al., 1986).
The function of a B. bacilliformis – encoded invasion-associated locus (ial) in
erythrocyte invasion has been demonstrated by cloning the genes into E. coli, where they
confer a marginally invasive phenotype to the recombinant E. coli (Mitchell et al., 1995).
The locus consists of two genes, ialA and ialB. IalA is a nucleoside polyphosphatase
hydrolase of the MutT family is thought to be involved in nucleotide regulation and the
metabolism. The ialB gene product is an 18kDa inner membrane protein (Cartwright et
al., 1999; Coleman et al., 2001). Mutations of ialB were found to decrease B.
bacilliformis binding to erythrocytes by 50% and the function was restored in
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transcomplementation mutants, thus establishing the role for IalB in erythrocyte
infections (Coleman et al., 2001).
B. bacilliformis entry into erythrocytes also can be triggered by bacterialmediated alterations in the cell membrane. Deformin, a bacterial protein found in B.
bacilliformis and B. henselae culture supernatants, is a small, hydrophobic, albuminbound substance (Derrick et al., 2001). Deformin is responsible for producing deep
invaginated pits and trenches in the erythrocyte membrane. Electron micrographs reveal
the presence of B. bacilliformis within these indentations, where they are ultimately
internalized (Derrick et al., 2001). Deformin function is reversible in the presence of the
ATPase inhibitor vanadate, the phospholipid dilauroylphosphatidylcholine, and
ionophores that increase intracellular calcium levels (Xu et al., 1995). The erythrocyte
receptors for B. bacilliformis have been identified using immunoblots and include the
carbohydrate moieties alpha, beta spectrin, and glcyophorins A and B (Buckles et al.,
2000).
Interactions of B. bacilliformis with endothelial cells
Vascular endothelial cells are not only the principal targets for B. bacilliformis,
but also may serve as a bacterial niche during the asymptomatic phase. B. bacilliformis
adhere to and invade endothelial cells, as seen in tissues from verruga lesions and in vitro
using primary cell lines (Arias-Stella et al., 1986b; Hill et al., 1992). Invasion is an
actin-dependent process and occurs over a period of a few hours. The key regulators of
actin restructuring are the small GTPases: Rho, Rac, and Cdc42. The first GTPase to be
activated during B. bacilliformis infection is Cdc42, followed by Rac. Activated Cdc42
and Rac stimulate the formation of filopodia and lamellipodia. Various bacterial
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aggregates are associated with leading membrane protrusions, which surround the
bacteria and finally engulf them through a phagocytic mechanism (Verma et al., 2002b).
Pretreatment of the host cell with Rac or Cdc42 inhibitors markedly reduces B.
bacilliformis invasion. In addition, Rho inhibition hampers bacterial uptake (Verma et
al., 2001). During the course of the infection, internal vesicles with single or clumped
bacilli can be detected with florescent microscopy. The vesicles are colocalized with the
Golgi complex in the perinuclear region, so that the disruption of the Golgi complex
leads to bacterial dispersion throughout the cytoplasm (Verma et al., 2001). Various host
cell kinases, such as protein tyrosine kinases and mitogen-activated protein kinases that
regulate actin organization, also are involved during B. bacilliformis internalization
(Verma et al., 2002b; Williams-Bouyer et al., 1999). The only host receptor identified in
epithelial cells thus far is the fibronectin receptor α5β1 integrin (Williams-Bouyer et al.,
1999). Endothelial cell receptors and bacterial factors required for endothelial
parasitization remain unidentified.
The most striking effect of B. bacilliformis infection of endothelial cells is the
ability of the bacteria to induce proliferation and angiogenesis. The angiogenic effects
appear with live bacteria and bacterial supernatants (Garcia et al., 1990; Garcia, F. U. et
al., 1992). Early studies lead to the suggestion that the angiogenic factor is a protein due
to its heat liability and precipitation with 45% ammonium sulfate (Garcia et al., 1990). A
recent report also proposes the molecular chaperone GroEL as a potential
vasoproliferative candidate (Minnick et al., 2003). The function of GroEL has been
confirmed in studies with purified GroEL from B. bacilliformis culture supernatants and
anti-GroEL antibodies, which inhibit neovascularization (Kohlhorst, D., personal
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communication). The inflammatory infiltrates also could be mitogen sources in vivo,
because B. henselae-infected macrophages release certain angiogenic factors, and the
conditioned medium can trigger endothelial cell proliferation (Resto-Ruiz et al., 2002).
Studies of clinical specimens of verruga peruana show that the primary source of the
vascular endothelial growth factor (VEGF) is the overlying epidermis (Cerimele et al.,
2003). Therefore, multiple sources of both bacterial and host origins may be required for
vasoproliferation and angiogenesis in vivo.
Interactions of B. henselae and B. quintana with endothelial cells
B. henselae and B. quintana can invade nucleated cells, such as endothelial and
epithelial cells, by phagocytosis (Batterman et al., 1995; Brouqui et al., 1996). When
they get inside, these bacteria can multiply within the host cell’s membrane-bound
vesicle. In addition to classical phagocytosis, B. henselae can be internalized through a
unique structure called invasome (Dehio et al., 1997), a slow process that takes 24 hours,
during which the leading lamella of endothelial cells aggregate the surface-bound
bacteria. The bacteria enclosed within the lamella then are engulfed and internalized in
an actin-dependent and microtubule-independent process (Dehio et al., 1997). The
bacterial factors facilitating infection by B. henselae and B. quintana are better defined
than those of B. bacilliformis. Both these bacteria possess type-IV pili, which confer a
twitching motility and self-aggregation properties (Batterman et al., 1995). Pili also play
an important role in host cell adhesion, a crucial step that precedes invasion. Bacteria
that have been passaged many times have decreased or no pili, and thus are unable to
attach to or invade host cells (Batterman et al., 1995). Pili structures mediate host cell
attachment. In addition, B. henselae pili are associated with VEGF production, which
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leads to host cell proliferation (Kempf et al., 2001). An outer membrane afimbrial
protein encoded by B. henselae, Bartonella adhesion A (BadA) represents another
bacterial factor with multiple functions. Only B. henselae strains that express BadA can
adhere to endothelial cells and fibronectin, an extracellular matrix protein (Riess et al.,
2007). The expression of BadA undergoes phase variation and, like the pili, can be lost
as a result of extensive passaging. Because BadA binds fibronectin, the putative host cell
receptors are predicted to be integrins. Indeed, B. henselae binds with decreased avidity
to cells that do not express the β1 integrin (Riess et al., 2004). The immunodominant
BadA also has a critical function in the activation of hypoxia-inducible factor 1 (HIF-1)
and pro-angiogenic cytokines such as VEGF in host cells (Riess et al., 2004). A few
other outer membrane proteins (OMP), ranging from 23kDa to 58 kDa, also interact with
endothelial cells, though the 43kDa protein provides the major adhesin (Burgess et al.,
1998). B. quintana also has outer membrane proteins that are homologous to BadA.
These variably expressed outer membrane proteins (Vomp) are immunodominant and
undergo phase variation in vivo. The four genes belonging to Vomp family are absent
from strains isolated from animal models and patients who have undergone prolonged
bacteremia (Zhang et al., 2004). The Vomp A and C proteins are involved in
autoaggregation and, when expressed in E. coli, are able to confer a collagen-binding
phenotype (Zhang et al., 2004). Their exact role in adhesion and invasion is unclear,
because B. quintana expressing Vomp A, B and C do not demonstrate increased
adhesion; however, these proteins are critical for VEGF expression in host cells (Schulte
et al., 2006).
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The type-IV secretion systems (T4SS) are transport machineries in Gram-negative
bacteria that are related to bacterial conjugation systems. Bacterial conjugation systems
originally functioned in DNA transfer among different bacteria, and virulent pathogens
have adopted T4SS to transfer DNA and virulence factors into host cells (Cascales et al.,
2003). A T4SS called virB/virD4 in Bartonella spps. was first identified in an analysis of
the locus of the 17kDa protein, a highly antigenic protein of B. henselae (Padmalyam et
al., 2000). Since then, virB/virD4 has been identified in other Bartonella spps. that cause
human diseases (Kohlhorst, personal communicaton) and may be acquired through a
process of lateral gene transfer (Saenz et al., 2007). The operon consists of 10 genes,
virB2-10, and virD4, located downstream of the operon. With the exception of virB5,
which encodes the 17kDa antigen, and virB7, all genes are homologous with the T4SS
loci of other bacteria. Because the virB5 product is immunodominant, it may be a
component of the pili and may function as an adhesin. B. tribocorum harboring
mutations in the virB4 and virD4 genes cannot infect erythrocytes in experimental rat
models. Moreover, virB4/virD4 is required even before intraerythrocytic infection, and is
thus necessary to establish the infection in the primary niche, probably the endothelial
cells (Schulein et al., 2002). The B. henselae virB operon is induced during infection of
endothelial cells in vitro (Schmiederer et al., 2001). The induced operon then is
responsible for mediating the transfer of seven substrates BepA-G (Bartonellatranslocated effector proteins), of which BepA has been characterized as having antiapoptotic properties (Schmid et al., 2006; Schulein et al., 2005). The B. henselae
virB/D4 locus mediates the physiological changes seen in infected endothelial cells
(Schmid et al., 2004). The virB4 mutants cannot induce invasome-mediated
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internalization, NF-κB–dependent pro-inflammatory response, or the anti-apoptotic
pathway. Moreover, the cytostatic and cytotoxic effects seen at high bacterial titres are
mediated by the virB system (Schmid et al., 2004). The virB system of B. quintana has
not been characterized, though it resembles B. henselae in genetic makeup and
pathogenesis, so the gene products may have similar functions. Interestingly, virB/D4 is
not present in B. bacilliformis, so the mechanism of host cell alterations mediated by B.
bacilliformis must differ significantly from that of B. henselae (Saenz et al., 2007).
The Bartonella-induced vasoproliferation of vascular cells in vivo and in vitro
depends on mitogen factors and enhanced cell survival. B. henselae and B. quintana each
inhibit apoptosis by different mechanisms (Kirby et al., 2002a; Liberto et al., 2004). As
mentioned previously, the virB system is critical for host cell survival, and the virB
effector protein BepA suppresses apoptosis (Schmid et al., 2004; Schulein et al., 2005).
No other proteins that affect cell survival have been identified in other Bartonella spps.
Bartonella spps. also have a mitogenic effect on infected endothelial cells. Thus far, the
only bacterial protein identified with mitogenic potential is GroEL in B. bacilliformis
(Kohlhorst, D., personal communication; Minnick et al., 2003).
The vasoproliferative skin eruptions that occur during Bartonella infections are
indicative of a chronic inflammation, characterized by the presence of mixed infiltrates of
monocytes, macrophages, leukocytes, and polymorphoneutrophils (PMN). The acute
inflammatory response that leads to chronic inflammation has been studied in B.
henselae-infected endothelial cells. This inflammation is mediated by the activation and
nuclear translocation of NF-κB (Fuhrmann et al., 2001). The infected cells cells have
increased and prolonged expression of the adhesion receptors E-selectin and the
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intercellular cell adhesion molecule 1 (ICAM1), which results in increased PMN rolling
on and attachment to the infected endothelial cultures (Fuhrmann et al., 2001). B.
henselae also interacts with activated macrophages to produce pro-angiogenic cytokines,
such as VEGF and interleukin-1beta (IL-1β), that are present in chronically inflamed
tissues attempting to heal (Resto-Ruiz et al., 2002). High levels of pro-inflammatory
cytokine productions of tumor necrosis factor alpha (TNF-α), IL-1 β, and interleukin 6
(IL-6) in B. henselae infected murine macrophage cell lines have been recorded (Musso
et al., 2001). Thus, the macrophages recruited at the site of infected endothelium in vivo
could serve as a major source of inflammatory cytokines and be involved in the
development of chronic inflammation.
Concluding remarks
Recent advances in molecular tools have helped scientists improve their
understanding of some of the complicated interactions between Bartonella and its host
cells. Endothelial cells are colonized by all Bartonella spps., and in humans these cells
undergo pathological angiogenesis and have a pro-inflammatory phenotype during the
later stages of infection. However, many experiments suggest a role for endothelial cells
as the primary niche in the host reservoir. Although endothelium is a major target for the
Bartonella-induced pathogenic response, nothing has been reported about the cell surface
receptors involved in Bartonella adhesion and invasion. These bacterial receptors could
be involved in not only invasion but also the mitogenic and angiogenic stimulation of
infected cells. This study therefore attempts to elucidate the endothelial cell surface
receptors and cell signaling molecules involved in B. bacilliformis infections. Microarray
profiling of the genes from B. bacilliformis-infected endothelial cells provides a means to
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understand some of the pathways recruited during the infection. These studies improve
our understanding of host cell responses during infections elicited by these fascinating
pathogens.
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Chapter I: Role of Integrins in B. bacilliformis infection of endothelial cells
Introduction
An established infectious disease occurs when a pathogen colonizes and
multiplies within specific host tissue. Adherence of the pathogen to the cell surface and
its subsequent internalization is a prerequisite for colonization. B. bacilliformis, a
bacterium that grows intracellularly, specifically targets erythrocytes in the first phase of
infection and then endothelial cells in the second phase (Minnick et al., 1996). The semipermeable cellular barrier at the blood–tissue interphase consists of endothelial cells.
Due to its location, the multifunctional endothelium provides an easy target for bloodborne pathogens and pathogen products. In addition to Bartonella spps, Rickettsiae
specifically target endothelial cells for infections (Valbuena et al., 2002). Endothelium
infection benefits the pathogen because it allows for an easy transition from the blood
stream to the internal tissues. From there, the infection can follow several pathways.
Some organisms use cell surface receptors and preexisting cell-signaling pathways for
adhesion and invasion. Alterations in membrane integrity, the endothelial matrix, and
intracellular junctions represent alternatives ways in which bacteria can infect endothelial
cells. In the following sections, we discuss the role of endothelial integrins and their
extracellular matrix ligands in B. bacilliformis infection. Integrins are expressed by
endothelial cells both in vivo and in vitro. Various bacteria initiate endothelial cell
infection by attachment to integrins; direct interaction involves bacterial adhesins
expressed on their surface, whereas indirect integrin contacts are established via integrin
ligands.
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Integrins involved in bacterial pathogenesis
Integrins are cell-surface receptors that link intracellular and extracellular
environments. A family of glycosylated, heterodimeric receptors, integrins are formed by
the non-covalent association of α and β subunits. Integrins play an important role in
maintaining cell shape, migration, growth, survival, and differentiation; in addition, they
are highly conserved from sponges to humans, in which there are 19 α and 8 β subunits
(Burke, 1999; Hynes et al., 2000). The combination of these subunits gives rise to 25
different receptors, in which the α–β pairing determines ligand specificity (Hynes, 2002).
mRNA splice variants and post-translational modifications diversify the integrin
repertoire. The globular head domains formed by α and β subunits constitute the ligand
binding site and are attached to the cell membrane through a single transmembrane helix.
The small cytoplasmic integrin tail consists of only 30–50 amino acids. Integrin–ligand
binding represents a promiscuous event, because different integrins interact with the same
ligands, and different ligands recognize the same integrin. The majority of the integrin
ligands belong to the extracellular matrix (ECM) protein group. Integrins can also
associate with other integrins, cell receptors, plasma proteins, and complement factors
(van der Flier et al., 2001). Ligand affinity depends on the cell types expressing the
integrin. Divalent cations also play critical roles in integrin–ligand interactions, as
indicated by the observation that integrins cannot bind molecules in the presence of metal
chelators (Gailit et al., 1988). The α chains present three cation-binding sites, of which
one is permanently occupied with either calcium or magnesium at their physiological
concentrations, and the other two are occupied upon ligand binding. In its inactive form,
the α subunit inhibits the interaction of β integrin with cytoskeletal proteins. Integrin
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engagement by ligands induces a conformational change that dissociates the α–β
subunits, activates the integrins, and initiates intracellular signaling (Hughes et al., 1996;
Vinogradova et al., 2000). Integrin activation triggers clustering, which in turn leads to
greater affinity for their ligands. The integrins cluster at cell attachment sites, called
focal adhesion or focal contacts, where bidirectional signaling occurs. Focal contacts
consist of integrins, cytoskeletal components, and signaling molecules. Integrins lack
intrinsic enzyme activity and rely on adaptor kinases for signal transduction. Activated
integrins recruit protein tyrosine kinases (PTKs), focal adhesion kinase (FAK), and small
GTPases (Rho, Rac and Cdc42), with the small GTPases being the key factors for
outside–inside–outside signaling.
Several bacteria and viruses exploit integrins and integrin-modulated signaling for
adhesion and invasion. The efficiency of pathogen invasion depends on the integrin
density and affinity for the bacterial binding site. The most common pathogen receptors
are the fibronectin and vitronectin integrins (α5β1 and αVβ3, respectively). Infectious
agents either express integrin-binding proteins that stimulate direct integrin binding or
synthesize ECM protein-binding molecules that allow pathogens to access integrins. For
example, Yersinia species express an invasion protein that engages up to five different
integrins with the β1 subunit (Hamzaoui et al., 2004). Shigella species directly interact
with α5β1 through invasion plasmid antigens (Ipas) (Watarai, M. et al., 1996).
Enteropathogenic E. coli, Borrelia burgdorferi and Bordetella spps provide other
examples of bacterial-expressing integrin-binding proteins (Coburn et al., 2003b; Coburn
et al., 2003a; Coburn et al., 2003c; Frankel et al., 1996; Ishibashi et al., 2001).
Bartonella spps can mediate host cell entry via integrins; in particular, Bartonella adhesin

33
A (BadA) is a trimeric autotransporter that plays a critical role in endothelial cell
adhesion (Riess et al., 2004). BadA is homologous to other adhesins of Yersinia (YadA)
and Neisseria (NadA) and, like YadA is thought to interact with β1. B. henselae
experiences reduced binding to fibroblasts lacking β1 integrins, suggesting that BadA
binds to β1 (Riess et al., 2004). In addition, B. bacilliformis invasion is reduced when
epithelial β1 and α5 antibodies are used (Williams-Bouyer et al., 1999). However, the
endothelial receptors for B. bacilliformis adherence and invasion are unknown. This
study therefore attempts to determine the cell surface molecules involved in B.
bacilliformis pathogenesis. Functional blocking antibodies against integrins provide a
means to study the hypothesis that B. bacilliformis internalization is an integrin-mediated
event.
Extracellular matrix proteins involved in bacterial pathogenesis
Integrins rest at the heart of numerous biological processes and function by
coupling ECM proteins to the interior milieu of the cell. Cell adherence to the substrate
is vital for multicellular organisms’ survival. Integrins provide the primary receptors that
not only attach the cell to ECM but also modulate the cell functions by sensing
environmental signals. As a scaffold of proteins that provides a stable base for cell
growth, ECM includes the basal membrane and interstitial matrix and is composed of
proteoglycans, collagen, elastin, and glycoproteins. The glycoproteins include
fibronectin, vitronectin, thrombospondin, tenascin, and laminin. These proteins are
secreted by the cells and organize themselves into a fibrous mesh within the preexisting
matrix. In addition to providing a platform for cell attachment, ECM is rich in growth
factors that mediate cellular functions. The protein-rich environment of ECM also serves
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as a safe haven for bacterial colonization and multiplication. In this report, we
concentrate on the two most widely used ECM proteins in bacterial infections, namely,
fibronectin and vitronectin.
Fibronectin
Fibronectin is a high molecular weight glycoprotein found in the plasma (soluble
form); the insoluble form in ECM is associated with fibrils. Fibronectin consists of two,
disulfide-linked polypeptide chains with three internal repeats. Splice variants from a
single gene generate various fibronectin isoforms. The most notable function of
fibronectin involves embryonic cell migration in the neural crest. It also has a therapeutic
role in wound healing and appears in large concentrations associated with fibrin.
Moreover, fibronectin maintains cell shape through integrin-mediated microfilament and
actin organization. At least six integrins recognize fibronectin, of which α5β1 is the most
significant and well characterized (Johansson et al., 1997). Although fibronectin can be
found in glycosylated, phosphorylated, or sulfated form, only the degree of
phosphorylation modulates its binding properties. Six peptide sites mediate cell
adhesion; of which the most significant is the tripeptide motif arginine-glycine-aspartate
(RGD). Secondary sequences work in synergy with the RGD motif, especially for
binding to α5β1. Two heparin-binding domains appear at the C-terminal and N-terminal
ends of the fibronectin molecule. The C-terminal domain binds to heparin with stronger
affinity, whereas the N-terminal domain can bind to fibrin, which allows cell migration in
fibrin clots during wound healing. Also, fibronectin has a collagen-binding domain that
is evolutionary conserved, suggesting that it could have an important biological function.
Fibronectin molecules undergo a two-step polymerization process to form fibronectin
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fibrils in ECM environment. The key integrin in fibrillogenesis is α5β1, and antibodies
against the α5β1 receptor binding domain curtail matrix assembly. Intracellular bacteria
often colonize the extracellular space, where they utilize ECM proteins to their advantage
to gain entry into the host cells. Bacterial surface proteins that interact with ECM
molecules bind to integrins via these proteins. The mostly commonly recognized ECM
component is fibronectin, and the function of fibronectin in Staphylococcus aureus and
Streptococcus pyogenes pathogenesis has been well established. The fibronectin binding
protein (Fnbp) A and B proteins of S. aureus indirectly link the cocci to α5β1 integrin,
which promotes bacterial uptake (Jonsson et al., 1991a). In addition, the fibronectinmediated attachment of S. aureus alters the integrin-dependent signal cascade, which
triggers cytoskeletal rearrangement and leads to its internalization. Streptococcus spps
can adhere to α5β1 directly via the M-protein or indirectly through a high-affinity
fibronectin binding protein (Cue et al., 2000). The Gram negative Neisseria meningitidis
expresses an outer membrane fibronectin binding protein called Opc that mediates
endothelial cell attachment (Unkmeir et al., 2002). Experiments with anti-integrin and
anti-ECM protein antibodies have demonstrated the role of α5β1 and fibronectin during
Pseudomonas aeruginosa invasion of respiratory cells (Leroy-Dudal et al., 2004; Yilmaz
et al., 2002). Another Gram negative bacterium Campylobacter jejuni expresses CadF,
an OMP that binds fibronectin and induces alterations in actin filaments (Moser et al.,
1997). B. henselae strains that express BadA can bind fibronectin. BadA expression is
phase variant, and the loss of BadA results in the loss of host cell attachment and
fibronectin interaction (Riess et al., 2006). The addition of anti-fibronectin, anti-B.
henselae antibodies, and exogenous fibronectin during B. henselae infection of
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endothelial cells decreases the effectiveness of bacterial pathogenesis (Dabo et al., 2006).
This research also identified Pap31, Omp43, and Omp89 as the three major surface
proteins that bind fibronectin; however, the role of fibronectin in B. bacilliformis
infection of endothelial cells remains undetermined. We performed binding assays with
immobilized and soluble fibronectin; in addition, we performed invasion assays with
fibronectin-coated B. bacilliformis and anti-fibronectin antibodies to examine the
function of fibronectin.
Vitronectin
Vitronectin is a multifunctional glycoprotein abundantly found in the blood and
ECM. It is not as well characterized as fibronectin but has similar functions in cell
adhesion. It represents a major component of platelets and plays an important role in
hemostasis in that it prevents cells from cytolytic destruction by complement and protects
thrombin inactivation by anti-thrombinIII. In its fibrillar form, vitronectin is often colocalized with fibronectin. The three known vitronectin integrins are αVβ3, αIIbβ3, and
αvβ5, all of which bind vitronectin through the RGD motif. In vitro, the cell adhesive
activity of serum is due to vitronectin; at low serum concentrations, fibronectin becomes
functional. A few of the previously mentioned bacteria can capture both fibronectin and
vitronectin and use them to their advantage. The phase-variable, opacity-associated
proteins (Opa) of Neisseria spps interact with vitronectin, facilitating its αVβ3 and αVβ5
mediated uptake of the bacteria (Dehio et al., 1998). Vitronectin forms a bridge
connecting P. aeruginosa to αVβ5 integrins, contributing to bacterial invasion of alveolar
cells (Leroy-Dudal et al., 2004). Little information is available about the interaction of
vitronectin with Bartonella spps. Although it has been reported that B. henselae binds
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vitronectin only in the presence of glycosaminoglycans, little is known about how the
ligand affects invasion (Dabo et al., 2006). We used vitronectin-binding studies,
vitronectin-opsonised B. bacilliformis, and anti-vitronectin antibodies to elucidate the
role of this ECM protein in B. bacilliformis pathogenesis.
Bacterial cell adhesion molecules that engage integrins
Several pathogens express surface proteins that recognize host receptors and help
translocation into non-phagocytic cells. These proteins are termed adhesins, and their
interaction with the receptors initiates a signal cascade involving tyrosine kinases,
adaptor proteins, and cytoskeletal molecules. The activation of these proteins leads to the
formation of phagocytic cups, which engulf the surface-bound pathogen. Almost all
bacterial adhesins that interact with integrins have the tripeptide RGD, the same motif
used by the integrin ligands fibronectin and vitronectin. Many of the pathogen molecules
with RGD are secreted by the type IV secretory pathway. The Gram negative bacteria
belonging to Bordetella spps cause respiratory infection and have several proteins that
adhere to and invade host cells via RGD attachment to integrins. The fimbrial surface
proteins of B. pertussis filamentous hemagglutinin (FHA) show decreased adhesion and
invasion when their RGD motif is mutated (Ishibashi et al., 2001). These mutants also
have decreased ICAM1 expression capabilities (Ishibashi et al., 2002). Site-directed
mutagenesis of the RGD motif in P 69/ pertactin-secreted toxin prevents the efficient
invasion of B. pertussis into mammalian cells (Everest et al., 1996). A variant of the
mature form of Streptococcal pyrogenic exotoxin (mSpeB2) that is crucial for invasive
disease also contains RGD. Exotoxin mSpeB mediates binding to vitronectin integrin
αVβ3 on endothelial cells and αIIbβ3 on platelets (Stockbauer et al., 1999). The RGD
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motifs in Serratia marcescens protein Ssp and E. coli antigen 43 also associate with
integrins on their host cells (Ohnishi et al., 1997; Owen et al., 1996). However, B.
bacilliformis adhesins that participate in host cell invasion remain unknown. A highly
antigenic protein, novel lipoprotein D (NlpDBb) has been identified as a potential outer
membrane protein that contains the RGD motif in the C-terminal domain (Padmalayam et
al., 2000b). In our studies, we used E. coli expressing NlpDBb and NlpDBb, containing a
site-directed mutation in the RGD motif, to determine the role of this tripeptide in B.
bacilliformis pathogenesis.
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Materials and Methods
HMEC-1 cell line growth and culturing.
The immortalized human microvascular endothelial cell line (HMEC-1) was a
kind gift from Dr. Ades of the Centers for Disease Control (CDC), Atlanta (Ades EW et
al., 1992). The HMEC-1 cells from passages 19-27 were grown in 15ml of growth media
consisting of 50% M199 (Cambrex), 15% FBS (Fetal Bovine SerumHyclone), 2%
Penicillin/Streptomycin (Cellgro), and 50% EGM-2 (Cambrex). Cells were grown and
maintained in T-75 flasks (Starstedt) at 37°C under 5% CO2 and humid conditions. This
medium was changed every 2–3 days until 70–80% confluence was reached. The cells
were maintained in 10ml of maintenance media (M199 +15%FBS+2% PenicillinStreptomycin) between passages. For cell detachment, confluent cells were washed twice
with PBS (Phosphate Buffered Saline pH 7.4) to remove all traces of serum before the
addition of 10ml/ 752mm Cell stripper (Cellgro). Cells were incubated at 37°C for 10
minutes and then gently scraped with cell scrapers (Starstedt). Detached cells were
collected in 15-ml Falcon tubes and centrifuged at 700xg for 10 minutes at 25°C. Cells
were resuspended in 1ml of maintenance media and enumerated microscopically using
the hemocytometer before seeding the T-25, T-75, or T-150 flasks or 6- or 24- well
plates. Cells were allowed to adhere for 1six hours before use.
To prepare frozen stocks, cell pellets were resuspended in DMSO (dimethyl sulfoxide)
freeze medium (Cellgro) to obtain a final concentration of 1x105 cells/ml. The vials were
allowed to freeze at -80°C in a cryofreezing container (Nalgene) for 24 hours and then
transferred to a liquid N2 tank facility.
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Bacterial growth and culturing.
B. bacilliformis KC584 was obtained from ATCC (35686) and grown on brain
heart infusion (BHI) plates supplemented with 10% sheep blood (BD Bioscience) at 26°C
for 4–7 days. Low-passaged bacteria (1–3 passages) were used for all experiments.
After the confluent colonies became visible, plates were overlaid with 7ml of PBS. The
bacteria were gently scraped off the plate with a loop. Bacterial suspension was
centrifuged at 2000xg for 10 minutes at 25°C. Pellets were washed once with PBS and
centrifuged as previously described. The final suspension was in 1ml BHI broth, unless
otherwise noted.
The E. coli HMS174 strain was a kind gift from Dr. Parjit Kaur. E. coli HMS174
was grown on Luria Bertani (LB) plates at 37°C for 16–20 hours. E. coli strains
containing the pET20b (+) plasmid were grown on LB plates or LB broth supplemented
with 100µg/ml ampicillin at 37°C for 16–20 hours.
Radiolabeling B. bacilliformis with 35S-methionine.
In the method adapted from Williams-Bouyer et al (Williams-Bouyer et al.,
1999), B. bacilliformis was harvested and pelleted as described previously. The bacterial
pellet was resuspended in 1ml methionine free RPMI (Cellgro) containing 2% FBS and
0.2% sheep erythrocyte lysate.
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S-labeled methionine (Perkin-Elmer) was added to a

final concentration of 50µCi/ml. B. bacilliformis was allowed to incorporate the
radioactivity for one hour at 26°C, after which the bacteria were washed twice with PBS
to remove unbound radioactivity. B. bacilliformis was resuspended in 1ml PBS
containing 10mM glucose. The number of bacteria was determined microscopically
using a hemocytometer.
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Antibodies.
The functional blocking, anti-integrin antibodies used were polyclonal anti-α5β1,
monoclonal anti- αVβ3, and monoclonal anti- β4, purchased from Chemicon International.
Anti-β1 monoclonal antibodies came from Labvision Corp. The monoclonal anti-human
fibronectin (clone IST-3) antibody was purchased from Sigma, and the polyclonal antihuman fibronectin antibodies were from Biomeda. Monoclonal and polyclonal antihuman vitronectin (Clone BE10) antibodies were supplied by ICN Biomedicals and
Chemicon, respectively. Polyclonal and monoclonal antibodies against green fluorescent
protein (GFP) (Invitrogen) served as controls. All antibodies used were at a 5µg/ml
(final) concentration in M199 media containing 1%BSA (Bovine Serum Albumin).
Generation of anti-B. bacilliformis antibodies.
B. bacilliformis were harvested from two plates and washed thoroughly in PBS, as
described previously. The final suspension was in 1ml of PBS. Washed bacteria were
killed by the addition of 10% formalin (final concentration 0.1%) at 25°C for four hours.
Killed bacteria were centrifuged at 1000xg for five minutes and washed six times with
1ml of PBS. After removing all traces of formalin, the bacteria were resuspended in 1ml
PBS and emulsified with an equal volume of complete Freund’s adjuvant. An aliquot of
0.1ml of the emulsified antigen was injected subcutaneously into two female New
Zealand rabbits. The rabbits were injected at 10 sites along the spine. A second booster
shot of bacterial emulsification in an incomplete Freund’s adjuvant was given after 15
days. Serum was collected every three weeks for three months. The IgG fraction was
concentrated and purified by SACRI antibody services at the University of Calgary,
Canada. The optimal antibody titers were determined using standard ELISA.
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Extracellular matrix proteins.
Human plasma fibronectin and vitronectin were from Chemicon. BSA fraction V
and fetuin were purchased from Sigma.
Invasion assays with anti-integrin antibodies.
HMEC-1 cells were seeded in 24 well plates containing maintenance media at a
concentration of 1x106 cells/ml. HMEC-1 cells were grown to 80% confluency, after
which they were washed twice with PBS before adding media. M199 plus 1%BSA (500
µl) with 5µg/ml antibodies was added to the experimental wells an hour before bacterial
infections. Control wells received media with GFP antibodies (5µg/ml) or media without
antibodies. HMEC-1 cells were infected with radiolabeled bacteria at a m.o.i of 1:100.
Infection was allowed to proceed for six hours at 37°C in a 5% CO2 incubator. The steps
to recover intracellular bacteria involved extensive washing of the wells (6X) with PBS
to remove any unbound bacteria. Cells were then treated with 500µl of 0.08% trypsinEDTA for 10–15 minutes at 37°C. This mild trypsin treatment gently detached the cells
and cleaved externally bound bacteria. Trypsinization was arrested by the addition of
500µl of maintenance media. The well contents were transferred to microfuge tubes and
centrifuged at 1000xg for 10 minutes at room temperature to pellet the eukaryotic cells.
The supernatant was removed, and the pellet was resuspended in 500µl of 1% TritonX100. Cells were lysed by vortexing briefly and were then mixed with 5ml of liquid
scintillation fluid (Optima GoldXR, Perkin-Elmer). The volume of bacteria used to infect
the cells was added to the scintillation fluid to determine the amount of radioactivity
added. Radioactivity (DPM: disintegrations per minute) was measured with a LS2500
scintillation counter (Beckman Coulter). Percent invasion was calculated as follows:
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(DPM recovered/DPM added)×100. The percent invasion results of the control
experiments were normalized to 100, and the invasion experimental values were
calculated in relation to the normalized control. Percent inhibition was calculated as
normalized percent invasion – 100.
Invasion assays with ECM opsonised B. bacilliformis and anti-ECM antibodies.
B. bacilliformis was harvested and washed by the method described previously.
B. bacilliformis was resuspended in 2.5ml methionine-free RPMI without serum or blood
lysate with 50µCi/ml of 35S methionine (final concentration), and 500µl was aliquoted
into fresh microfuge tubes. Fibronectin at final concentrations of 5, 10, 25, 50, 100, and
200µg/ml or vitronectin at 0.5, 2.5, 7.5, and 10µg/ml was added to each tube. The tubes
were incubated at 26°C for one hour. The unbound radioactivity and protein were
removed by washing the bacteria three times with PBS. The bacteria were resuspended
in 500µl of PBS containing 10mM glucose. Bacterial enumeration was done using a
hemocytometer, and HMEC-1 cells were infected at 1:100 m.o.i for six hours.
Intracellular B. bacilliformis was recovered and percent invasion was determined as
explained previously. Invasion assays were also carried out with 35S-methionine labeled
B. bacilliformis in the presence of 5µg/ml (final concentration) of polyclonal and
monoclonal anti-fibronectin and vitronectin antibodies.
Invasion assays in the presence of human serum.
Pooled human serum was a kind gift from Dr. Yuang Liu. Serum was heated for
30 minutes in a 50°C water bath to inactivate serum complement proteins. The serum
was triple filtered through a 0.22μm syringe filter. Filtered serum was diluted in M199
media to achieve final concentrations of 1%, 2.5%, 5%, 7.5%, and 10%. Semi-confluent
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HMEC-1 cells in 24 wells were infected with 35S-methionine labeled B. bacilliformis in
the presence of different human serum concentrations. Percent invasion was calculated
as described in the previous sections.
Adhesion assays.
Infection assays were performed with 35S-methionine labeled B. bacilliformis, as
described. After treating the cells with 0.08% trypsin-EDTA, the reaction was terminated
by the addition of maintenance media. The cells were spun down at 1000xg to settle host
cells with intracellular bacteria. Supernatant containing the externally bound bacteria
was collected in clean microfuge tubes. Bacteria from the supernatant were pelleted at
2000xg for 10 minutes. The bacteria were resuspended in 500µl of 1% TritionX-100 and
mixed with liquid scintillation fluid. Radioactivity was measured with a LS2500
scintillation counter. Percent adhesion was calculated as follows: (DPM recovered/DPM
added)×100. The percent adhesion results of control experiments again were normalized
to 100, and the adhesion experimental values were calculated in relation to the
normalized control. Percent inhibition thus was calculated as normalized percent
adhesion – 100.
Infection of HMEC-1 cells with B. bacilliformis for RT-PCR studies.
HMEC-1 cells were grown in T150 flasks containing 30ml of growth media,
incubated at 37°C, 5% CO2, under conditions of saturated humidity. The HMEC-1 cells
were allowed to reach 90% confluence, after which the media were replaced with 30ml of
M199 containing 5% FBS, and the cells were incubated for 24 hours. Cells from a single
flask were counted to give an approximation of the growth in the remaining flasks. B.
bacilliformis, at a m.o.i. of 100:1 in 100µl of PBS, was added to each experimental flask,
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and 100µl of sterile PBS, pH 7.4, was added to each control flask. The media were
aspirated at 30 minutes, one hour, three hours, and six hours post infection, and the flasks
were washed three times to remove detached cells and unbound bacteria. The cells were
detached from the flasks, as described previously, and centrifuged at 700xg for 10
minutes at 25°C. The cells were immediately processed for total RNA.
Preparation of HMEC-1 total RNA.
Total RNA from HMEC-1 cells was extracted using the Qiagen RNeasy column
(Qiagen). Briefly, the harvested HMEC-1 cells were resuspended gently in 600µl of lysis
buffer with β-mercaptoethanol. The lysate was pipetted into a QIAShredder spin column
(Qiagen) for homogenization and centrifuged at 14,000xg for two minutes. The spin
columns were washed with 700µl of 70% ethanol and mixed well with a pipette. Next,
700µl of the lysate-ethanol mixture was added, and the column was centrifuged at
14,000xg for 24 seconds, after which the flow-through was discarded. Into the spin
column, 700µl of wash buffer was added, and the spin column was again centrifuged at
14,000xg for 24 seconds. This flow through also was discarded. The bound RNA was
then washed twice with 500µl of wash buffer. The first wash required centrifugation at
14,000xg for 24 seconds, and the second needed two minutes. The RNA was eluted with
30µl of RNase-free water into a fresh 1.5ml of RNase-free microcentrifuge tube (USA
Scientific). To increase the elution efficiency, the tubes were incubated at room
temperature for five minutes, and then centrifuged at 14,000xg for one minute. The
elutate was pipetted back into the spin column and allowed to incubate for 30 minutes at
room temperature, after which the tubes were centrifuged again at 14,000xg for one
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minute. The RNA concentrations were determined by BioPhotometer (Eppendorf), and
the total HMEC-1 RNA was stored at -80°C until needed.
Real-time RT-PCR.
cDNA was synthesized from 500ng of cellular RNA using the High-Capacity
cDNA reverse transcription kit (Applied Biosystems). The reverse transcriptase (RT)
Master Mix (2X) was prepared with 2µl of 10XRT buffer, 0.8µl, 25XdNTP mix
(100mM), 2µl of 10X RT random primers, 1ul of MultiScribe TM reverse transcriptase,
1µl RNase inhibitor, and 3.2µl of nuclease-free DEPC-treated water (Ambion). The
Master Mix was kept on ice after gentle mixing. Individual reactions for cellular RNA
from each time point were prepared by mixing 10µl of RNA with 10µl of 2X Master
Mix. The reverse transcription was performed in an Eppendorf thermal cycler under the
following conditions: 25°C for 10 minutes, 37°C for 120 minutes, and 85°C for five
seconds. cDNA was stored at -20°C until further use. Real-time quantitative PCR (rtqPCR) was performed with the synthesized cDNA using the TaqMan Universal PCR
Master Mix (Applied Biosystems) protocol. Briefly, 1 µl of cDNA was diluted with 8µl
of DEPC-treated water, followed by the addition of 10µl of Master Mix and 1µl of the
assay primer (TaqMan Gene Expression Assay, Applied Biosystem). The catalog
numbers of the assay primer used for the genes (in parenthesis) were Hs002337443_m1
(integrin α5), Hs00236976_m1 (integrin β1), Hs00233808_m1 (integrin αv), and
Hs01001469_m1 (integrin β3). The RNA was quantified in an Applied Biosystem 7500
using the following cycling settings: 48°C for 30 minutes, AmpliTaq activation at 95°C
for 10 minutes, denaturation at 95°C for 15 seconds, and, finally, annealing/extension at
60°C for 1 minute (40 cycles). Cyclophin A (PPIA, Hs99999904_m1) was used as the
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endogenous control. All reactions were performed in triplicate, and the comparative
threshold values (ΔΔCT) were calculated in Microsoft Excel. All threshold values (CT)
were first normalized to the endogenous reference (PPIA). ΔΔCT was calculated by
subtracting the control (uninfected) CT from the experimental (infected) CT. Relative
quantification (RQ) for mRNA for each sample was determined by 2(-ΔΔCT). The p-value
was then calculated using Student’s t-test for unequal variances; a value of ≤0.1 was
considered significant.
B. bacilliformis binding to immobilized ECM.
Fibronectin, vitronectin, and fetuin were diluted in bicarbonate coating buffer
(1.59g Na2CO3, 2.93g NaHCO3, and 1000ml distilled H2O, pH 9.6) to give a final
concentration of 5µg/ml. Then, 100µl was added to EIA/RIA plates (Corning), and the
plates were incubated at 4°C for 16 hours. The wells were washed three times with 200µl
of PBST (phosphate-buffered saline with 1% Tween), then blocked with PBST
containing 5%BSA for two hours at 37°C. The wells were washed three times with
PBST to remove blocking buffer. B. bacilliformis was diluted to 2x106 -1x107 CFU/ml in
blocking buffer, and 100µl was added to the wells and incubated for three hours at 37°C.
The wells were washed, and anti-B. bacilliformis antibodies (diluted 1:1000) were added
for one hour at 37°C. Unbound antibodies were removed with PBST washes, and 100µl
of secondary alkaline phosphatase (AP)-conjugated anti-rabbit antibodies (diluted
1:5000) were added for one hour at 37°C. Excess, unbound secondary antibody was
washed out with PBST. Alkaline phosphatase substrate p-NPP (p-Nitrophenyl
Phosphate) tablet (5mg) (KPL) was dissolved in 10ml of diethanolamine buffer (48.5ml
dithanolamine, 500ml distilled H2O, pH9.8, 0.5mM MgCl2), of which 75µl was added to
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each well. Color was allowed to develop in the dark for 15 minutes at room temperature.
The reaction was stopped by the addition of 25µl of 0.2M EDTA. Plates were read with
a Biomek plate reader at 405 nm.
ECM protein binding to immobilized B. bacilliformis.
B. bacilliformis pellets were diluted in bicarbonate coating buffer to give a final
concentration of 1x106 cells/ml. E. coli at log phase were diluted in bicarbonate buffer so
that the final cell counts were 1x106 cells/ml. Next, 100µl of the bacteria were added to
wells of EIA/RIA plates that were incubated at 4°C for 16 hours. Unbound bacteria were
removed by washing the well three times with 200µl of PBST, and then blocked for two
hours with 100µl of PBST+5%BSA. Various dilutions of fibronectin (0.1-100 µg/ml),
vitronectin (0.1-10 µg/ml), or fetuin were prepared in blocking buffer, and 100µl of the
diluted proteins were added to the wells for three hours at 37°C. Unbound proteins were
removed by washing with PBST, and 100µl of anti-ECM antibody (diluted 1:1000) was
added for one hour at 37°C. The wells were washed as described previously; then, 100µl
of secondary, AP-conjugated anti-rabbit antibody (diluted 1:5000) was allowed to react
with the primary antibody for one hour at 37°C. Alkaline phosphatase substrate was
added and allowed to develop as described. Plates again were read in a Biomek plate
reader at 405 nm.
Plasmids and DNA manipulations.
The cloning and expression vector pET20b(+) was a kind gift from Dr. Zellers.
The vector was propagated in E. coli XL-1 Blue cells and expressed in E. coli HMS174
strains. Plasmids were isolated using the Plasmid Midi Kit (Qiagen), according to the
manufacturer’s protocol. The nlpD gene was amplified from the pKK-223 vector
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containing the nlpD gene that had been constructed Dr. Padmalayam (Padmalayam et al.,
2000a). The following primers were synthesized at the Georgia State University (GSU)
DNA/Protein core facility:
5’CCCCCAAGCTTTGAGTTCTCTAAATACTG3’ (nlpDRvc)
5’CCCCCGAATTCATGAGAAGATTCA3’ (nlpDFwd)
The underlined sequences are the HindIII and EcoRI restriction enzyme-cutting sites in
the reverse and forward primers, respectively.
Restriction enzyme digestion, ligation, and transformation.
Purified amplicons and pET20b(+) were digested with HindIII and EcoRI for four
hours at 37°C. All digested products were gel purified (Qiagen), and ligation was
performed overnight at 16°C with T4 ligase (New England Biolabs). The CaCl2
competent E. coli HMS174 were transformed with 5µl of the ligation mixture, and
tranformants were plated on LB ampicillin plates. Plasmids were isolated from
transformed colonies and sequenced to confirm the presence of the nlpD gene. The E.
coli BL21 strains were transformed with pKK223-3, pKK-NlpD, or pKK223-3
containing mutant nlpD, as described. Sequencing was performed at the GSU core
facility using an ABI 3100 Genetic Analyzer. The recombinant plasmid containing
nlpDBb was named pNlpD20.
Protein expression.
Recombinant E. coli strains were grown at 37°C in LB-ampicillin broth to an
OD600 of 0.6. Cells were then induced by incubating with 0.5mM IPTG for three hours.
The cells were sunsequently collected by centrifugation at 8000xg for 10 minutes at 4°C.
Bacterial pellets were stored at -80°C if not used immediately. Pellets were resuspended
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in an appropriate volume of 1XQAE buffer (25mM Tris-HCl, pH7.5, 20% glycerol w/v,
2mM EDTA and 1mM DTT) and disrupted in a French pressure cell at 108Pa (1.5x104lbf
in.-2). Cell debris was removed by centrifugation at 9000xg for 15 minutes at 4°C. The
supernatant was aspirated for further use. Proteins from the cell lysates were separated
by SDS-PAGE, and then transferred to PVDF membranes for Western blot analysis.
Membranes were probed with anti-NlpD antibodies (diluted 1:5000) to determine protein
expression.
Site-directed mutagenesis.
A two-step overlap extension PCR method was used to introduce a point mutation in
the aspartate residue of NlpD. Two separate reactions were performed with a set of the
following primers:
Set 1: 5’CAAAGAGTAAAACGTGGTGAGGAAATTGCTAAATCGGGT3’
(RGEFwd) and 5’CCCCCAAGCTTTGAGTTCTCTAAATACTG3’ (nlpDRvc)
Set 2: 5’ACCCGATTTAGCAATTTCCTCACCACGTTTTACTCTTTG3’
(RGERvc) and 5’CCCCCGAATTCATGAGAAGATTCA3’ (nlpDFwd)
The bolded nucleotides differ from the wild type to mutate the aspartate (D) residue to a
glutamate (E) residue, whereas the underlined sequences indicate the restriction enzyme
sites for HindIII and EcoRI, respectively. The PCR products from the first step were gel
purified and used as DNA templates for the second PCR reaction, along with nlpDFwd and
nlpDRvc primers. The products from this reaction were also gel purified and then ligated
with HindIII/EcoRI digested pET20b(+). Ligation, transformation, sequence analysis,
and protein expression were carried out as described previously. The plasmid containing
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the mutant nlpDgene was designated as pNlpD.E20. This plasmid was used to amplify
mutant nlpD to sub-clone into pKK223-3 vector as described.
Isolation of inner and outer bacterial membranes.
Bacterial cell lysates from induced E. coli cultures were prepared as described in
the previous section. The supernatant obtained after cell disruption was subjected to
ultracentrifugation at 40,000xg for one hour at 4°C in a Ti75 Rotor. The supernatant was
discarded, and the pellet fraction, which contains the total membrane fraction, was
resuspended in 1ml of ice-cold 20% sucrose-3mM EDTA solution. The resuspended
mixture was overlayed on a 70–53% sucrose gradient in SW41 polyallomer tubes. The
tubes were spun in a SW41 rotor at 37,000xg for 24 hours at 4°C. The inner membrane,
separated at the 20–53% sucrose interface, and the outer membrane fraction, at the 53–
70% sucrose interface, were carefully transferred out with a Pasteur pipette into
ultracentrifuge tubes. The samples were diluted with two volumes of water and onequarter volume of 10mM MgCl2. The tubes were centrifuged for one hour at 47,0000 xg
in a Ti70 rotor to concentrate the membrane fractions. Membrane pellets were
resuspended in 500 µl of 1XQAE and subjected to Western blots to determine the
presence of NlpD, as described previously. Membrane fractions were also probed with
anti-OmpA antibodies to determine the purity of the outer membrane fractions.
Gentamicin protection assays.
E. coli HMS174 and Bl21 harbouring the pET20 b(+) vector, or recombinant
plasmids expressing expressing wild-type B. bacilliformis NlpD or NlpD RGD mutants
were grown and induced as described. Cells from 1ml of the induced culture were spun
down at 7000xg for 5 minutes. The cells were washed twice with 1X PBS and

52
resuspended in 1ml of M199 media containing 0.5% D-mannose. Bacteria were
enumerated microscopically. Semi-confluent HMEC-1 cells were infected with 100
bacteria/cell for three hours at 37°C in a CO2 incubator. The media were then replaced
with fresh M199 media. The infection was allowed to proceed for another three hours,
after which the cells were washed three times. M199 media containing 100µg/ml of
gentamicin was added to the washed cells, and the plates were incubated for three hours.
The cells then were washed six times with PBS, detached using a cell stripper
(Mediatech), and then lysed with sterile 1% Triton X100 to release intracellular bacteria.
Serial dilutions of the released bacteria were plated on LB-ampicillin plates. Plates were
incubated at 37°C for 16 hours. The next day colonies on the plates were counted.
Adhesion assays with recombinant E. coli.
Recombinant E. coli were grown and prepared for HMEC-1 cell infections as
described in the invasion assay section. HMEC-1cells were grown to 80% confluency on
chamber slides (Nunc). E. coli were allowed to infect HMEC-1 cells at 1:100 m.o.i for
three hours. The wells were washed six times with PBS. The cells were then fixed with
ice-cold 70% methanol for 15 minutes. The methanol was rinsed out and stained with
fresh 10% Giemsa in distilled H2O for 30–45 minutes. The slides were rinsed with
distilled H2O and then destained by dipping four times in 1% acetic acid. After a last
rinse in distilled H2O, the slides were air dried and examined microscopically to
determine bacterial adherence to host cells.
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Statistical analysis
All experiments were performed in triplicate. Standard error means for each data set
were calculated in Microsoft Excel. Confidence levels (p-values) were determined in
Microsoft Excel using Student’s test for unequal variances.
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Results
Integrin blocking antibodies decrease B. bacilliformis invasion
Endothelial cells are the primary target for B. bacilliformis infection during the
secondary phase of Bartonellosis. The bacterium is found on and in the endothelial cells
of patients with verruga peruana. In vitro, B. bacilliformis-infected endothelial cells
suffer altered morphology and undergo proliferation (Verma et al., 2001). However, the
endothelial cell receptors involved in B. bacilliformis invasion remain unidentified.
Epithelial cell infection in the presence of antibodies against epithelial α5 and β1 integrins
reduced the number of intracellular B. bacilliformis (Williams-Bouyer et al., 1999). We
have used the same approach to determine which integrins could be required for B.
bacilliformis invasion into endothelial cells. Endothelial cells were pre-incubated with
antibodies against α5β1, αVβ3, β1, and β4. Polyclonal and monoclonal antibodies against
GFP represent the controls and thus eliminate the effects of a non-specific interaction of
an antibody with the bacteria. Microvascular cells were infected with radiolabeled
bacteria for six hours, after which the externally bound B. bacilliformis was removed by
mild trypsinization. Host cells were lysed, and the amount of radiolabeled bacteria
released was determined in terms of the DPM recovered. Invasion was inhibited in the
presence of anti-integrin antibodies, signifying the need for integrins during invasion.
Invasion was significantly decreased by 84%, 27%, and 31% in the presence of anti-α5β1,
anti-αVβ3, and β1, respectively (Figure 1.1. and table 1.1.). The maximum number of
intracellular bacteria was recovered from those cells treated with anti-β4 antibodies; the
level of inhibition observed with these antibodies was not significant (p-value = 0.11).
No inhibition was seen in cells infected with the control anti-GFP antibody. These
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observations demonstrate the involvement of endothelial cell integrins in B. bacilliformis
invasion.
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Effect of anti-integrins antibodies on B. bacilliformis invasion
into HMEC-1 cells
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Figure 1.1. Effect of anti-integrin antibodies on B. bacilliformis infection of HMEC-1
cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at 1:100 m.o.i in the presence or absence of anti-integrin or control
antibodies. Cell lysates were prepared six hours post infection and used to determine the
radiolabeled intracellular bacterial content. The radioactivity recovered indicated the
number of internalized bacteria. The percent invasion was calculated as (recovered
DPM/added DPM)×100; that in the control experiments was set to 100, and the percent
invasion of the treated samples was calculated in relation to 100%. The X-axis denotes
the antibody used, whereas the relative percent invasion is plotted on the Y-axis. The
numbers are the average of three replicates; error bars represent standard error mean
(SEM). The p-value was obtained with Student’s t-test, such that a p-value (*) ≤ 0.05
was considered significant, relative to the control.
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Table 1.1. Effect of anti-integrin antibodies on B. bacilliformis invasion of HMEC-1
cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of 5µg/ml of anti-integrin or control antibodies and serum-free M199 media
with 1% BSA. Percent invasion and percent inhibition values are the means ±SEM of
three experiments. Invasion values were calculated as (recovered DPM/added
DPM)×100, set to 100 for untreated samples. Percent invasion from treated samples was
calculated in relation to the 100% invasion in untreated samples. Percent inhibition was
determined by normalized invasion – 100. Student’s t-test was performed with data from
both treated and untreated samples. The p-value < 0.05 is considered significant, and NA
indicates not applicable.
Antibody
used
Control
Anti-β1
Anti-αvβ3
Anti-α5β1
Anti-β4

Percent
Invasion
100±1.33
68.52±7.77
72.39±2.29
20.56±5.07
84.94±3.22

Percent
Inhibition
NA
31.62±7.82
27.82±2.21
84.20±5.80
13.00±3.52

p-Value
NA
0.03
0.01
0.01
0.11
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Integrins are involved in B. bacilliformis attachment to endothelial cells
Ubiquitous integrins can serve as bacterial receptors (Scibelli et al., 2007). In the
previous section, we showed that masking of integrins affects B. bacilliformis invasion.
Here, we analyze whether the unavailability of integrins also affects the attachment of B.
bacilliformis to host cells. Mild trypsin treatment released the externally bound bacteria
into the media and these bacteria were separated from intact host cells by centrifugation.
This trypsin treatment removes extracellular bacteria without affecting the intracellular
bacteria (Hill et al., 1992). Bacterial pellets were then measured for their radioactive
content. The results showed that the extracellular bacterial numbers decreased
significantly in assays containing anti-integrin antibodies. Adhesion was dramatically
reduced by 63% when infection was performed with anti-α5β1 antibodies (Figure 1.2.,
table 1.2). Blocking antibodies for αVβ3 and β1 inhibited adherence by 28% and by 23%,
respectively. Anti-β4 did not affect bacterial attachment. The adhesion inhibition pattern
correlates well with the invasion inhibition values, which suggests that integrins prevent
bacterial internalization by obstructing their adherence to integrins.
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Effect of anti-integrin antibody on B. bacilliformis adherence to
HMEC-1 cells
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Figure 1.2. Effect of anti-integrin antibodies on B. bacilliformis adhesion to HMEC-1
cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at 1:100 m.o.i in the presence or absence of anti-integrin antibodies. Six
hour post infection, cell were treated with 0.08% trypsin treatment, and cell supernatants
were collected. B. bacilliformis were centrifuged at 2000xg for 10 minutes and then
resuspended in liquid scintillation fluid to determine the amount of radioactivity
incorporated; the radioactivity recovered indicated the number of externally bound
bacteria. Percent adhesion was calculated as (recovered DPM/added DPM)×100, and the
percent adhesion from the control experiments was set to 100, whereas the percent
adhesion of the treated samples was calculated in relation to 100%. The X-axis denotes
the antibody used, and the Y-axis represents the relative percent adhesion. The numbers
depict the average of three replicates; error bars represent the SEM. The p-value was
obtained by Student’s t-test, such that p-values (*) ≤ 0.05 and (**)≤ 0.01 are considered
significant.
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Table 1.2. Effect of anti-integrin antibodies on B. bacilliformis adhesion of HMEC-1
cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of 5µg/ ml of anti-ECM protein antibodies or control antibodies in serumfree M199 media containing 1% BSA. Percent adhesion and percent inhibition values are
means ±SEM of three experiments. Adhesion values were calculated as (recovered
DPM/added DPM)×100, set to 100 for untreated samples. Percent adhesion from treated
samples was calculated in relation to 100% invasion of untreated samples. Percent
inhibition was determined by normalized adhesion – 100. Student’s t-test was performed
with data from treated and untreated samples. The p-value < 0.05 is considered
significant, and NA indicates not applicable.
Antibody
Used
Control
Anti-β1
Anti-αvβ3
Anti-α5β1
Anti-β4

Percent
Adhesion
100±0.12
76.54±1.41
69.61±1.65
35.14±1.14
112.16±7.46

Percent
Inhibition
NA
23.23±1.41
28.48±1.19
63.93±1.82
NA

p-Value
NA
0.057
0.003
0.003
NA
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B. bacilliformis affects the gene expression of integrins
Real time RT-PCR was done to study the integrin gene expression in infected
HMEC-1 cells. Inventoried primers for integrins α5, β1, αv, and β3 internal control PPIA
(cyclophilin A, CAG32988) were used to study the gene expression. PPIA expression in
experimental and control cells was comparable according to RT-PCR and microarray
analysis; therefore, we choose it as the internal control. The comparative threshold
method was used to determine the relative quantification (RQ). First, the threshold
values (Ct) obtained for each sample (control, uninfected and experimental, infected)
were normalized against the endogenous control, PPIA. Second, the normalized Ct (ΔCt)
of the control was subtracted from the treated dCt to obtain the comparative threshold
value (ΔΔCt). The relative quantification was obtained by the formula 2(-ΔΔCt). The
integrin α5 expression in infected samples increased significantly by 2.2-fold at 30
minutes post infection, then gradually decreased over time. At six hours post infection,
the expression remained unchanged (Figure 1.3a). Integrin β1 gene expression increased
slightly but significantly at 30 minutes, after which the expression between infected and
uninfected cells appeared comparable (Figure 1.3a). Integrin αv mRNA levels were
marginally elevated at 30 minutes, but the RQ values were not significant, and the
expression was down-regulated in infected cells at one, three, and six hours post infection
(Figure 1.3b). The same trend can be observed with Integrin β3 gene expression (Figure
1.3b).
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Gene expression of ITA5 as determined by real time RT-PCR
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Gene expression of ITGB1 as determined by real time RT-PCR
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Figure 1.3a. Determination of integrin α5 and integrin β1 gene expression in B.
bacilliformis infected HMEC-1 cells.
Real-time RT-PCR analysis was done to profile the expression of integrin genes using
total RNA from infected HMEC-1 cells at various times points. The relative
quantification (RQ) of mRNA from infected cells was calculated after normalization to
internal control (PPIA) and in relation to threshold values obtained from mock-infected
cells. The time in hours is plotted on the X-axis, and RQ is depicted on the Y-axis. Data
points are the average of three replicates, and error bars represent the SEM. The p-values
obtained by Student’s t-test indicate p-values (*) ≤ 0.05 is significant.
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Gene expression of ITAV as determined by real timeRT-PCR
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Gene expression of ITB3 as determined by real time RT-PCR
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Figure 1.3b. Determination of integrin αv and integrin β3 gene expression in B.
bacilliformis infected HMEC-1 cells.
Real-time RT-PCR analysis helped profile the expression of integrin genes using total
RNA from infected HMEC-1 cells at various times points. The relative quantification
(RQ) of mRNA from infected cells was calculated after normalization to internal control
PPIA and in relation to threshold values obtained from mock-infected cells. The time in
hours is plotted on the X-axis, and RQ is depicted on the Y-axis. Data points are the
average of three replicates; error bars represent the SEM. The p-value was obtained by
Student’s t-test, and p-values (*) ≤ 0.05 and (**)≤ 0.01 were considered significant.
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B. bacilliformis binds to immobilized fibronectin and vitronectin
Fibronectin and vitronectin are the optimal natural ligands for α5β1 and αVβ3,
respectively. Bacteria synthesize proteins that bind fibronectin and vitronectin, which in
turn interact with their receptors. In this study, we examine the interaction of B.
bacilliformis with immobilized or soluble fibronectin and vitronectin. Fibronectin,
vitronectin, or the control protein fetuin (5µg/ml), a serum glycoprotein, was coated on
EIA/RIA plates. The wells were blocked with PBST containing 5% BSA. Various
dilutions of B. bacilliformis were added to the bound proteins. Bound B. bacilliformis
were detected with anti-B. bacilliformis antibodies, followed by alkaline phosphatase
conjugated secondary antibodies. The color intensity of the enzyme substrate p-NPP was
proportional to the amount of secondary antibody bound to anti-B. bacilliformis
antibodies. B. bacilliformis interacted with immobilized fibronectin, as seen in the
significant increase in absorbance (Figure 1.4.). A bacteria dose-dependent response
binding to fibronectin and vitronectin was obtained from 2x106-5x106CFU/ml, after
which binding reaches saturation. B. bacilliformis also bound to control protein fetuin,
but the absorbance remained low, regardless of the amount of bacteria in the assays.
These observations indicate that B. bacilliformis is able to bind to immobilized ECM
proteins.
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B. bacilliformis binding to ECM proteins
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Figure 1.4. B. bacilliformis binding to ECM proteins studied by ELISAs.
Fibronectin, vitronectin, or fetuin (control) was coated on EIA plates. After blocking
with 5%BSA, B. bacilliformis dilutions were incubated with bound proteins. Unbound
bacteria were washed and bound bacteria were detected with anti-B. bacilliformis
antibodies, followed by AP-conjugated secondary antibodies. The p-NPP substrate was
allowed to react with AP-conjugated antibodies, and then absorbance was read at 405 nm.
The binding event correlated with the increase in absorbance compared with the control
wells. All experiments were performed in triplicate, and the p-value calculated by
Student’s t-test was <0.05.
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B. bacilliformis binding to soluble fibronectin and vitronectin
Immobilized proteins could have different interaction domains compared with the
free soluble form. B. bacilliformis–coated EIA plates were used to investigate the effect
of increasing concentrations of soluble ECM proteins on bacterial binding patterns. A
sharp increase in absorbance was recorded at 0.1µg/ml of fibronectin. The binding
reached a plateau, followed by a second phase of increased absorbance from 1µg/ml to
75µg/ml. The increase in absorbance after 10µg/ml of fibronectin probably is due to the
addition of excess fibronectin and not bacteria binding (Figure 1.5a.). B. bacilliformis did
not bind to the control protein fetuin, and no fibronectin was detected in E. coli–coated
wells. Soluble vitronectin’s attachment to B. bacilliformis also was detected (Figure
1.5b). A linear increase occurs from 0.5µg/ml to 10µg/ml, followed by a decrease at
25µg/ml. E. coli used as a control does not show any binding to ECM proteins. Taken
together these results suggest that B. bacilliformis has the capacity to capture soluble
ECM proteins as well as bind immobilized ECM proteins.

67
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Figure 1.5a. B. bacilliformis binding to soluble fibronectin studied by ELISAs.
B. bacilliformis and E. coli (1x106cells/ml) were coated on EIA plates. After blocking
with 5%BSA, 5µg/ml of fibronectin was incubated with bound bacteria. Unbound
proteins were washed and detected with anti-fibronectin, followed by AP-conjugated
secondary antibodies. The p-NPP substrate was allowed to react with AP-conjugated
antibodies; absorbance was read at 405 nm. The binding event correlates with the
increase in absorbance compared with the control wells. All experiments were performed
in triplicate, and the p-value calculated by Student’s t-test was 0.0001.
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Figure 1.5b. B. bacilliformis binding to soluble vitronectin studied by ELISAs.
B. bacilliformis and E. coli (1x106cells/ml) were coated on EIA plates. After blocking
with 5%BSA, 5µg/ml of vitronectin was incubated with bound bacteria. Unbound
proteins were washed and detected with anti-vitronectin, followed by AP-conjugated
secondary antibodies. The p-NPP substrate was allowed to react with AP-conjugated
antibodies, and absorbance was read at 405 nm. The binding event correlates with the
increase in absorbance compared with the control wells. All experiments were performed
in triplicate, and the p-value calculated by Student’s t-test was 0.0001.
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Effect of ECM-coated B. bacilliformis on HMEC-1 cell invasion
B. bacilliformis has the ability to bind fibronectin and vitronectin, as determined
by ELISAs. These two proteins are freely available in the serum and extracellular matrix
surrounding the endothelial cells. Histological examination of tissues from verruga
lesions showed that B. bacilliformis is localized in and around endothelial cells (AriasStella et al., 1986a). According to these findings, the bacteria have easy access to
fibronectin and vitronectin in and around the endothelial cells. Because fibronectin and
vitronectin are ligands for integrins believed to be involved in B. bacilliformis
pathogenesis and because they interact with the bacterial surface, we studied their role in
endothelial cell infections. B. bacilliformis were pre-incubated with varying
concentrations of fibronectin or vitronectin. ECM protein-coated bacteria were then used
to infect HMEC-1 cells, following the standard protocol. Fibronectin-opsonised B.
bacilliformis showed enhanced invasion, depending on the protein concentration (Figure
1.6a.). A 51% increase in the number of intracellular bacteria was observed when
bacteria were treated with 25µg/ml of fibronectin. Increases in fibronectin concentration
above 25µg/ml did not result in additional invasion. This result suggested that the
fibronectin-binding sites on B. bacilliformis probably were saturated at this concentration.
B. bacilliformis pre-treated with vitronectin also invaded with greater efficiency
than the untreated bacteria (Figure 1.6b.); however, the degree of invasion enhancement
was much less pronounced than that seen with fibronectin. This relatively low level of
increase was probably due at least in part to the need to use lower vitronectin
concentrations for these studies, since the ELISAs showed that beyond 2.5µg/ml of
vitronectin, B. bacilliformis-protein interaction was inhibited (Figure 1.6b). The
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maximum increase in invasion occured at 5µg/ml of vitronectin and remained unchanged
at further concentrations. At equal concentrations of 10µg/ml of both ECM proteins, the
internalization efficiency of fibronectin- and vitronectin-coated bacteria were comparable
at 11% for vitronectin and 13% for fibronectin (Table 3a and 3b).
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Figure 1.6a. Effect of fibronectin-coated B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected at 1:100 m.o.i with 35Smethionine labeled B. bacilliformis, pretreated with varying concentrations of fibronectin.
Cell lysates were prepared six hours post infection, then used to determine the
radiolabeled intracellular bacteria. The radioactivity recovered indicated the number of
internalized bacteria. Percent invasion was calculated as (recovered DPM/added
DPM)×100. Again, percent invasion from the control experiments was set to 100, and
the percent invasion of the treated samples was calculated in relation to 100%. The Xaxis denotes the concentration of fibronectin used in contrast to the bacteria used, and the
Y-axis reveals the relative percent invasion. The numbers are the average of three
replicates, and error bars represent the SEM. The p-values were obtained by Student’s ttest; those values of (*) ≤ 0.05 and (**) ≤ 0.01 were significant.
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Figure 1.6b. Effect of vitronectin-coated B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected at 1:100 m.o.i with 35Smethionine labeled B. bacilliformis that were pre-treated with varying concentrations of
vitronectin. Cell lysates were prepared after six hours, and then used to determine the
number of intracellular bacteria. The radioactivity recovered indicated the number of
internalized bacteria. The percent invasion was calculated as (recovered DPM/added
DPM) ×100. Whereas the percent invasion from the control experiments was set to 100,
the percent invasion of the treated samples was calculated in relation to 100%. The Xaxis denotes the concentration of vitronectin used to opsonize the bacteria; the relative
percent invasion is plotted on the Y-axis. The numbers are the average of three
replicates, and error bars represent the SEM. The p-value was obtained by Student’s ttest, and p-values (*) ≤ 0.05 and (**)≤ 0.01 were significant.
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Table 1.3a. Effect of fibronectin-treated B. bacilliformis on invasion of HMEC-1 cells.
HMEC-1 cells were infected with, fibronectin-opsonised, 35S-methionine labeled B.
bacilliformis for six hours in serum-free M199 media. Percent invasion and percent
increase values are the means ±SEM of three experiments. Invasion values were
calculated as (recovered DPM/added DPM)×100 and were set to 100 for untreated
samples. Percent invasion from treated samples was calculated in relation to 100%
invasion of untreated samples. Percent increase was determined by normalized invasion
– 100. Student’s t-test was performed with data from treated and untreated samples. The
p-value of <0.05 is considered significant, and NA indicates not applicable.
Fibronectin
Concentration
(μg/ml)
0
5
10
25
50
100
200

Percent
Invasion
100±0.83
99.42±4.07
113.86±5.86
151.97±4.72
151.14±3.78
151.08±6.91
152.17±0.76

Percent
Increase
NA
0.58±4.07
13.80±5.86
51.97±4.71
51.14±3.90
50.10±6.91
52.17±0.89

p-Value
NA
NA
NA
0.002
0.001
0.011
0.002
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Table 1.3b. Effect of vitronectin-treated B. bacilliformis on invasion of HMEC-1 cells.
HMEC-1 cells were infected with vitronectin-opsonised, 35S-methionine labeled B.
bacilliformis for six hours in serum-free M199 media. Percent invasion and percent
increase values are the means ±SEM of three experiments. Invasion values were
calculated as (recovered DPM/added DPM)×100, set to 100 for untreated samples.
Percent invasion from treated samples was calculated in relation to 100% invasion of
untreated sample. Percent increase was determined by normalized invasion – 100.
Student’s t-test was performed with data from treated and untreated samples, and pvalues <0.05 were considered significant.
Vitronectin
Concentration
(μg/ml)
0
0.5
2.5
5
7.5
10

Percent
Invasion
100±0.83
106.55±0.67
109.78±2.29
112.05±2.04
111.92±0.79
111.00±0.19

Percent
Increase
NA
6.63±0.67
9.78±2.29
12.05±2.04
11.92±0.79
11.00±0.19

p-Value
NA
0.007
0.058
0.002
0.001
0.011
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Cellular ECM involved in B. bacilliformis internalization
Endothelial cells synthesize extracellular matrix proteins (Berge et al., 1992; Jaffe
et al., 1978). These proteins are secreted into the extracellular environment, where they
interact with themselves, with other extracellular proteins, and with cell receptors.
Histological analysis of tissues from verruga lesion detected the presence of B.
bacilliformis in the region surrounding endothelial cells. The extracellular milieu is rich
in fibronectin and vitronectin, which indicates that it could serve as a source for these
proteins for bacterial interaction. Bacterial–ECM interactions could help the bacteria
connect indirectly to integrins through ECM proteins. Fibronectin and vitronectin could
also be present on cell surfaces. Collectively, the ECM and surface fibronectin or
vitronectin are called cellular ECM. The role of cellular ECM proteins was studied by
performing invasion assays in the presence of anti-ECM or control antibodies, with
serum-free media. In serum-free conditions, the only proteins the antibodies would
recognize would be cellular in nature. Data showed that B. bacilliformis uptake was
inhibited by 47% in the presence of monoclonal anti-fibronectin antibodies (Figure 1.7,
table 1.4). Furthermore, the number of externally bound bacteria was reduced by 52% in
the presence of monoclonal fibronectin antibodies. Thus, unavailability of cellular
fibronectin decreases B. bacilliformis adhesion to and internalization into HMEC-1 cells.
Monoclonal vitronectin antibodies caused cell rounding and detachment six hours post
infection, for unexplained reasons; therefore, they could not be used in these studies.
However, polyclonal vitronectin antibodies also lowered bacterial invasion by 31%
(Figure 1.7, table 1.4). Adhesion was also affected by 15% in assays with antivitronectin antibodies. Because adhesion was not affected as much as invasion with anti-
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vitronectin antibodies, it is possible that a portion of the bacteria that bind, but do not
subsequently invade the cells. This would suggest that adhesion does not ensure bacterial
uptake, and additional cellular vitronectin–dependent factors may be required for
invasion. Finally, fibronectin and vitronectin antibodies do not abolish invasion
completely, and therefore, B. bacilliformis may bind directly to integrins to establish the
invasion of endothelial cells.
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Figure 1.7. Effect of anti-ECM protein antibodies on B. bacilliformis infection of
HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at 1:100 m.o.i. in the presence or absence of anti-fibronectin (FN), antivitronectin (VN), and control ant-GFP antibodies. Cells were treated with 0.08% trypsin
to release extracellular bacteria into the media, six hour post infection. Media containing
bacteria and detached cells were centrifuged at 1000xg for 10 minutes to pellet out the
host cells. The supernatants were centrifuged again at 2000xg to obtain bacterial pellets.
B. bacilliformis was resuspended in liquid scintillation fluid to determine the radioactivity
incorporated. HMEC-1 cells were lysed with 0.1% Triton-X100 to release intracellular
B. bacilliformis. Lysed cells were added to liquid scintillation fluid. Percent
adhesion/invasion was calculated as (recovered DPM/added DPM)×100, with the control
experiments set to 100, and treated samples calculated in relation to 100%. The X-axis
denotes the antibody used, and the Y-axis plots the relative percent adhesion/invasion.
The numbers reflect the average of three replicates, and error bars represent the SEM.
The p-values obtained by Student’s t-test were significant at (*) ≤ 0.05 and (**) ≤ 0.01.
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Table 1.4. Effect of anti-ECM antibodies on B. bacilliformis invasion of HMEC-1 cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of 5µg/ ml of anti-ECM protein antibodies or control antibodies in serumfree M199 media with 1% BSA. Percent adhesion/invasion and percent inhibition values
are the means ±SEM of three experiments. Adhesion/invasion values were calculated as
(recovered DPM/added DPM)×100 and set to 100 for untreated samples. Percent
adhesion/invasion from the treated samples was calculated in relation to 100%
adhesion/invasion of control. Percent inhibition was determined by the normalized
adhesion/invasion – 100. Student’s t-test was performed with data from treated and
untreated samples; a p-value of <0.05 is considered significant. In the table, NA
indicates not applicable.
Antibody
Used
Control
Antifibronectin
Antivitronectin

Percent
Adhesion
100±0.1

Percent
Inhibition
NA

p-Value
NA

Percent
Invasion
100±0.1

Percent
Inhibition
NA

p-Value
NA

46.47±2.25

52.35±3.58

0.0003

53.02±1.70

46.98±1.69

0.001

84.36±3.25

15.70±3.25

0.001

68.57±6.38

31.41±6.39

0.025
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Human serum enhances B. bacilliformis invasion into HMEC-1 cells
B. bacilliformis is a human pathogen, and humans are the only known reservoir
for these bacteria. The bacteria are transmitted via sandflies that feed on the blood of
infected patients. Previous data suggest that B. bacilliformis interacts with human plasma
proteins such as fibronectin and vitronectin. Invasion assays, therefore, were performed
in the presence of human serum to determine whether invasion was enhanced under these
conditions. Serum was first heated to 56°C to inactivate complement proteins that could
be inhibitory to the bacteria. Serum was serially diluted in M199 to determine the most
effective concentration for invasion. B. bacilliformis invasion was enhanced in the
presence of human serum in a concentration dependent manner (Figure 1.8, table 1.5).
An increase of 40% in the number of intracellular bacteria was noted in assays performed
in the presence of 5% serum. The same number of bacteria was obtained from infections
with 7.5% serum, after which the invasion levels diminished with 15% human serum
(Table 1.5). It is possible that at high concentrations, human serum proteins prevent B.
bacilliformis invasion through steric hindrance. Similar experiments with fetal calf serum
(FCS) did not affect B. bacilliformis infectivity as much as human serum (Figure 1.9,
table 1.6). Invasion peaked at 17% when the media contained 7.5–10% FCS, as opposed
to a 51% jump with human serum. Use of human serum could provide conditions more
similar to those experienced by the bacteria in vivo; therefore, future experiments carried
out in the presence of human serum would provide results that more closely mimic the
infectious process.
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B. bacilliformis invasion into HMEC-1 cells in the presence of
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Figure 1.8. Effect of human serum on B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100. in the presence of varying concentrations of human
serum. Cell lysates prepared after six hours, were used to determine the number of
intracellular bacteria. The radioactivity recovered provided an indicator of the number of
internalized bacteria. Percent invasion was calculated as (recovered DPM/added
DPM)×100. Percent invasion from the control experiments was set to 100, whereas
percent invasion of the treated samples was calculated in relation to 100%. The X-axis
denotes the percentage of human serum added to the media, whereas relative percent
invasion is plotted on the Y-axis. The numbers are the average of three replicates, and
error bars represent the SEM. The p-values obtained by Student’s t-test indicate
significant p-values of (*) ≤ 0.05 and (**) ≤ 0.01.
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Table 1.5. Effect of human serum on B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
M199 media with increasing concentrations of human serum. Percent invasion and
percent increase values are the means ±SEM of three experiments. Invasion values were
calculated as (recovered DPM/added DPM)×100, set to 100 for untreated samples; for
treated samples, the percent invasion was calculated in relation to 100% control invasion.
Percent increase was determined by normalized invasion – 100. Student’s t-test was
performed with data from treated and untreated samples; a p-value of <0.05 was
considered significant.
Human Serum
Concentration
(%)
0
1
2.5
5
7.5
10

Percent
Invasion
100±0.40
110.12±2.87
116.60±3.91
140.55±4.05
139.18±2.57
125.44±2.36

Percent
Increase
NA
10.12±2.89
16.60±3.91
40.5±4.05
39.18±2.57
25.44±2.36

p-Value
NA
0.088
0.029
0.003
0.004
0.012
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B. bacilliformis invasion into HMEC-1 cells in the presence of
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Figure 1.9. Effect of fetal calf serum on B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of varying concentrations of fetal calf
serum. Cell lysates prepared after six hours, were used to determine the number of
intracellular bacteria. The radioactivity recovered served as an indicator of the number of
internalized bacteria. Percent invasion was calculated as (recovered DPM/added
DPM)×100. Percent invasion from the control experiments was set to 100, and percent
invasion of the treated samples was calculated in relation to that level. The X-axis
denotes percentage of human serum added to the media; the Y-axis denotes the relative
percent invasion. The numbers represent the average of three replicates, and error bars
represent the SEM. The p-values were obtained by Student’s t-test, indicating
significance at (*) ≤ 0.05 and (**) ≤ 0.01.
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Table 1.6. Effect of fetal calf serum on B. bacilliformis invasion into HMEC-1 cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
M199 media with increasing concentrations of fetal calf serum (FCS). Percent invasion
and percent increase values are the means ±SEM of three experiments. Invasion values
were calculated as (recovered DPM/added DPM)×100 and were set to 100 for untreated
samples, whereas percent invasion from the treated samples was calculated in relation to
the untreated sample invasion. Percent increase was determined by normalized invasion
– 100. Student’s t-test was performed with data from treated and untreated samples. A pvalue <0.05 is considered significant.
FCS
Concentration
(%)
0
1
2.5
5
7.5
10

Percent
Invasion
100±0.4
109.95±3.77
104.36±2.43
102.38±0.79
117.83±3.86
117.15±4.84

Percent
Increase
NA
9.95±3.77
4.36±2.43
2.38±0.79
17.83±3.86
17.15±4.84

p-Value
NA
0.023
0.043
0.048
0.004
0.011
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NlpD is an outer membrane protein
The highly antigenic B. bacilliformis protein NlpDBb contains RGD, a tripeptide
that is commonly found in bacterial adhesions. Sequence analysis of NlpDBb has shown
the presence of a leader peptide that allows the translocation of the protein to the outer
membrane. To determine whether this highly antigenic protein is present in the outer
membrane, membrane fractions from B. bacilliformis and NlpD expressing E. coli
expressing clones nlpD were prepared and analyzed. Total membrane fractions were
isolated by differential ultracentrifugation, and then separated by centrifugation in a
sucrose gradient. When separated by this method, the inner membrane appears lighter
than the outer membrane at the 20–53% sucrose junction. The heavier outer membrane
moves through the gradient to settle at the 53–70% interface. These bands were
concentrated, and the separated proteins were analysed with anti-NlpD antibodies. NlpD
(43kDa) can be clearly detected in the outer membrane fractions of E. coli expressing the
B. bacilliformis protein (Figure 1.10). The analysis of the B. bacilliformis membrane
yielded the same results (Figure 1.10). Membranes were also probed with OmpA
antibodies to check for outer membrane protein contamination in the inner membrane
fractions. The absence of a distinct 35kDa band corresponding to the OmpA band from
the inner membrane fractions confirmed the purity of the membrane preparations (data
not shown).
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Figure 1.10. Western immunoblot showing the presence of the 43kDa antigen in the
outer membrane preparations from B. bacilliformis and recombinant E.coli expressing
NlpDBb.
Outer and inner membrane fractions were isolated from total membrane fractions of B.
bacilliformis (Panel A) and E. coli HMS174 cells expressing B. bacilliformis nlpD (Panel
B) by the sucrose gradient centrifugation. The individual membrane proteins were
separated by SDS-PAGE and then transferred onto PVDF membranes. These membrane
were probed with primary anti-NlpD peptide antibodies, followed by AP-conjugated,
anti-Rabbit antibodies. The blots were developed with AP- substrate according to the
method described in materials and method section. Lane 1 of both panels is the outer
membrane proteins and lane 2 the inner membrane proteins. The numbers on the left are
the approximate molecular masses in kilodaltons (kDa) and the arrow indicates the NlpD
band.
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Site-directed mutagenesis and expression of NlpD mutants
The C-terminal domain of the NlpD protein has an arginine-glycine-aspartate
(RGD) motif. Various bacterial and viral proteins containing the RGD motif are involved
in host cell attachment and invasion. Previously, NlpD was found to be highly
immunogenic, and our studies also show that it is an outer membrane protein. These
factors make it an attractive adhesion and/or invasion molecule. The asparate amino acid
of the RGD motif was mutated to glutamate through a two-step PCR. The point mutation
was confirmed by sequencing; immunoblots with anti-NlpD antibody showed that the
level of protein expression by the mutant was comparable to that of the wild type protein
(Figure 1.11).
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Figure 1.11. Western immunoblot of recombinant E. coli expressing wild type NlpDBb
and mutant NlpDBb.
Whole cell lysates of recombinant E. coli HM174 expressing B. bacilliformis nlpD and
the nlpD gene (lane 1) harboring a point mutation in the RGD motif (lane 2) were
separated by SDS-PAGE and then transferred onto PVDF membranes. The membranes
were screened with polyclonal rabbit serum against a cocktail of synthetic peptides of
NlpDBb. The position of the wild type and mutant form of NlpD is indicated by the
arrow. The numbers on the left are the approximate molecular masses in kilodaltons
(kDa).
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Adhesion and gentamicin protection assays
Pathogens expressing proteins with the RGD tripeptide often mediate host binding
via this motif. B. bacilliformis NlpD also has a RGD motif, and therefore, its function in
cellular binding and invasion was examined.
Giemsa staining was used to detect adherence to HMEC-1 cells by E. coli
pNlpD20 (expressing wild type gene) or E. coli pNlpD.E20 (expressing mutanat gene). E.
coli with the vector alone was used as a control. The controls and E. coli expressing the
mutant NlpD did not adhere to the HMEC-1 cells. A few bacteria expressing the wild
type NlpD were found attached to the host cells, however, these were not significant
enough in number to conclude that NlpD confers an adhesion phenotype to non-adhesive
E. coli strains.
Gentamicin protection assays were performed to determine whether B.
bacilliformis NlpD expression results in E. coli uptake by HMEC-1 cells. Bacteria were
allowed to invade for six hours. Gentamicin (100µg/ml) was then added to kill
extracellular E. coli. Eukaryotic cells are impermeable to gentamicin, so intracellular
bacteria would be protected from the lethal effects of this antibiotic. Host cells were
washed extensively to remove unbound bacteria. The cells were then lysed to release
intracellular bacteria. Cell lysates were plated on LB-ampicillin plates to allow the
growth of viable bacteria. No bacterial colonies were recovered from cell lysates of
HJMEC-1 cells infected with E. coli wild-type NlpD or RGD mutants. Unfortunately,
numerous colonies were obtained from HMEC-1 cells infected with control E. coli with
plasmids alone. Because of the failure of the control experiments failed, the
interpretation of the experimental results remains questionable.
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Discussion
Role of Integrins in B. bacilliformis Pathogenesis
Bartonella spps invade endothelial cells in vivo and stimulate their proliferation.
Endothelial cells are also thought to serve as the primary niche for B. bacilliformis, where
the bacteria reside and possibly multiply before they infect the erythrocytes. In additon,
endothelial cell infection could help B. bacilliformis disseminate into tissues and protect
it from immune response molecules. The first step of a successful cellular infection
involves bacterial interaction with the host surface molecules. Endothelial cell receptors
that recognize Bartonella spps are not known. This study is the first to identify
endothelial integrins as B. bacilliformis receptors. Antibodies that block integrin function
by preventing ligand interactions were used, and B. bacilliformis invasion was inhibited
significantly by 84.2% by anti-α5β1 antibodies during microvascular endothelial cell
infection assays. Furthermore, the blocking antibodies for α5 and β1 decreased B.
bacilliformis invasion into epithelial cells (Hep-2) when used individually or in
conjunction with one another (Williams-Bouyer et al., 1999). The level of inhibition
reported for epithelial cell invasion was only 33%, significantly lower than the inhibitory
effect seen in our studies. The use of polyclonal antibodies against α5β1, coupled with the
different cell line used, could explain the variance in the degree of inhibition in these two
studies. An analysis of the number of extracellular B. bacilliformis showed that not only
is B. bacilliformis invasion affected in the presence of anti-α5β1, but adherence is also
lowered. The other two antibodies tested, anti-β1 and anti-αVβ3, also had an inhibitory
effect on B. bacilliformis attachment and invasion of 31.62% and 27.82%, respectively.
Moreover, these antibodies decreased the attachment of B. bacilliformis to cell surfaces.

90
As mentioned previously, monoclonal antibodies against β1 decreased B. bacilliformis
entry into epithelial cells (Williams-Bouyer et al., 1999). Therefore it was not surprising
to find an inhibitory effect in endothelial cells as well. The role of β1 integrin in B.
henselae infection of host cells also has been suggested. B. henselae expresses an
adhesin, BadA, that mediates its binding to ECM and endothelial cells (Riess et al.,
2004). BadA resembles Yersinia protein YadA, which indirectly interacts with β1
integrins (Bliska et al., 1993). BadA expressing B. henselae showed decreased binding
capacity to β1-null fibroblasts, suggesting that β1 functions as a receptor during B.
henselae infections (Riess et al., 2004).
Various intracellular pathogens alter the host gene expression upon infection.
Transcriptional factors in B. bacilliformis-infected endothelial cells are activated
throughout the infection period (Verma et al., 2002a). Changes in fibronectin and
vitronectin integrin gene expression, determined by real time RT-PCR, suggested that the
integrin genes were differentially regulated in the B. bacilliformis infection (Figure 3a
and 3b). Levels of α5 integrin mRNA were two times higher in infected cells and
decreased with time; in addition, expression of the β1 integrin genes showed a similar
trend. S. pyogenes-infected epithelial cells also indicated a significant increase in α5
expression; this integrin was found to be utilized for adhesion and invasion (Halasz et al.,
2008). In the studies reported here, the αV and β3 genes showed an elevated
transcriptional response at 30 minutes post infection, after which they were significantly
down regulated (Figure 3b). The data suggest that, transcriptional induction of genes
encoding B. bacilliformis receptors were beneficial for increased bacterial uptake and
enhance infection efficiency. One possibility for the eventual down regulation is that
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host responses curtail B. bacilliformis ingestion and control the number of intracellular
bacteria.
The use of integrins as receptors for invasion may be advantageous, because these
molecules are involved in bidirectional cell signaling. One of the most critical functions
of integrins is the modulation of the internal actin network through signaling pathways
such as phosphatidylinositol 4.5-biphosphate (PtdIns (4,5)P2) and Rho family GTPases.
Cytoskeletal proteins are regulated by integrin binding to ligands, and bacterial binding to
integrins could manipulate the internal signaling environment to facilitate their ingestion.
Furthermore, α5β1 is the most commonly expressed integrin for several cell types. The
ubiquitous expression also makes α5β1 the most commonly targeted integrin for bacterial
attachment and invasion. The definitive role of α5β1 in Streptococcal infection of host
cells already has been established using non-peptide agonists (Cue et al., 2000). In
addition, attachment of the causative agent for lyme disease, Borrelia burgdorferi, onto
endothelial cells decreases in the presence of anti-α5β1 antibodies (Coburn et al., 1998).
Anti-α5 and anti-β1 antibodies also inhibit the ingestion of Mycobacterium avium subsp
paratuberculosis into M cells. Functional blocking of α5β1 has been used to demonstrate
the integrin’s role in Neisseria spps and Porphyromonas gingivalis infections of host
cells (Unkmeir et al., 2002; Yilmaz et al., 2002). Finally, Shigella flexneri attachment to
mammalian cells varies with the differential expression of α5β1 integrins on the cell
surface (Watarai, M et al., 1996). The role of αVβ3 has not been demonstrated in other
Bartonella spps, although a few bacteria exploit this integrin for effective host
colonization. Borrelia spps bind to purified αVβ3, and mutations in the OMP P66 disrupt
bacterial adherence to the αVβ3 integrin (Coburn et al., 2003c; Coburn et al., 1998).
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Invasion of Neisseria gonorrhoeae relies heavily on the Opa protein interactions with
αVβ3 via vitronectin (Dehio et al., 1998), because anti-αVβ3 antibodies minimize the
intracellular bacteria recovered.
This study thus demonstrates effects of blocking of integrins with antibodies in B.
bacilliformis attachment and invasion. Neutralization of α5β1 has the maximum
inhibitory effect on B. bacilliformis infection. However, the other antibodies also
reduced bacterial ingestion, which suggests the involvement of multiple integrins in
efficient B. bacilliformis infection of endothelial cells. Experiments with cell lines
deficient in integrin expression would strengthen these observations and help establish
the definitive role of integrins.
Role of ECM proteins in B. bacilliformis pathogenesis
The binding of B. bacilliformis to the integrin ligands fibronectin and vitronectin
was determined by ELISAs. Pretreatment of B. bacilliformis with these proteins
significantly enhanced their uptake by endothelial cells. ECM proteins are often used by
bacteria to form an indirect link between their surface and integrins. Bacterial attachment
to host proteins allows the pathogen to target specific cell types that express receptors for
the bound proteins. The two well-characterized bacteria that bind host molecules are S.
pyogenes and S. aureus, which express high-affinity fibronectin-binding proteins
(Jonsson et al., 1991b; Vercellotti et al., 1984). These bacteria trigger their uptake by
interacting with the α5β1 integrin via fibronectin, which leads to integrin-mediated cell
signaling changes (Agerer et al., 2005; Purushothaman et al., 2003). Fibronectin coating
of S. pyogenes enhances its internalization into epithelial cells, and the percentage of cells
internalized plateaus when the concentration of fibronectin used to opsonize the bacteria
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exceeds 20µg/ml (Ozeri et al., 1998). Pretreatment of M. avium subspp paratuberculosis
with fibronectin also augments its entry into M-cells (Secott et al., 2004). B.
bacilliformis invasion increased by a maximum of 51% when the bacteria were pretreated
with upto 25 µg/ml of fibronectin. This pattern suggests that the fibronectin binding sites
on B. bacilliformis achieve saturation at a ligand concentration of 25µg/ml, and therefore,
a further addition of fibronectin does not affect its infectivity. However, a saturation
effect was not seen in B. henselae opsonized with fibronectin, as a dose-dependent
inhibition of endothelial cell surface adherence was noted (Dabo et al., 2006). The study
reported by Dabo et al (2006) did not look at the effect of fibronectin pretreated B.
henselae on invasion, but it is reasonable to assume that a decrease in invasion would
result from reduced B. henselae attachment. The discrepancy between the two Bartonella
species could be explained by analyzing the fibronectin-binding properties of B.
bacilliformis and B. henselae; it seems likely that B. henselae binding to fibronectin
prevents fibronectin from interacting with integrins by binding to the integrin-binding
regions of fibronectin. B. bacilliformis, in contrast, may bind to a region of fibronectin
that is not involved in integrin adherence. The role of fibronectin in B. henselae remains
controversial though, because another study of the role of fibronectin-binding protein
BadA suggests that B. henselae binds to the β1 integrin via fibronectin (Riess et al.,
2004). Fibronectin is present in a soluble form in plasma, cerebral spinal fluid, and
inflammatory exudates. The insoluble fibronectin forms a part of the extracellular matrix
and cross-links with other fibronectin molecules to form a fibrillar network. Fibronectin
is synthesized and secreted by the cells themselves. The fibronectin from the ECM
interacts with cellular receptors and coats the cell surface. This fibronectin, called
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cellular fibronectin, in the absence of serum is the only source of fibronectin available to
maintain cellular functions. Cellular fibronectin neutralized with monoclonal antibodies
decreased B. bacilliformis entry by 46% and also affected its adhesion. The approach
described here has also been used to investigate the function of fibronectin in the
attachment of various bacteria, such as Treponema palladium, S. aureus, and
Pneumocystis carinii (Peacock et al., 1999; Peterson et al., 1983; Pottratz et al., 1990).
The inhibition of invasion by anti-fibronectin antibodies in the absence of serum implies
that B. bacilliformis uses surface-bound and/or ECM fibronectin as a bridge to interact
with endothelial cell integrins.
In 1996, Ihler suggested that B. bacilliformis could interact with integrins and
vitronectin because a phylogenetically related organism, Agrobacterium tumefaciens, can
bind to carrot cells via vitronectin (Ihler, 1996; Wagner et al., 1992). Our studies on B.
bacilliformis binding with vitronectin support this hypothesis. In addition to binding
vitronectin ECM protein, plasma vitronectin-coated B. bacilliformis invaded endothelial
cells with greater efficiency than did untreated bacteria. Like anti-fibronectin antibodies,
anti-vitronectin affected B. bacilliformis adhesion and internalization, though the
inhibitory effects of anti-vitronectin on invasion were slightly lower than those of
fibronectin. The absorbance values for B. bacilliformis binding to fibronectin were also
higher in comparison with vitronectin. Finally, almost complete inhibition of B.
bacilliformis entry occurred when the αVβ3 fibronectin integrin α5β1 was neutralized,
though blocking of the vitronectin integrin decreased B. bacilliformis ingestion to a much
lesser degree than anti-α5β1. Taken together, these results suggest that B. bacilliformis

95
employs both ECM proteins and their receptors for endothelial infection. However,
fibronectin and its integrin may play a more significant role than vitronectin and αVβ3.
Fibronectin and vitronectin are both available in serum. B. bacilliformis is
released into the blood stream upon hemolysis, where it can freely interact with human
serum proteins that would enhance their recognition by cell receptors. When we
compared the effect of human serum and fetal bovine serum on B. bacilliformis
internalization, we found that human serum improved B. bacilliformis translocation into
endothelial cells by 40% at a concentration of just 5%. Invasion increased by just 2% in
the presence of FCS at this dilution. Of course, human pathogens generally have a higher
affinity for human proteins compared with other mammalian proteins. A similar effect of
human serum was seen in the N. meningitides infection of human brain microvascular
endothelial cells (Unkmeir et al., 2002). Additional experiments that use human serum
may be required to more effectively mimic in vivo conditions and thereby provide a
greater understanding of the events surrounding B. bacilliformis infection.
We have shown that plasma fibronectin and vitronectin-coated B. bacilliformis
invade endothelial cells with greater efficiency than uncoated bacteria. The
unavailability of cellular ECM proteins and their receptors has a detrimental effect on B.
bacilliformis attachment and uptake. During host infection, it is possible that the B.
bacilliformis released from erythrocytes capture plasma fibronectin and vitronectin,
which predisposes them to anchor onto integrins (e.g., α5β1 and αVβ3, respectively). B.
bacilliformis also can be found in the interstitial spaces and extracellular matrix. B.
bacilliformis-bound fibronectin and vitronectin could interact with their ECM
counterparts, which would favor bacterial survival in the extracellular spaces. However,
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cellular fibronectin and vitronectin also are required for B. bacilliformis adherence and
invasion; therefore, the bacteria could engage extracellular proteins directly and increase
integrin attachment efficiency. Because B. bacilliformis infects endothelial cells in the
absence of ECM proteins, pathways independent and/or alongside ECM binding
pathways maybe involved in B. bacilliformis and endothelial interaction.
Analysis of B. bacilliformis NlpD as a potential adhesion molecule
B. bacilliformis NlpD/Lpp (Lipoprotein) was identified when the B. bacilliformis
genomic library was screened with serum from a patient with the verruga phase of
Carrion’s disease (Padmalayam et al., 2000b). This highly antigenic protein is conserved
among the Bartonella spps. NlpD/Lpp is homologous to the LppB protein in
Haemophilus somnus, an outer membrane protein with potential hemin-binding
properties. NlpDBb has an N-terminal signal peptide that allows its transport to the outer
membrane. In this study, we show that the protein is present in the outer membrane
fractions of B. bacilliformis and E. coli expressing wild-typeNlpDBb. Bacterial and viral
proteins that attach and/or play a role in invasion are generally present on the surface,
which provides accessibility to the host cell receptors that allow for optimal interactions
in support of subsequent infection events. However, pathogen surface molecules are also
great targets for the host immune system, making them excellent antigens. On the basis
of the observations that NlpDBb is an OMP and highly immunogenic, and has the RGD
motif, known to be involved in infections, we studied the role of NlpDBb in infection. E.
coli expressing wt NlpDBb and RGD mutants were allowed to adhere to endothelial cells.
Bacterial attachment to host cells was observed microscopically. Unfortunately, only 1%
of the host cells bound recombinant E. coli. The absence of more externally bound
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bacteria suggests that NlpDBb expression may not be involved in host cell attachment.
When expressed on the outer member of E. coli, no successful assays to determine the
functionality of NlpDBb expressed by E. coli have been developed thus far. Therefore,
the absence of recombinant E. coli on endothelial cells’ surface could result from the
improper expression of B. bacilliformis protein. The recognition of the tripeptide RGD
depends on the amino acids that flank the motif. The neighboring sequence determines
the optimal RGD conformation that enables it to fit the integrins (Ruoslahti et al., 1987).
The amino acids surrounding the RGD motif in NlpDBb may not allow the tripeptide to be
exposed to the protein surface, which would prevent its interaction with the integrin.
Standard gentamicin protection assays were performed to study the function of
NlpDBb in endothelial cell invasion. E. coli pNlpD20 or pNlpD.E20 could not invade; we
did not recover any colonies from the cell lysate after killing the extracellular bacteria
with gentamicin. However, colonies were recovered from the control E. coli with just the
vector. This result was obtained with different E. coli strains, expressing different
recombinant plasmids. The E. coli used were noninvasive laboratory strains that are
sensitive to gentamicin. Therefore, it is unusual to recover colonies from the control
experiments. At this point, we do not have an explanation for these results.
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Chapter II: Role of cell signal molecules during B. bacilliformis infection
Introduction
Intracellular bacteria require the concerted action of several cell signaling
molecules for optimal invasion and the subsequent establishment of infection. Invasive
pathogens can subvert and control cellular functions to aid their ingestion and
dissemination. Cytoplasmic proteins regulating cellular functions also can be altered by
bacterial interactions with host cell receptors, the injection of bacterial proteins into the
cell, or the internalized bacteria themselves. Cytoskeletal proteins are the most common
target for virulent organisms, because cytoskeletal components modify membrane
structures involved in bacterial uptake. The cytoskeleton is composed of actin filaments,
microtubules, and intermediate filaments. Pathogens manipulate the actin network
indirectly by modulating small GTPases (Rho, Cdc42, Rac), and kinases, which control
transcription factors and other actin-related proteins. A few cytosolic components have
been identified, but existing information has been insufficient to understand in any detail
the interactions between the molecules and the role they play during infection. The
inhibitory effects of cytochalasin D, an actin inhibitor, on invasion by B. bacilliformis
demonstrated the need for actin reorganization during the infectious process (Hill et al.,
1992). Subsequent studies showed that endothelial cell exposure to B. bacilliformis
results in actin rearrangement along with Rac and Cdc42 activation (Verma et al.,
2002b). Activated Rac and Cdc42 generate the membrane protrusions lamellipodia and
filopodia, respectively, which surround and engulf the bacterial aggregates. Inhibition of
tyrosine kinases also decreases invasion (Williams-Bouyer et al., 1999). Small GTPases
participate in complex signal networks, resulting in the phosphorylation of various
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kinases. Downstream kinases engaged by B. bacilliformis that control the
phosphorylation or actin cytoskeleton for efficient invasion have not been identified. The
premise of this study is to indentify kinases belonging to mitogen-activated protein
kinases (MAPK) that play a role in the infection of endothelial cells by B. bacilliformis.
Involvement of Mitogen Activated Protein Kinases in bacterial pathogenesis
Bacteria interfere with phosphorylated state of signaling kinases that promote
their internalization. Kinase modulation can be achieved by bacterial effector proteins or
by bacterial interaction with host cell receptors. Receptors are linked to intracellular
signaling pathways, such as mitogen-activated protein kinase (MAPK) (Pelech et al.,
1992). This cascade is initiated by the phosphorylation of MAPKKKs (MAPK kinase
kinase), followed by MAPKKs (MAPK kinase) and finally MAPKs. Activated MAPKs
are phosphorylated at threonine and tyrosine residues of the activation loop. The MAPKs
can be divided into three groups on the basis of the different motifs in the activation loop:
the extracellular signal-regulated kinases 1 and 2 (ERK1/2) contain a Thr-Glu-Tyr motif
and two groups of stress-activated protein kinases/c-Jun N-terminal kinases (SAPK1,
JNK1/2/3) contain Thr-Pro-Tyr motif and four p38 enzymes (α, β, γ, δ, or SAPK2)
contain a Thr-Ala-Tyr motif (Johnson et al., 2002; Kyriakis et al., 2001). The MAPK
pathway plays a central role in several cell functions, including growth, differentiation,
survival, and cytoskeletal rearrangements through interactions of the enzymes with
cytoplasmic proteins and modulation of transcriptional factors. Activators of this
pathway include cytokines, environmental stress factors, mitogens, and pathogens.
Activation of MAPKs by bacteria and their subsequent requirement for successful
infection has been reported. Listeria monocytogenes activates and requires the MAPKK,
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MEK1/2, and the upstream kinase for the ERK1/2 pathway for invasion into epithelial
cells (Tang et al., 1994; Tang et al., 1998). MEK1/2 involvement in Campylobacter
jejuni and Staphylococcus aureus for host cell entry also has been established (Ellington
et al., 2001; Hu et al., 2006). Neisseria meningitidis, Neisseria gonorrhoeae, and
Porphyomonas gingivitis phosphorylate the stress response kinases, JNK, upon host cell
infection, which then participate in bacterial internalization (Naumann et al., 1998;
Sokolova et al., 2004; Watanabe et al., 2001). B. bacilliformis also activates
SAPK/JNK1, 2 and p38 kinase during infection of endothelial cells (Verma et al.,
2002b). SAPK/JNK 1, 2 is phosphorylated at 1 and 8 hours after infection, and activated
p38 is observed until 8 hours post infection. These kinases also activate transcription
factor AP-1. The function of stress-activated kinases JNK, p38 kinase, and MEK1/2 in B.
bacilliformis uptake by endothelial cells is unknown. The present study attempts to
elucidate the role of MAPKs in B. bacilliformis invasion of endothelial cells.
Involvement of Phosphoinsotidine 3 Kinase in bacterial pathogenesis
Phosphotidylinositol kinases refer to a group of conserved molecules that
orchestrate receptor-mediated signaling. One of the membranes of this group of kinases,
phosphotidylinositol 3 kinase (PI3K), phosphorylates the three-position ring of
phosphatidylinositides at the plasma membrane. The resulting secondary messengers
modulate actin cytoskeletal functions and recruit effector molecules, which causes
changes in the membrane structure (Cantley, 2002). The cytoskeletal functions regulated
by PI3K are phagocytosis, migration, adhesion, and macropinocytosis. Due to these
functions, PI3K is necessary for the invasion of several pathogens, such as Pseudomonas
aeruginosa, Neisseria gonorrhoeae, and E. coli (Booth et al., 2003; Kierbel et al., 2005a;
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Sukumaran et al., 2002). The human herpes virus 8 (HHV8), the causative agent of
Kaposi’s sarcoma; a condition with similar etiology similar to that of verruga peruana,
relies on PI3K for efficient cellular entry (Naranatt et al., 2003). However, the role of
PI3K in B. bacilliformis infection of endothelial cells remains unexplored. Because
cytoskeletal regulation is heavily dependent on PI3K and required by several pathogens,
we examine the effect of PI3K inhibition on B. bacilliformis invasion into endothelial
cells.
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Materials and Methods
HMEC-1 cell line growth and culturing.
The immortalized human microvascular endothelial cell line (HMEC-1) was a
kind gift from Dr. Ades at the CDC, Atlanta (Ades EW et al., 1992). HMEC-1 cells from
passages 19–27 were grown in 15ml of growth media, consisting of 50% M199
(Cambrex), 15% FBS (Hyclone), 2% penicillin/streptomycin (Cellgro), and 50% EGM-2
(Cambrex). Cells were grown and maintained in T-75 flasks (Starstedt) at 37°C under
5% CO2 and humid conditions. The media were changed every 2–3 days until 70-80%
confluence was reached. The cells were maintained in 10ml of maintenance media
(M199 + 15%FBS + 2% penicillin/streptomycin) between passages. For cell detachment,
confluent cells were washed twice with PBS to remove all traces of serum, before adding
10mls/752mm cell stripper (Cellgro). The cells were incubated at 37°C for 10 minutes
and then gently scraped with cell scrapers (Starstedt). Detached cells were collected in
15ml Falcon tubes and centrifuged at 700xg for 10 minutes at 25°C. Cells were
resuspended in 1ml maintenance media and enumerated microscopically using the
hemocytometer, before seeding the T-25, T-75, and T-150 flasks or 6- or 24-well plates.
Cells were allowed to adhere for 1six hours before use.
To prepare frozen stocks, cell pellets were resuspended in the DMSO freeze
medium (Cellgro) to obtain a final concentration of 1x105 cells/ml. The vials then were
allowed to freeze at -80°C in a cryofreezing container (Nalgene) for 24 hours and
transferred to a liquid N2 tank facility.
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Bacterial growth and culturing.
B. bacilliformis KC584 was obtained from ATCC (35686) and grown on brain
heart infusion (BHI) plates supplemented with 10% sheep blood (BD Bioscience) at 26°C
for 4–7 days. Low-passage bacteria (1–3 passages) were used in all experiments. When
confluent colonies became visible, the plates were overlaid with 7mls of PBS. The
bacteria were gently scraped off the plate with a loop. The bacterial suspension was
centrifuged at 2000xg for 10 minutes at 25°C. Pellets were washed once with PBS and
centrifuged again. The final suspension was in 1ml of BHI broth, unless otherwise noted.
Radio-labeling of B. bacilliformis with 35S-methionine.
The method for radio-labeling is adapted from Williams-Bouyer et al (WilliamsBouyer et al., 1999). B. bacilliformis was harvested and pelleted as described. Bacterial
pellets were resuspended in 1ml methionine-free RPMI (Cellgro) containing 2% FBS and
0.2% sheep erythrocyte lysate. Radioactive, 35S-methionine (Perkin-Elmer) was added to
a final concentration of 50µCi/ml. B. bacilliformis was allowed to incorporate the
radioactivity for one hour at 26°C, after which the bacteria were washed twice with PBS
to remove unbound radioactivity. B. bacilliformis was resuspended in 1ml of PBS
containing 10mM glucose. The number of bacteria was determined microscopically
using a hemocytometer.
Kinase inhibitors.
The PD98059, SB203580, SP600125, and LY294002 all were purchased from
Calbiochem. Wortmannin was supplied by Axxora chemicals and the U0126 by Cell
Signaling Technologies. All compounds were dissolved in DMSO and diluted in M199
media containing 5% FCS. The concentrations used were 12.5µM, 25µM and 50µM,
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75µM, and100µM for PD98059, U0126, SB203580, and SP600125, respectively.
Wortmannin was diluted to 12.5nM, 25nM, 50nM, 100nM, and 250nM. The LY294002
concentrations used were 15µM, 30µM, 50µM, 75µM, 150µM, and 225µM. Dilutions
were prepared in such a manner that the final DMSO concentration was less than 0.1%.
Adhesion and invasion assays.
HMEC-1 cells were seeded at a concentration of 1×106cells/ml in 24-well plates
containing maintenance media. The media were aspirated after the cells were allowed to
adhere for 24 hours. Cells were washed three times with PBS. To the experimental
wells, 500μl of media containing different concentrations of inhibitor was added. Media
with DMSO also was added to control wells. Cells were incubated at 37°C under 5%
CO2 for one hour before the addition of radio-labeled B. bacilliformis at a m.o.i. of 1:100
m.o.i. in 100μl of PBS. Infection was allowed to proceed for six hours at 37°C with 5%
CO2. Unbound bacteria were removed by washing the cells four times with 1ml of PBS.
Surface-bound bacteria and cells were detached with 500μl of 0.08% trypsin-EDTA. An
equal volume of maintenance media then was added to neutralize the trypsin. The
bacterial and cell mixture was collected and centrifuged at 700xg for 10 minutes to pellet
the eukaryotic cells. The supernatant was aspirated and centrifuged at 2000xg for 10
minutes to collect B. bacilliformis. The HMEC-1 cell pellet was treated with 500μl of
1% Triton X100 to release internalized bacteria, then mixed with 5ml of Optima GoldXR
scintillation fluid. Bacterial pellets were resuspended in 500μl of PBS before being
added to the scintillation fluid. The volume of bacteria used to infect the cells also was
added to 5ml of scintillation fluid to determine the amount of radioactivity added.
Radioactivity was measured in a LS2500 scintillation counter. The percent
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adhesion/invasion was calculated as follows: (DPM recovered/DPM added)×100. The
percent adhesion/invasion results of the control experiments were normalized to 100, and
the adhesion/invasion experimental values were calculated in relation to that normalized
control. The percent inhibition was calculated as (normalized invasion –100). All
experiments were performed in triplicate, and p-values were determined by Student’s ttest.
Cell viability assay.
HMEC-1 cells were seeded at a concentration of 1×106cells/ml in 24-well plates
in maintenance media. Media were aspirated after the cells were allowed to adhere for 24
hours. Cells were washed three times with PBS. HMEC-1 cells were incubated for one
hour with 50µM of LY29004 prior to infection with B. bacilliformis at a m.o.i. of 1:100.
The three sets of controls consist of HMEC-1 cells, HMEC-1 cells with 50µM
LY294002, and HMEC-1 cells with B. bacilliformis. Plates were incubated at 37°C in a
5% CO2 incubator. The cells were processed for enumeration for two hours, six hours,
and 24 hours post infection. The unbound bacteria were removed by washing the cells
three times with PBS. Cells were incubated with 0.08% trypsin-EDTA to detach the
cells, and the tubes were centrifuged at 700xg for 10 minutes to pellet the cells. Cells
were resuspended in 50μl of PBS and stained with the same volume of trypan blue dye.
Cell enumeration was performed microscopically using a hemocytometer. Only viable
cells that did not take up trypan blue dye were counted. The percentage of viable cells
was calculated as (treated cells/untreated cells)×100.
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Fluorometric detection of apoptosis.
Cell viability assays were set up as written previously. At two hours, six hours,
and 24 hours post infection, the supernatant from all the wells was collected, and
adherent cells were subjected to trypsin treatment. The supernatant and detached cells
were pooled and spun down at 700xg for 10 minutes. The cell pellets were washed three
times with 500μl of PBS. The cells were resuspended in 100μl of 1X binding buffer from
the AnnexinV Apoptosis Kit (BD Biosciences). Cells were incubated with 5μl of 7AAD
(7-Amino actinomycin D) dye for 15 minutes in the dark at room temperature, then
concentrated by centrifugation at 700xg for five minutes. Cells were resuspended in 10μl
of1Xbinding buffer, and the entire volume was placed on glass slides for microscopic
examination. The cells were observed under white light, and the same field was
examined for apoptosis using fluorescent filters on the Axioplane microscope (Ziess).
Apoptosis was visually observed in cells that were stained red under the fluorescent
fliters.
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Results
Effect of MEK1/2 inhibitors on B. bacilliformis invasion into endothelial cells
MEK1/2 is one of many cell signal molecules that are a part of the extracellular
signaling pathway. These kinases regulate cell growth and differentiation regulators and
can be activated by membrane depolarization, growth factors, cytokines, and calcium
influx (Alessi et al., 1994; Crews et al., 1992; Rosen et al., 1994). In addition to the
functions mentioned, MEK1/2 is also implicated in bacterial uptake by host cells. The
MEK inhibitors PD98059 and U0126 were used to determine whether MEK1/2 is
involved in B. bacilliformis internalization by endothelial cells. Semi-confluent HMEC-1
cells in 24 wells were treated with different dilutions of MEK inhibitors for one hour of
MEK inhibitors. Media with 5% FCS and 0.1% DMSO were used as vehicle controls.
Pretreated cells were infected with radio-labeled B. bacilliformis at a m.o.i. of 1:100. for
six hours. Infected cells were processed to recover externally bound and internalized
bacteria. Results presented in figures 2.1a, 2.1b and tables 2.1a and 2.1b show that both
the compounds caused a decrease in B. bacilliformis uptake in a dose-dependent manner.
With PD9805809, the maximal degree of inhibition (41%) was achieved at 100µM
inhibitor concentration (Figure 2.1a and table 2.1a). However, it took only 50μM of
inhibitor to obtain this level of reduction when the inhibitor was U0126 (Figure 2.1b and
table 2.1b). At higher concentrations of U0126, the uptake was inhibited even more and
reached 81% at 100µM. B. bacilliformis uptake was not affected in assays with DMSO
alone (Figure 2.1b and table 2.1b). Bacterial attachment was not compromised by
inhibitors or DMSO. All results were statistically significant with p-values of <0.05. On
the basis of these studies, we conclude that MEK1/2 is required for optimal entry of B.
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bacilliformis into host cells. Because internalization was not completely abrogated,
additional factors may be required as well.
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Effect of MEK1/2 inhibitor PD98059 on B. bacilliformis invasion
into HMEC-1 cells
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Figure 2.1a. Effect of MEK1/2 inhibitors PD98059 on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various PD98059 concentrations.
Control infections were performed with DMSO concentrations to dissolve the inhibitor.
Cell supernatants were collected six hours post infection, after treatment with 0.08%
trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and then
resuspended in liquid scintillation fluid. The radioactivity recovered indicates the
number of externally bound bacteria. Percent invasion was calculated as (recovered
DPM/added DPM)×100. The percent invasion from the control experiments was set to
100, and percent invasion of the treated samples was calculated in relation to this
standard 100%. The X-axis denotes the concentration of inhibitor (µM) used; the Y-axis
shows the relative percent invasion. The numbers are the average of three replicates, and
error bars represent the SEM. The p-value was obtained by Student’s t-test, such that pvalues (*) ≤ 0.05 and (**)≤ 0.01 are considered significant.
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Table 2.1a. Effect of MEK inhibitor PD98059 on B. bacilliformis invasion into
endothelial cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of PD98059 or DMSO dissolved in M199 media with 5% serum. Percent
invasion and percent inhibition values are the means, ±SEM, of three experiments.
Invasion values were calculated as (recovered DPM/added DPM)×100, set to 100 for
untreated samples. Percent invasion from treated samples was calculated in relation to
100% invasion in untreated samples. Percent inhibition was calculated as (normalized
invasion – 100). Student t-test was performed with data from treated and untreated
samples; p-values of <0.05 are considered significant, and NA indicates not applicable.
Concentration
(µM)
0
12.5
25
50
75
100

Percent
Invasion
100±0.52
81.50±1.57
76.56±3.57
65.49±3.67
51.23±1.34
41.63±5.96

Percent
Inhibition
NA
18.58±1.57
23.04±3.57
34.33±3.67
48.18±1.34
59.00±5.96

p-Value
NA
0.035
0.026
0.004
0.002
0.002
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Effect of MEK1/2 inhibitor U0126 on B. bacilliformis invasion
into HMEC-1 cells
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Figure 2.1b. Effect of MEK1/2 inhibitor U0126 on B. bacilliformis invasion into HMEC1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various U0126 concentrations.
Control infections were performed with DMSO concentrations used to dissolve the
inhibitor. Cell supernatants were collected six hours post infection, after treatment with
0.08% trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and
then resuspended in liquid scintillation fluid. The radioactivity recovered indicates the
number of externally bound bacteria. Percent invasion was calculated as (recovered
DPM/added DPM)×100. The percent invasion from the control experiments was set to
100, and the percent invasion of the treated samples was calculated in relation to 100%.
The X-axis denotes the concentration of U0126 (µM) used, whereas the relative percent
invasion is plotted on the Y-axis. The numbers are the average of three replicates, and
error bars represent the SEM. The p-value was obtained by Student’s t-test, such that pvalues (**)≤ 0.01 are considered significant.
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Table 2.1b. Effect of MEK inhibitor U0126 on B. bacilliformis invasion into HMEC-1
cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of increasing concentrations of U0126 or 0.1% DMSO in M199 with 5%
FCS. Percent invasion and percent inhibition values are the means, ±SEM, of three
experiments. Invasion values were calculated as (recovered DPM/added DPM)×100 and
set to 100 for untreated samples. Percent invasion from treated samples was calculated in
relation to the 100% invasion in untreated samples; percent inhibition is (normalized
invasion – 100). Student’s t-test, performed with data from treated and untreated
samples, provides p-values, and those <0.05 were considered significant. NA indicates
not applicable.
Concentration
(µM)
0
12.5
25
50
75
100

Percent
Invasion
100±0.14
89.54±0.59
80.04±1.06
48.22±1.28
26.06±0.43
18.85±0.62

Percent
Inhibition
NA
10.46±0.59
19.96±1.06
51.78±1.28
73.94±0.43
81.15±0.62

p-Value
NA
0.005
0.0008
0.0007
0.0003
0.0003
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Effect of p38 kinase inhibitor on B. bacilliformis invasion into HMEC-1 cells
The p38 kinase belongs to the stress response signaling pathway and is activated
by numerous factors, such as LPS, inflammatory cytokines, and growth factors (Han et
al., 1994; Raingeaud et al., 1995). Its role in uptake of certain bacteria also has been
demonstrated. A highly specific inhibitor of p38 kinase, SB203580 also suppresses
MAPKAP kinase-2 (mitogen activated protein kinase-activated protein kinase2) and Hsp27 activation in response to IL-2, stress factors, and bacterial endotoxin (Cuenda et al.,
1995). Concentrations of SB203580 ranging from 12.5µM to 100µM were used to treat
monolayers before the addition of B. bacilliformis. Bacterial uptake was determined after
six hours of infection by the method previously described. An inhibitor concentrationdependent decrease in B. bacilliformis ingestion was observed (Figure 2.2 and table 2.2).
Bacterial uptake was significantly inhibited by 26.3% at 50µM and 40.7% at 100µM
(Figure 2.2 and table 2.2). Bacterial adhesion to cell surfaces was not affected at any
point. Control experiments with 0.1% DMSO had no effect on B. bacilliformis adhesion
or invasion. These observations suggest that a p38 kinase pathway is required for
optimal B. bacilliformis ingestion by HMEC-1 cells.
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Effect of p38 kinase inhibitor SB203580 on B.
bacilliformis invasion into HMEC-1 cells
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Figure 2.2. Effect of p38 kinase inhibitor SB203580 on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various SB203580 concentrations.
Control infections were performed with DMSO concentrations, used to dissolve the
inhibitor. Cell supernatants were collected six hours post infection, after treatment with
0.08% trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and
then resuspended in liquid scintillation fluid. The radioactivity recovered indicates the
number of externally bound bacteria. Percent invasion was calculated as (recovered
DPM/added DPM)×100, with percent invasion from the control experiments set to 100
and that of the treated samples calculated in relation to 100%. The X-axis denotes the
concentration of SB203580 (µM) used, and the relative percent invasion is plotted on the
Y-axis. The numbers reflect the average of three replicates, and error bars represent the
SEM. The p-value was obtained by Student’s t-test, such that p-values (*) ≤ 0.05 and
(**)≤ 0.01 are considered significant.
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Table 2.2. Effect of p38 kinase inhibitor, SB203580 on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of SB203580 or DMSO dissolved in M199 media with 5% serum. Percent
invasion and percent inhibition values are the means, ±SEM, of three experiments.
Invasion values were calculated as (recovered DPM/added DPM)×100 and set to 100 for
untreated samples. The percent invasion from treated samples was calculated in relation
to the 100% invasion in untreated samples, whereas percent inhibition equals (normalized
invasion – 100). Student’s t-tests performed with data from treated and untreated
samples suggests p-values <0.05 are significant. NA indicates not applicable.
Concentration
(µM)
0
12.5
25
50
75
100

Percent
invasion
100±0.3
85.66±1.58
79.75±4.02
73.72±3.28
55.98±2.41
59.23±1.88

Percent
inhibition
NA
14.26±1.58
20.97±2.20
26.26±0.37
43.98±0.71
40.7±1.24

p-Value
NA
0.02
0.015
0.002
0.002
0.002
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Effect of JNK1/2/3 kinase inhibitor on B. bacilliformis invasion into HMEC-1 cells
Stress-activated protein kinase/Jun amino terminal kinase (SAPK/JNK) is
potently and preferentially stimulated by cellular stress factors. This kinase is activated
early during B. bacilliformis infection. However, the role of SAPK/JNK during B.
bacilliformis uptake remains unresolved. A potent yet reversible inhibitor of JNK,
SP600125 was used to block JNK phosphorylation. HMEC-1 cells were infected with B.
bacilliformis for six hours in the presence of various SP600125 dilutions. At the end of
the infection, intracellular bacteria were recovered from lysed cells, and radioactivity was
measured.
Inhibition of JNK decreased B. bacilliformis internalization by HMEC-1 cells,
depending on the inhibitor concentration. As seen in figure 2.3 and table 2.3, bacterial
invasion decreased from 76.6% at 12.5 µM to 52.71% at 75µM of SP600125. However,
the inhibitor did not affect the adhesion of B. bacilliformis to the cell surface. No change
in invasion or adhesion was recorded in experiments carried out in the presence of 0.1%
DMSO, the control drug vehicle used to dissolve SP600125. Therefore, JNK
phosphorylation appears to play a role in B. bacilliformis penetration into HMEC-1 cells.
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Effect of JNK1/2/3 kinase inhibitor SP600125 on B.
bacilliformis invasion into HMEC-1 cells
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Figure 2.3. Effect of JNK1/2/3 inhibitor SP600125 on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various SP00125 concentrations.
Control infections were performed with the DMSO concentrations used to dissolve the
inhibitor. Cell supernatants were collected six hours post infection, after treatment with
0.08% trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and
then resuspended in liquid scintillation fluid. The radioactivity recovered indicates the
number of externally bound bacteria. Percent invasion, calculated as (recovered
DPM/added DPM)×100, is set to 100 for the control experiments; the percent invasion of
the treated samples was calculated in relation to this 100% level. Whereas the X-axis
denotes the concentration of SP600125 (µM) used, the Y-axis reveals the relative percent
invasion. The numbers indicate the average of three replicates; error bars represent the
SEM. The p-value was obtained by Student’s t-test, such that p-values (*) ≤ 0.05 and
(**)≤ 0.01 are considered significant.
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Table 2.3. Effect of JNK inhibitor SP600125 on B. bacilliformis invasion into HMEC-1
cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of SP600125 or DMSO dissolved in M199 media with 5% serum. Percent
invasion and percent inhibition values are the means, ±SEM, of three experiments.
Invasion values were calculated as (recovered DPM/added DPM)×100 and set to 100 for
untreated samples. Percent invasion from treated samples was calculated in relation to
the 100% invasion in untreated samples, whereas percent inhibition was calculated as
(normalized invasion – 100). The Student’s t-test was performed with data from treated
and untreated samples. A p-value ≤0.05 was considered significant, and NA means not
applicable.
Concentration
(µM)
0
12.5
25
50
75
100

Percent
Invasion
100±0.39
76.6±1.2
72.41±1.88
63.42±1.83
52.71±2.16
58.15±4.13

Percent
Inhibition
NA
23.31±1.2
27.44±1.88
36.46±1.83
47.09±2.16
40.05±4.13

p-Value
NA
0.012
0.007
0.003
0.005
0.05
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Effect of PI3K inhibition on B. bacilliformis invasion into HMEC-1 cells
Phosphoinositide 3 kinase (PI3K) is an integral part of the signal cascades
involved in diverse cellular functions. These functions range from cell growth and
survival to intracellular trafficking of molecules. Various pathogens employ PI3K for
translocation into host cells. The role of PI3K in B. bacilliformis invasion into
endothelial cells was determined by using the specific inhibitors wortmannin and
LY294002. Both inhibitors are specific for PI3K and have been used in previous studies.
The HMEC-1 cells were incubated for one hour with different concentrations of
wortmannin or LY294002. B. bacilliformis then were allowed to infect the cells in the
presence of these compounds. The cells were processed to recover intracellular bacteria
after six hours of infection. The radioactivity of the radio-labeled intracellular B.
bacilliformis was measured with a liquid scintillation counter, which revealed that PI3K
inhibition had a dramatic effect on B. bacilliformis internalization. Although, no change
in invasion was recorded at 12.5 and 25nM of wortmannin a gradual decrease in the
number of intracellular bacteria recovered occurred at concentrations greater than 25nM
(Figure 2.4a and table 2.4a). The maximal effect on invasion took place at 250nM, at
which point only 35% of intracellular bacteria were recovered (Figure 2.4a and table
2.4a). Low concentrations of LY294002—15µM and 30µM—also inhibited invasion by
41% and 44%, respectively (Figure 2.4b and table 2.4b). B. bacilliformis attachment to
external cell surfaces was not affected by the inhibitors, whereas invasion and adhesion
remained unaffected in the presence of 0.1% DMSO control assays. These studies
demonstrate the need for PI3K during B. bacilliformis invasion into endothelial cells.
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Effect of PI3K inhibitor wortmannin on B. bacilliformis invasion
into HMEC-1 cells
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Figure 2.4a. Effect of PI3K inhibitor wortmannin on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various wortmannin concentrations.
Control infections were performed with DMSO concentrations, used to dissolve the
inhibitor. Cell supernatants were collected six hours post infection, after treatment with
0.08% trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and
then resuspended in liquid scintillation fluid. The radioactivity recovered indicates the
number of externally bound bacteria. Percent invasion was calculated as (recovered
DPM/added DPM)×100. The percent invasion from the control experiments was set to
100, and the percent invasion of the treated samples was calculated in relation to 100%.
The X-axis denotes the concentration of wortmannin (nM) used; the Y-axis displays the
relative percent invasion. The numbers equal the average of three replicates, and error
bars represent the SEM. The p-value was obtained by Student’s t-test, such that p-values
(*) ≤ 0.05 is considered significant.
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Table 2.4a. Effect of PI3K inhibitor wortmannin on B. bacilliformis invasion into
HMEC-1 cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of wortmannin or DMSO dissolved in M199 media with 5% serum. Percent
invasion and percent inhibition values are the means, ±SEM, of three experiments.
Invasion values, calculated as (recovered DPM/added DPM)×100, were set to 100 for
untreated samples; the percent invasion from treated samples then was calculated in
relation to the 100% invasion in untreated samples. Percent inhibition was calculated as
(normalized invasion – 100). Student’s t-tests were performed with data from treated and
untreated samples. The p-value <0.05 was considered significant, and NA indicates not
applicable.
Concentration
(µM)
0
12.5
25
50
100
250

Percent
Invasion
100±0.04
100.44±2.10
96.59±4.10
79.55±4.77
64.37±5.90
35.10±0.03

Percent
Inhibition
NA
0.44±2.10
3.41±4.10
20.45±4.77
35.63±5.90
61.90±3.75

p-Value
NA
0.4
0.2
0.02
0.03
0.012
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Effect of PI3K inhibitor LY294002 on B. bacilliformis invasion
into HMEC-1 cells
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Figure 2.4b. Effect of PI3K inhibitor LY294002 on B. bacilliformis invasion into HMEC1 cells.
HMEC-1 cells were grown in 24-well plates and infected with 35S-methionine labeled B.
bacilliformis at a m.o.i. of 1:100 in the presence of various LY294002 concentrations.
Control infections were performed with DMSO concentrations that dissolve the inhibitor.
Cell supernatants were collected six hours post infection, after treatment with 0.08%
trypsin. Cell pellets obtained by centrifugation were lysed in 1% Triton X100 and
resuspended in liquid scintillation fluid. The radioactivity recovered reveals the number
of externally bound bacteria. Percent invasion was calculated as (recovered DPM/added
DPM)×100. The percent invasion from the control experiments was set to 100, and the
percent invasion of the treated samples was calculated in relation to this 100% level. The
X-axis denotes the concentration of LY294002 (μM) used. The relative percent invasion
is plotted on the Y-axis. These numbers average three replicates. Error bars represent
the SEM. The p-value was obtained by Student’s t-test, such that p-values (*) ≤ 0.05 is
considered significant.
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Table 2.4b. Effect of PI3K inhibitor LY294002 on B. bacilliformis invasion into HMEC-1
cells.
HMEC-1 cells were infected with 35S-methionine labeled B. bacilliformis for six hours in
the presence of LY294002 or DMSO dissolved in M199 media with 5% serum. Percent
invasion and percent inhibition values equal the means, ±SEM, of three experiments.
Invasion values were calculated as (recovered DPM/added DPM)×100, set to 100 for
untreated samples. Percent invasion from treated samples was calculated in relation to
the 100% invasion in untreated samples. Percent inhibition was calculated as
(normalized invasion – 100). Using data from treated and untreated samples, Student’s ttests demonstrate significance at p-values <0.05. NA is not applicable.
Concentration
(µM)
0
15
30

Percent
Invasion
100±0.32
58.28±3.0
55.36±5.86

Percent
Inhibition
NA
41.72±3.20
44.64±5.86

p-Value
NA
0.045
0.015
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Effect of PI3K inhibition on viability of B. bacilliformis infected HMEC-1 cells
PI3K plays an extremely important role in cell survival by inactivating proapoptotic factors. At concentrations greater than 50µM, LY294002 inhibited B.
bacilliformis invasion by 61% (data not shown). However, this effect was due to cell
death that leads to cell detachment. Therefore to understand the function of PI3K in cell
attachment and survival, the cell viability of infected cells was examined in the presence
of 50µM LY294002. HMEC-1 cells were incubated with 50µM of LY294002 in the
presence or absence (control) of B. bacilliformis. Control wells consisted of untreated
HMEC-1 cells and B. bacilliformis–infected cells without the inhibitor. At two, six, and
24 hours, cells were washed thoroughly and detached with a mild trypsin treatment.
Cells were stained with trypan blue to enable differentiation between unstained live cells
and blue dead cells. Viable cells were scored microscopically, and the percentage of
viable cells was calculated with respect to the appropriate controls as described in the
materials and method section. As figure 2.5a shows, inhibition of PI3K affects the
viability of both uninfected and infected cells, but the detrimental effects of the PI3K
inhibitor are more pronounced in the presence of B. bacilliformis. The number of viable
LY294002-treated cells decreases by 25% after two hours of bacterial infection, and by
81%, six hours post infection (Figure 2.5a and table 2.5). Control cells that received only
LY294002 retained 85% and 79% viable cells after two and six hours of incubation,
respectively. By 24 hours, no surviving cells were recovered from wells containing
HMEC-1, inhibitor, and B. bacilliformis, whereas 58% of uninfected cells remained
viable at that point (Figure 2.5a and table 2.5). Cell viability remains unaffected in the
absence of the inhibitor.
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Cell death was also examined with 7AAD fluorescent dye, a DNA stain that
permeates only compromised membranes of dead cells. The stained cells that took up the
dye were viewed under a fluorescence microscope, which revealed that the number of
fluorescent cells increased with time. At two hour post infection, no apoptic cells were
detected in cell treated with LY294002 in the presence or absence B. bacilliformis
(Figure 2.5b and 2.5c). The increase in the number of dead cells infected with B.
bacilliformis, in the presence of inhibitor is much more dramatic at six and 24 hours post
infection (Figure 2.5e and 2.5g), whereas uninfected cells (with LY294002) did not
undergo cell death at these times points (Figure 2.5d and 2.5f) These results strongly
support the hypothesis that B. bacilliformis-induced cell survival depends on the PI3K
pathway.
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Effect of LY294002 on HMEC-1 cell viability in the presence of
B. bacilliformis
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Figure 2.5a. Effect of LY294002 on HMEC-1 cells infected with B. bacilliformis.
HMEC-1 cells were infected with B. bacilliformis in the presence of 50µM of LY294002.
Another set of experimental wells contained HMEC-1 and 50µM of LY294002. Wells
that contained HMEC-1 cells serve as the controls for this set of experiments. At two,
six, and 24 hours post infection, the cells were washed to remove unbound bacteria and
detached cells. The adherent cells were trypsinized with 0.08% trypsin-EDTA for 10
minutes, then cells were centrifuged at 700xg, and the pellet was resuspended in 50µl of
PBS and 50µl of trypan blue. The tubes were incubated for 10 minutes; cells then were
enumerated microscopically using a hemocytometer. The percentage of viable cells was
calculated with respect to the controls. The X-axis in the figure denotes the time in
hours, whereas the Y-axis plots the percentage of viable cells. The numbers indicate the
average of three replicates; error bars represent the SEM. The p-value was obtained by
Student’s t-test, such that p-values (*) ≤ 0.05 and (**)≤ 0.01 are considered significant.
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Table 2.5. Effect of PI3K inhibitor LY294002 on the viability of infected HMEC-1 cells.
HMEC-1 cells in the presence of M199 media with 5% serum containing 50μM
LY294002 were infected with B. bacilliformis (Bb) for two, six, and 24 hours. Control
wells received only bacteria. HMEC-1 alone or with 50µM LY294002 were used to
determine the effect of the inhibitor on uninfected cells. Viable cell values are the means,
±SEM, of three experiments. Invasion values were calculated as (untreated cells/treated
cells)×100.
Condition
Time in hours
HMEC-1+LY294002

2
85.38±6.30

HMEC1+LY294002+Bb

75.15±0.3

Viable Cell (%)
6
24
79.67±4.85 58.24±6.94
19.48±1.78

0.00±0.00
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Figure 2.5b. Effect of PI3K inhibitor, LY294002, on endothelial cell viability, two hours
post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for two hours. Control cells
were left untreated. Cells were washed and detached with 0.08% trypsin-EDTA, then
stained with fluorescent dye 7AAD and examined under the microscope. Panels A and B
display untreated HMEC-1 cells, as seen under light and fluorescent filters, respectively.
Panels C and D depict LY294002-treated HMEC-1 cells, again as seen under light and
fluorescent filters, respectively.

129

A

B

C

D

Figure 2.5c. Effect of PI3K inhibitor, LY294002, on B. bacilliformis-infected endothelial
cell viability, two hours post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for two hours. Control cells
were left untreated. Cells were washed and detached with 0.08% trypsin-EDTA, then
stained with fluorescent dye 7AAD and examined under the microscope. Panels A and B
reveal B. bacilliformis-infected HMEC-1 cells under light and fluorescent filters,
respectively. Panels C and D show LY294002-treated, B. bacilliformis-infected HMEC1 cells under light and fluorescent filters, respectively.
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Figure 2.5d. Effect of PI3K inhibitor, LY294002, on endothelial cell viability, six hours
post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for six hours. Whereas the
control cells were left untreated, other cells were washed and detached with 0.08%
trypsin-EDTA, then stained with fluorescent dye 7AAD and examined under the
microscope. Panels A and B show untreated HMEC-1 cells under light and fluorescent
filters, respectively. Panels C and D depict LY294002-treated HMEC-1 cells, again
under light and fluorescent filters.
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Figure 2.5e. Effect of PI3K inhibitor, LY294002, on B. bacilliformis-infected endothelial
cell viability, six hours post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for six hours. Control cells were
left untreated. After being washed and detached with 0.08% trypsin-EDTA, cells were
stained with fluorescent dye 7AAD and examined under the microscope. Panels A and B
display B. bacilliformis-infected HMEC-1 cells, as seen under light and fluorescent
filters, respectively. Panels C and D are LY294002-treated, B. bacilliformis-infected
HMEC-1 cells, as seen under light and fluorescent filters.
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Figure 2.5f. Effect of PI3K inhibitor, LY294002, on endothelial cell viability, 24 hours
post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for 24 hours. Control cells were
left untreated. Cells were washed and detached with 0.08% trypsin-EDTA, then stained
with fluorescent dye 7AAD and examined under the microscope. Untreated HMEC-1
cells appear under light and fluorescent filters in Panels A and B, respectively. The
LY294002 treated HMEC-1 cells under light and fluorescent filters appear in Panels C
and D, respectively.
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Figure 2.5g. Effect of PI3K inhibitor, LY294002, on B. bacilliformis-infected endothelial
cell viability, 24 hours post-infection.
HMEC-1 cells were incubated with 50µM of LY294002 for 24 hours. Control cells were
left untreated. Cells were washed and detached with 0.08% trypsin-EDTA and then
stained with fluorescent dye 7AAD and examined under the microscope. Panels A and B
reveal B. bacilliformis-infected HMEC-1 cells under light and fluorescent filters,
respectively. Panels C and D are LY294002-treated, B. bacilliformis-infected HMEC-1
cells under light and fluorescent filters, respectively.
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Discussion
Role of MAP kinases in B. bacilliformis invasion of endothelial cells
Pathogens commonly hijack cytosolic signaling pathways to establish intracellular
infection. After the bacteria attach to cell receptors, they initiate a signaling cascade that
results in the modulation of the cytoskeletal network and optimizes bacterial translocation
into the cells. The recruitment of signaling molecules by bacteria also ensures their
intracellular survival and the prevention of host cell death. Incubation of B. bacilliformis
with host cells results in ingestion and subsequent host cell proliferation (Garcia, F. et al.,
1992; Hill et al., 1992). Electron transmission observations of infected cells show the
presence of B. bacilliformis both inside and outside endocytotic vesicles, which suggests
internalization by phagocytosis (Hill et al., 1992). The same study reveals the incomplete
inhibition of B. bacilliformis invasion in the presence of cytochalasin D, an actin
polymerization inhibitor. Inactivation of small GTPases also impairs B. bacilliformis
invasion into endothelial cells (Verma et al., 2000; Verma et al., 2002b). Activated
MAPKs, SAPK/JNK1 and 2, p38 kinase, and their downstream JNK-dependent
transcription factors have been detected in B. bacilliformis-infected endothelial cells
(Verma et al., 2002b), though the relation between activated MAPKs and B.
bacilliformis internalization remains unclear. The role of MAPKs in B. bacilliformis
infection is studied herein by inhibiting the kinases during the course of the invasion
assay. All three MAPKs are required for B. bacilliformis invasion; furthermore, the
percentage of internalized B. bacilliformis is reduced but never completely inhibited at
the various inhibitor concentrations investigated.
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PD98059 and U0126 are highly selective inhibitors of MEK1/2, PD98059 and
U0126 and prevent the activation of MAP kinase and their substrates (Alessi et al., 1995;
Favata et al., 1998). The suppression of microbial invasion in the presence of MEK1/2
inhibitors already has been reported for several bacteria. For example, C. jejuni 81-176
invasion decreased by 75% in the presence of 50μM PD98059, and at 100μM of
PD98059, L. monocytogenes invasion was reduced by a factor of 10; similar effects were
observed in the context of S. aureus infection of osteoblasts (Ellington et al., 2001; Tang
et al., 1998). In the study described here, MEK1/2 inhibition has a negative effect on B.
bacilliformis uptake by endothelial cells. Specifically, invasion was inhibited by 59%
and 81% with 100μM of the compounds PD98059 and U0126, respectively, without any
detrimental effect on bacterial attachment. However, U0126 had a stronger inhibitory
effect on B. bacilliformis than PD98059, perhaps because U0126 has a significantly
greater affinity for MEK1 than PD98059 and the capacity to suppress both MEK1 and 2,
unlike PD98059, which inhibits MEK1 more potently than it does MEK2 (Favata et al.,
1998). Thus, both MEK1 and 2 may be required for B. bacilliformis penetration into host
cells. The MAPK substrates for activated MEK1/2 are ERK1/2. When activated,
ERK1/2 transmit signals to the migration pathways of various cell types in response to
extracellular matrix (ECM) proteins such as fibronectin, vitronectin, and collagen
(Anand-Apte et al., 1997). The activation state of ERK1/2 in B. bacilliformis-infected
cells is not known, but the need for MEK1/2 during B. bacilliformis invasion supports the
notion that MEK1/2 could be phosphorylated upon B. bacilliformis infection. In
addition, phosphorylated paxillin can be detected in B. bacilliformis infected endothelial
cells, which in turn is known to facilitate activation of ERKs (Ishibe et al., 2003; Verma
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et al., 2001). Activated ERKs have several cytoskeletal elements that could be required
for bacterial internalization. In particular, some activated ERK molecules affect
cytoplasmic protein phosphorylation. One of the cytosolic targets modulated by ERK2 is
phospholipase A2, an essential regulator of endothelial motility (Sa et al., 1995). In
addition, ERK2 appears colocalized in a cytoskeleton signaling complex, targeted by
leukocyte-specific protein1 to the peripheral actin filaments (Harrison et al., 2004).
ERKs also phosphorylate paxillin, which participates in regulation of adhesion and
morphogenesis (Ishibe et al., 2003; Ku et al., 2000). Determination of the ERK1/2
activation state and further elucidation of the receptors that mediate their stimulation
during B. bacilliformis invasion should help delineate more precisely the events that lead
to B. bacilliformis uptake accurately.
Phosphorylated JNK acts on a wide range of substrates, including transcription
factors, apoptosis-related proteins, signaling molecules, and cytoskeletal associated
proteins. As a result of its association with cytoskeletal molecules, JNK plays an
important role in cell migration and reorganization (Huang et al., 2004). Previous studies
have demonstrated the presence of activated JNK in B. bacilliformis infected endothelial
cells(Verma et al., 2002b). We show that inhibition of JNK with SP600125 affects B.
bacilliformis ingestion. In a similar study with N. meningitidis, the invasion process has
been shown to depend on JNK (Sokolova et al., 2004), and JNK activation may be
associated with the internalization of P. gingivalis in epithelial cells (Watanabe et al.,
2001). Although B. bacilliformis invasion was affected by JNK inhibition, adhesion
remained unaffected; this indicates that the decrease in invasion actually is a function of
JNK inhibition, not inefficient adhesion. Furthermore, B. bacilliformis uptake by
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endothelial cells was not abrogated completely in the presence of SP600125; therefore,
JNK-independent pathways could be involved during the infection process.
Kinase p38 traditionally is involved in cytokine responses, apoptosis, and cell
differentiation. The role of p38 kinase in cell migration also is becoming clearer in recent
studies. For example, the p38 kinase inhibitor SB203580 impairs growth factors and
cytokine-induced cell migration in various cell types. One of the substrates for p38
kinase, heat shock protein 27 (Hsp-27), modulates cell migration through actin dynamics
(Rousseau et al., 1997). In addition, SB203580 suppresses not only p38 but also Hsp-27
in response to bacterial endotoxin, IL-1, and cellular stress (Cuenda et al., 1995). The α
isoform of p38 kinase specifically is inhibited by SB203580; this isoform is the
predominant form of p38 kinase in the endothelial cells we use in our invasion assays
(Gum et al., 1998). This inhibitor also has been used effectively to demonstrate a
requirement for p38 in C. jejuni and S. typhi invasions (Hobbie et al., 1997; Hu et al.,
2006). B. bacilliformis penetration into HMEC-1 cells also is partially inhibited when
p38 activation is inhibited. The degree of bacterial attachment remains the same as that
observed in control assays; hence, the reduced invasion can be considered due to the
effects of p38 kinase inhibition, not decreased adhesion. At the present time, the
cytoskeletal proteins affected by p38 kinase in B. bacilliformis-infected cells are
unknown. One attractive substrate for activated p38 kinase, caldesmon (caD), is an actin,
myosin-binding protein. Previous caD mutation studies show that it plays a critical role
in endothelial cell cytoskeletal remodeling and its activation depends on p38 kinase
(Mirzapoiazova et al., 2005).
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Invasive pathogens bind to receptors and trigger host signal cascades. Receptormediated signal transduction also recruits various MAPKs that participate in the
cytoskeletal modulation required for efficient bacterial ingestion. Our work provides data
in support of the hypothesis that B. bacilliformis invasion is a complex process involving
multiple kinases. The MAPK effector proteins engaged in B. bacilliformis have not been
previously studied. Most downstream MAPK mediators are transcription factors and
cytoskeletal proteins that must be identified to understand the course of cytoskeletal
alterations that lead to optimized B. bacilliformis uptake and pathogenesis.
Role of PI3K in B. bacilliformis endothelial cell invasion and survival
The actin network is regulated by kinases other than those of the MAPK family.
Phosphoinositides such as PI3K are short-lived lipid kinases that play a significant role in
the modulation of the cytoskeletal scaffold. These lipid kinases also have an established
role in cell motility and phagocytosis and can be synthesized at cell membrane sites
through carefully orchestrated events that themselves can be altered by pathogens to
optimize their cell entry. InlA- and B-mediated L. monocytogenes entry, P. aeruginosa
and C. pneumoniae invasion, and FimH-dependent uropathogenic E. coli entry into host
cells all depend on the activation of PI3K (Coombes et al., 2002; Ireton et al., 1996;
Kierbel et al., 2005b; Martinez et al., 2002). Furthermore, small GTPases and PI3K are
part of a complex regulation system. Rac activates PI3K, and PI3K inhibition prevents
GTP loading of Rac (Kotani et al., 1995). Thus, Rac can act both upstream and
downstream of PI3K. In addition to Rac activation, PI3K inhibition can prevent
membrane ruffling and actin assembly in PDGF and insulin-stimulated cells (Kotani et
al., 1995; Wennstrom et al., 1994). The inhibitory effects of pharmacological PI3K
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inhibitors also emerge in Helicobacter pylori-infected cells. Specifically, H. pylori
mediated, activated PI3K molecules accumulate at the leading phagosomes, but this
accumulation (along with actin polymerization) is blocked in the presence of nanomolar
concentrations of the PI3K inhibitor wortmannin (Allen et al., 2005). Although we did
not examine the subcellular location and activation state of PI3K in B. bacilliformisinfected cells, we observed that PI3K inhibition by two different compounds, namely,
wortmannin and LY294002, markedly reduces the number of intracellular B.
bacilliformis recovered from endothelial cells. Wortmannin is an irreversible, nonspecific inhibitor that is unstable in aqueous solutions, whereas LY294002 is a stable,
specific, but reversible inhibitor. The exact mechanism by which B. bacilliformis
exploits PI3K to gain entry into host cells remains unclear, but B. bacilliformis can be
found in small aggregates surrounded by membrane protrusions that eventually engulf the
membrane-bound bacteria; furthermore, the requirement for Rho, Rac, and Cdc42 in B.
bacilliformis infection already has been elucidated.(Arias-Stella et al., 1986a; Verma et
al., 2002b). Because small GTPases act both upstream and downstream of PI3K, it is
tempting to assume that the PI3K requirement involves both Rac and Cdc42. Additional
experiments that link the small GTPases to the PI3K pathway would help expand the
knowledge base pertaining to invasion tactics employed by B. bacilliformis.
Alternatively, PI3K could also impede B. bacilliformis internalization by preventing the
Rac stimulated pseudopod extension during bacterial engulfment (Cox, D. et al., 1999).
Beyond its function in regulating cytoskeleton dynamics, PI3K is an essential
member of the anti-apoptotic pathway (Kennedy et al., 1997; Qi et al., 1999). Activated
PI3K induces the phosphorylation of protein kinase B/Akt (PKB/Akt) through PIP3,
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which in turn contributes to cell survival by inactivating the pro-apoptotic Bcl-2 proteins,
such as BAD (Bcl-2 associated death promoter) (Datta et al., 1997). The intracellular
survival of Bartonella spps and endothelial proliferation requires that anti-apoptotic
signals prevent cell death. B. henselae-associated endothelial proliferation results from
the suppression of caspase activation in the early stages of infection and the prevention of
DNA fragmentation in the later stages by unidentified factors (Kirby et al., 2002b).
Furthermore, B. quintana infected endothelial cells show an interesting pattern of
programmed cell death. Initially, B. quintana induces apoptosis with peaks at six hours
post infection, after which anti-apoptotic factors become activated and mitogenesis
occurs. The factors analysed during this process include caspase 8, the APAF-1 gene,
and Bcl-2 (Liberto et al., 2003). No information indicates which host cell survival
proteins are involved in B. bacilliformis-infected endothelial cells. During the course of
the invasion assays with the PI3K inhibitor LY294002, we observed that at
concentrations at or above 50μM, the infected cells underwent detachment. Upon further
examination, we found that in the presence of LY294002 (50μM), the number of viable,
B. bacilliformis-infected cells dramatically decreased during the course of the infection,
becoming undetectable by 24 hours post infection. We examined the viability using
trypan blue and 7AAD stain, both of which permeate cells with compromised plasma
membranes. Cells stained with 7 AAD showed distinct nuclear condensation at six hours
post infection, a hallmark of cells undergoing apoptosis (Figure 2.5e). LY294002 also
influenced the uninfected endothelial cells to a certain degree, though 59% of viable cells
still were recovered after 24 hours. Other bacteria also use the PI3K pathway for cell
survival, including P. gingivalis, S. enterica serovar Typhimurium, and M. tuberculosis,
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which promote cell survival through the PI3K/Akt cascade (Forsberg et al., 2003; Maiti
et al., 2001; Yilmaz et al., 2004). In transformed epithelial cells and serum-deprived
fibroblasts, small GTPases (Rac and Cdc42) prevent apoptosis by maintaining the actin
network (Cheng et al., 2004; Ruggieri et al., 2001). In both these cases, the protective
function of Rac and Cdc42 can be inhibited by PI3K inhibitors. Activation of Rac and
Cdc42 occurs in B. bacilliformis-infected endothelial cells. Further research focused on
the function of small GTPases and PI3K during cell survival could provide important
information about how B. bacilliformis manipulates the host cell pathways for its
propagation.
This study provides the first demonstration of the necessity of PI3K for the
survival of B. bacilliformis-infected endothelial cells. The data provide a platform for
further analysis of apoptosis kinetics modulated by B. bacilliformis in endothelial cells.
The bacterial regulation of cell survival mediators varies during the course of the
infection; therefore, it would be interesting to investigate whether B. bacilliformis inhibits
apoptosis like B. henselae or causes early apoptosis, followed by anti-apoptotic signals,
as seen with B. quintana and to determine how PI3K participates in these events.
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Chapter III: Expression patterns of genes involved in B. bacilliformis uptake
Introduction
Bartonella bacilliformis is an ancient human pathogen that causes the bi-phasic
Carrion’s disease. The primary hematic phase results from erythrocytic infection by B.
bacilliformis, whereas the persistent intracellular colonization of endothelial cells is the
hallmark of the second phase. Endothelial cell parasitization induces several
morphological changes, including the subversion of apoptosis and the activation of
proinflammatory, mitogenic, and angiogenic factors. These changes ultimately culminate
in vasoproliferative tumor growth, manifested as blood-filled lesions on bodily
extremities.
Bacterial interaction with cell receptors and prolonged colonization results in the
modulation of various host cytolosic and nuclear proteins and genes. We have shown
that B. bacilliformis engages integrins to gain entry into endothelial cells. The integrin–
B. bacilliformis interaction could be direct or indirect via integrin ligands. Integrins, the
dynamic receptors that maintain cell adhesion to the extracellular matrix and thus ensure
cell survival, represent anchoring molecules that also function in relaying extracellular
signals to the cells and intracellular signals to the outside environment, which enables the
cells to adapt to any changes. Additional, critical roles of integrins include cytoskeletal
organization and regulation of cell proliferation signaling pathways. Integrin activation
has also been known to alter the activation state of various transcription factors.
Some endothelial cytoplasmic proteins required for the establishment of B.
bacilliformis have been studied in our laboratory and documented by other researchers,
including the small GTPases Rac, Cdc42, and Rho, which are activated upon infection
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and alter the actin network to facilitate B. bacilliformis internalization (Verma et al.,
2000; Verma et al., 2002b). The protein kinases with multiple functions that participate
in B. bacilliformis infection are mitogen activated protein kinases (MAPKs), protein
tyrosine kinases (PTKs) such as focal adhesion kinase, p21-activated kinase and lipid
kinase phosphotidyl inositol 3 kinase (PI3K) (Verma et al., 2002b; Williams-Bouyer et
al., 1999). The activation of these proteins can be controlled by integrin-mediated
pathways and then the activated MAPKs can regulate DNA transcription factors.
Inhibition of MAPKs, PTKs, and PI3K impairs B. bacilliformis invasion into endothelial
cells, possibly by disrupting the optimal organization of actin scaffold for bacterial
invasion (Williams-Bouyer et al., 1999). Activation of the transcription factor AP-1 also
has been recorded in endothelial cells infected with B. bacilliformis (Verma et al.,
2002b), though the implications of this activation are unclear.
B. bacilliformis invades a variety of cell types in vitro but induces mitogenesis
only in endothelial cells (Garcia et al., 1990). Effective proliferation requires direct
contact between B. bacilliformis and host cells and can occur within 30 minutes of
bacterial contact (Garcia, F. U. et al., 1992). Infected endothelial cells also form tubules
indicative of angiogenesis on the appropriate substrate. The activation of AP-1 and the
proliferative effect of B. bacilliformis on endothelial cells thus suggest several
unidentified changes in the host transcriptosome. As the first step in characterizing these
changes, the Affymetrix GeneChip microarray technology was used to investigate the
transcriptional response of human microvascular endothelial cells to B. bacilliformis.
This powerful method profiles changes in the gene expression in response to stimuli such
as infection by a pathogen and previously has monitored cellular responses to bacteria,
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including B. henselae, S. typhimurium, H. pylori, and S. aureus (Bryant et al., 2004;
Dehio et al., 2005).
The GeneChip consists of cDNA probes of known identity immobilized on a
nylon surface by robotics. The probe size varies from 500 to 5000 base pairs. The added
target, fluorescently labeled cDNA, obtained from sample RNA, is hybridized onto the
chip. A fluorescent signal, digitized by a fluorescent scanner, detects the complementary
binding of sample cDNA to the probes. The signal intensity represents the expression
level of that gene, and gene profiling relates to the reference. The biggest advantage of
DNA microarray analysis is that it enables investigation of the behavior of multiple genes
simultaneously. However, this information pertains to the gene transcription level,
whereas post-translational modifications provide the next level of cell function
regulation. Therefore, DNA microarray studies should be supplemented with highthroughput proteomics to obtain accurate information about factors affecting cellular
responses.
We report here our analysis of some of the genes that become highly
differentiated during the course of the infection by B. bacilliformis and a few that are a
part of the integrin-signaling pathways. Almost all of the genes related to the
cytoskeletal networks and integrin signaling have increased transcript levels by 30
minutes after the infection. The up-regulation persists for one hour, after which a
decrease in gene expression is noted, which may indicate host response to counteract
bacterial infection. Other potential defense factors, such as the expression of cytokine
and inflammation responsive genes, are enhanced at later points in time, after the initial
down-regulation.
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Materials and Methods
HMEC-1 cell line growth and culturing.
The immortalized human microvascular endothelial cell line (HMEC-1) was a
kind gift from Dr. Ades of the Centers for Disease Control (CDC), Atlanta (Ades EW et
al., 1992). The HMEC-1 cells from passages 19-27 were grown in 15ml of growth media
consisting of 50% M199 (Cambrex), 15% FBS (Hyclone), 2% Penicillin/Streptomycin
(Cellgro), and 50% EGM-2 (Cambrex). Cells were grown and maintained in T-75 flasks
(Starstedt) at 37°C under 5% CO2 and humid conditions. This medium was changed
every 2–3 days until 70–80% confluence was reached. The cells were maintained in
10ml maintenance media (M199 +15%FBS+2% Penicillin-Streptomycin) between
passages. For cell detachment, confluent cells were washed twice with PBS to remove all
traces of serum before the addition of 10mls/ 752mm Cell stripper (Cellgro). Cells were
incubated at 37°C for 10 minutes and then gently scraped with cell scrapers (Starstedt).
Detached cells were collected in 15-ml Falcon tubes and centrifuged at 700xg for 10
minutes at 25°C. Cells were resuspended in 1 ml maintenance media and enumerated
microscopically using the hemocytometer before seeding the T-25, T-75, or T-150 flasks
or 6- or 24-well plates. Cells were allowed to adhere for 16 hours before use.
To prepare frozen stocks, cell pellets were resuspended in DMSO freeze medium
(Cellgro) to obtain a final concentration of 1x105 cells/ml. The vials were allowed to
freeze at -80°C in a cryofreezing container (Nalgene) for 24 hours and then transferred to
the liquid N2 tank facility.
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Bacterial growth and culturing.
B. bacilliformis KC584 was obtained from ATCC (35686) and grown on brain
heart infusion (BHI) plates with 10% sheep blood (BD Bioscience) at 26°C for 4–7 days.
Low-passaged bacteria (1–3 passages) were used for all experiments. After the confluent
colonies were visible, plates were overlaid with 7ml of PBS. The bacteria were gently
scraped off the plate with a loop. The bacterial suspension was centrifuged at 2000xg for
10 minutes at 25°C. Pellets were washed once with PBS and centrifuged as previously
described. Final suspension was in 1ml of BHI broth, unless otherwise noted.
Infection of HMEC-1 cells with B. bacilliformis for RT-PCR and microarray studies.
HMEC-1 cells were grown in T150 flasks containing 30ml of growth media, were
incubated at 37°C and 5% CO2, under humid conditions. The HMEC-1 cells were
allowed to reach 90% confluence, after which the media were replaced with 30ml of
M199 with 5% FBS, and the cells were incubated for 24 hours. Cells from a single flask
were counted to give an approximation of the growth in the remaining flasks. B.
bacilliformis, at a m.o.i. of 100:1 in 100 µl of PBS, was added to each experimental flask,
and 100µl of sterile PBS was added to each control flask. The media were aspirated for
30 minutes and one, three, and six hours post infection, and washed three times to remove
detached cells and unbound bacteria. The cells were detached from the flasks, as
described previously, and centrifuged at 700 xg for 10 minutes at 25°C. The cells were
immediately processed to prepare total RNA.
Preparation of HMEC-1 total RNA.
Total RNA from HMEC-1 cells was extracted using the Qiagen RNeasy column
(Qiagen). Briefly, the harvested HMEC-1 cells were resuspended gently in 600µl of lysis
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buffer with β-mercaptoethanol. The lysate was pipetted into a QIAShredder spin column
(Qiagen) for homogenization and centrifuged at 14,000xg for two minutes. The spin
columns were washed with 700µl of 70% ethanol and mixed well with a pipette. Next,
700µl of the lysate-ethanol mixture was added, and the column was centrifuged at
14,000xg for 24 seconds, after which the flow-through was discarded. Into the spin
column, 700µl of wash buffer was added, and the spin column was again centrifuged at
14,000xg for 24 seconds. This flow-through also was discarded and the bound RNA was
then washed twice with 500µl of wash buffer. The first wash required centrifugation at
14,000xg for 24 seconds, and the second needed two minutes. The RNA was eluted with
30µl of RNase-free water into a fresh 1.5-ml RNase-free microcentrifuge tube (USA
Scientific). To increase the elution efficiency, the tubes were incubated at room
temperature for five minutes, then centrifuged at 14,000xg for one minute. The eluate
was pipetted back into the spin column and allowed to incubate for 30 minutes at room
temperature, after which the tubes were centrifuged again at 14,000xg for one minute.
The RNA concentrations were determined by BioPhotometer (Eppendorf), and the total
HMEC-1 RNA was stored at -80°C until needed.
Microarray analysis of B. bacilliformis-infected HMEC.
For microarray studies, the HG-U133 Chip Sets (Affymetrix) that contain two
Gene Chip® arrays, representing approximately 33,000 human genes, were used.
Experiments were performed on two different biological replicates, according to the
manufacturer’s instructions. Double-stranded cDNA was synthesized using total HMEC1 RNA, as prepared previously, employing the Affymetrix-supplied SuperScript II firststrand synthesis kit for each sample. Second-strand cDNA was synthesized from the first
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cDNA, which had been cleaned using Phase-lock gel tubes (Eppendorf) with a ratio of
25:24:1 phenol:chloroform:isoamyl alcohol (Boehringer Mannheim) and used to
synthesize biotin-labeled RNA according to the Enzo BioArray High Yield RNA
Transcription Labeling Kit. The labeled RNA was cleaned using Qiagen RNeasy
columns, and the required concentration of cRNA was fragmented using the supplied
fragmentation buffer. The supplied Affymetrix controls, including the B2
Oligonucleotide and Eukaryotic Hybridization Controls, were mixed with the fragmented
cRNA as specified; this mixture then was hybridized onto the HG-U133A chip for 1six
hours at 45°C, rotating 60 rpm. After HG-U133A hybridization, the same cRNA mixture
was removed and allowed to hybridize onto the HG-U133B chip. The hybridized chips
were then developed using the GeneChip Fluidics Station for automated washing and
staining. Finally, the chips were scanned using the GeneArray scanner, operating with
GeneChip Operating System (GCOS) 5.0. The cell intensity files (CEL) generated from
the GCOS analysis, contain information about probe intensity. Each probe intensity for
is normalized against the spiked in endogenous controls to give normalized values for
each gene. This data was then analyzed further by GeneSpring v7.3 (Agilent).
GeneSpring analysis of human microarray data.
Data were preprocessed using GCOS and then analyzed with GeneSpringv7.3
(Agilent). To normalize the data, the following rules were applied. Raw signal values
below 0.01 were set to 0.01. The 50.0th percentile of all measurements in that sample
serves as the dividing line for each measurement. Each gene was divided by the median
of its measurements in all samples. If the median of the raw values was below 10, each
measurement for that gene was divided by 10, assuming the numerator was greater than
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10; otherwise, the measurement was discarded. Genes selected for pathway and further
analysis were those determined as significantly differentially expressed genes by a
Volcano plot, built by comparing "Timed Control" with "Timed Experimental" using all
normalized genes. To complete the statistical analysis, a parametric test assumes unequal
variances. Genes that were differentially expressed passed this testing method, defined
by a fold difference of 2 and a p-value of 0.1.
Real-time RT-PCR.
cDNA was synthesized from 500ng of cellular RNA using the High-Capacity
cDNA reverse transcription kit (Applied Biosystems). The reverse transcriptase (RT)
Master Mix (2X) was prepared with 2.0µl of 10XRT buffer, 0.8µl of 25XdNTP mix
(100mM), 2µl of 10XRT random primers, 1 µl of MultiScribe

TM

reverse transcriptase,

1.0µl of RNase inhibitor, and 3.2µl of nuclease-free DEPC-treated water (Ambion). The
Master Mix was kept on ice after gentle mixing. Individual reactions for cellular RNA
from each time point were prepared by mixing 10µl of RNA with 10µl of 2X Master
Mix. The reverse transcription was performed in an Eppendorf thermal cycler under the
following conditions: 25°C for 10 minutes, 37°C for 120 minutes, and 85°C for five
seconds. cDNA was stored at -20°C until further use. Real-time quantitative PCR (RTqPCR) was performed with the synthesized cDNA using the TaqMan Universal PCR
Master Mix (Applied Biosystems) protocol. In short, 1 µl of cDNA was diluted with 8µl
of DEPC-treated water, followed by the addition of 10µl of Master Mix and 1µl of the
assay primer (TaqMan Gene Expression Assay, Applied Biosystem).

The catalog

numbers of the assay primer used for the genes (in parenthesis) were Hs002337443_m1
(integrin α5), Hs00236976_m1 (integrin β1), Hs00233808_m1 (integrin αv), and
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Hs01001469_m1 (integrin β3). The RNA was quantified in an Applied Biosystems 7500
using the following cycling settings: 48°C for 30 minutes, AmpliTaq activation at 95°C
for 10 minutes, denaturation at 95°C for 15 seconds, and, finally, annealing/extension at
60°C for one minute (40 cycles). Cyclophin A (PPIA, Hs99999904_m1) was used as the
endogenous control. All reactions were performed in triplicates, and the comparative
threshold values (ΔΔCT) were calculated in Microsoft Excel. All threshold values (CT)
were first normalized to the endogenous reference (PPIA). The ΔΔCT was calculated by
subtracting the control (uninfected) CT from the experimental (infected) CT. Relative
quantification (RQ) for mRNA for each sample was determined by 2(-ΔΔCT). The p-value
was then calculated using Student’s t-test for unequal variances; a value of ≤0.1 was
considered significant.
Fold-change calculations
The relative quantification for the normalized values for control (uninfected) and
experimental (infected) data from microarray data was obtained by dividing the
experimental data to the control data. The fold-change for this normalized ratio (NR)
was calculated using the formula: IF(NR<1,-1/NR) (Ingenguity ™). According to this
formula if the normalized ratio is less than one, then the values are divided by -1 to give a
negative integer representative of gene down-regulation. If the normalized ratio value is
more than 1, then this value represents a positive fold-change or gene up-regulation. If
normalized ratio is 1, then this value represents no change in gene expression. The same
parameters were used to calculate the fold-change for the RQ values IF(RQ<1,-1/RQ)
obtained from real time RT-PCR experiments described above.
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Results
Scatter plot analysis of HG-U133A Microarray chips
HG-U133A chips were hybridized with HMEC-1 cDNA from the control and B.
bacilliformis-infected cells. The results of a scatter plot analysis conducted on the control
and experimental gene profiles appear in Figure 3.1a. The blue dots represent a downregulation of the genes in the experimental sample relative to the control, whereas the
orange/red dots indicate an up-regulation of the genes relative to the control compared
with the experiment. With the exception of the 30-minute post infection reading, the
microarray results show the expected expression variability at most time points in terms
of B. bacilliformis infection of the HMEC-1 cells. As Panel A shows, there is an upward
shift in overall gene expression, such that 8.6% of the genes present are up-regulated and
6.3% of the genes present are down-regulated at the 30-minute post infection point.
Wider variability marks Panel A, 30 minutes post-infection, compared with the other
panels. Panels B and C show the one hour and three hour post infection time points. As
expected, the majority of gene expression levels were altered by a less than twofoldchange, as indicated by the yellow dots within the green bars. A 3.5% up-regulation
appears at both the one hour and three hour points, though this up-regulation is slight
compared with the down-regulation of these genes at the same times (22.2% and 13.4%,
respectively).
The scatter plot generated from the host cell gene expression levels six hours after
B. bacilliformis infection appears in Panel D. The blue dots that indicate that 2.3% of the
host genes are up-regulated, and 6.7% are down-regulated.
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Figure 3.1a. Endothelial gene expression at various time points.
Total mRNA isolated from B. bacilliformis-infected HMEC-1 cells and from, uninfected
HMEC-1 control cells was hybridized to Affymetrix HG-U133A microarray chips. The
five scatter plots represent gene expression profiles comparing the infected to the
uninfected endothelial cells at different time points after infection: (A) 30 minutes, (B)
one hour, (C) three hours, and (D) six hours. The relative mean hybridization intensity of
one of the transcripts represents the Y-axis, and the PBS-mock infected control appears
on the X-axis. Yellow dots represent unchanged gene expression, blue dots indicate
down-regulated genes, and orange/red dots symbolize up-regulated genes compared with
the control. Green bars represent twofold-change range for each chip hybridized. Each
point depicts an individual element of the microarray.
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Scatter plot analysis of HG-U133B microarray chips
The HG-U133B microarray chip scatter plot analysis shows a higher variability
than that of the HG-U133A microarray chips. Figure 3.1b, Panel A displays the gene
variation 30 minutes after B. bacilliformis infection. The blue dots indicate that
approximately 35.0% of the genes have been down-regulated, while only 5.3% of them
have been up-regulated. This large number of down-regulated cells could be due to the
direct interaction of HMEC-1 cells from B. bacilliformis, corresponding to the mRNA
transcripts found on the HG-U133B chip.
At the one hour post infection time point, shown in Panel B, 5.4% of all genes are
down-regulated, and 3.7% are up-regulated relative to the control samples. This
downward trend continues in Panel C, where 12.2% of the genes are down-regulated and
3.8% is up-regulated at the three hour point. Finally, Panels D, which represents the time
point six hours post infection reveals a more characteristic pattern of gene expression. As
the data show, at this time point 6.8% genes are down-regulated, and a 2.0% are upregulated, as indicated by their position within the twofold parameter change.
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Figure 3.1b. Endothelial gene expression at various time points.
Total mRNA isolated from B. bacilliformis-infected HMEC-1 cells and from, uninfected
HMEC-1 control cells was hybridized to Affymetrix HG-U133B microarray chips. The
five scatter plots represent gene expression profiles comparing the infected to the
uninfected endothelial cells at different time points after infection: (A) 30 minutes, (B)
one hour, (C) three hours, and (D) six hours. The relative mean hybridization intensity of
one of the transcripts represents the Y-axis, and the PBS-mock infected control appears
on the X-axis. Yellow dots represent unchanged gene expression, blue dots indicate
down-regulated genes, and orange/red dots symbolize up-regulated genes compared with
the control. Green bars represent twofold-change range for each chip hybridized. Each
point depicts an individual element of the microarray.
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Analysis of highly differentially expressed gene transcripts
GeneSprin software was used to determine the fold-change ratio of the gene
expression in B. bacilliformis-infected endothelial cells. From these data, 20 genes
showing maximum and minimal gene expression were identified. These code for
proteins involved in various cellular functions, such as JunD proto-oncogene, a
component of the transcriptional factor AP1 complex, which exhibits a 23-fold-change at
30 minutes and then decreases to 9-fold by six hours. RNA levels of other transcription
factors also show significant decreases and include the POU transcription factor (-21.93
at 30 minutes), transcription factor EC isoform A and B (-58.48 at one hour), and ironresponsive element binding protein 2 (-21.18 at one hour) (Tables 3.1a and 3.1b).
Several cell surface receptor genes show a positive regulation in this analysis. For
example, transcripts coding for the toll-like receptor 7 and calcitonin show a 13.47-fold
and 9.76-fold increase, respectively, at 30 minutes (Table 3.1a); the CD69 antigen
exhibits a 10.74-fold increase at one hour; cadherin is up-regulated by 17.43-fold at three
hours; and the fibroblast growth factor receptor 4 increases by 6.28-fold at six hours
(Tables 3.1b, 3.1c, and 3.1d). With the exception of the integrin β1 isoform, no cell
surface receptor genes with a negative fold-change were detected in this study
(Table3.1a).
A down-regulation of growth factor receptors, including FGF (fibroblast growth
factor) receptor substrate 2 and TRAF3 (TNF receptor-asscociated factor 3) modulator,
occurs at three hours after infection, which suggests a decreased role for the selected FGF
modulators and the TNF pathways (Table3.1c). The cell growth regulators, the Ras-like
p21 activator 3, and the Ras-like estrogen-regulated growth inhibitor each exhibit
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significant up-regulation relative to mock cell transcript levels at three and six hours post
infection (Tables 3.1c and 3.1d). Significant changes in immune response genes occur in
TNF ligand super-family member 8 (8.98 at 30 minutes) and in interleukin 17 (-19.76),
interleukin 24 (-7.09), and interleukin 26 (-8.55) at six hours after infection (Tables 3.1a
and 3.1d).
Finally, cell morphology modulators exhibiting differential expression in this
study include A disintegrin and metalloproteinase domain 7 and tubulin β 8. At 30
minutes after infection, transcriptosomes of these two genes show a negative change of
23.20 fold and 17.36 fold, respectively. Collagen -type XXIV α1 is also down-regulated,
decreasing by 17.06 fold at one hour post infection (Tables 3.1a and 3.1b). Another
collagen type, XI isoform A, pre-protein exhibits a positive change with a 8.96-fold
increase over the control cells at six hours (Table 3.1d). Finally, the actin-related protein
2/3 complex subunit A shows a 9.28-fold increase at six hours post infection (Table
3.1d).
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Table 3.1a. Highly differentially expressed functional HMEC-1 transcriptomes, 30 minutes after B. bacilliformis infection.
GeneSpring analysis of microarray data from uninfected control HMEC-1 cells, compared with data of B. bacilliformis-infected
HMEC-1 cells was performed to determine the fold-change of the highly differentially expressed HMEC-1 genes. Up-regulated and
down-regulated genes referred in text are highlighted in red and blue, respectively.
Accession
Gene Product
No.
Up-Regulated Gene Products
Jun D proto-oncogene
AI339541
Cystic fibrosis transmembrane
conductance regulator, ATP-binding
cassette (sub-family C, member 7)
A-kinase anchor protein 13 isoform
1,2&3
Toll-like receptor 7
Guanine nucleotide binding protein (G
protein), beta polypeptide 2-like 1
DNA-damage-inducible transcript 3
Lymphocyte cytosolic protein 2
X-linked eukaryotic translation
initiation factor 1A
Delta-sarcoglycan isoform 1; deltasarcoglycan isoform 2
NADH dehydrogenase (ubiquinone)
Fe-S protein 1, 75kda precursor
Basic helix-loop-helix domain
containing, class B, 2
Cathepsin S preproprotein
Translocase of inner mitochondrial
membrane 50 homolog
Clpx caseinolytic protease X homolog

Foldchange

Foldchange

23.55

Accession
Gene Product
No.
Down-Regulated Gene Products
Coiled-coil domain containing 102B
NM_024781

W60595

14.72

Centrosome protein 4

NM_025009

-39.841

NM_006738
NM_016562

14.32
13.47

Zinc finger protein 711
Msh homeobox 2

NM_021998
NM_002449

-35.971
-33.333

AA443762

12.61

AA777793

-32.258

BC003637
AI123251

12.38
11.98

Xylulokinase homolog
Urotensin 2 preproprotein, isoform
A&B
H3 histone family, member I

NM_021995
NM_021018

-30.581
-26.596

BE542684

11.29

AA215854

-25.189

U58331

11.27

AF215824

-23.202

NM_005006

10.99

NM_004951

-22.779

NM_003670

10.8

AI686582

-21.93

BC002642

10.8

NM_002994

-21.834

BE378994
NM_006660

10.71
10.67

NM_024743
AF208967

-19.96
-19.724

Integrin beta 1 isoform 1A-E
A disintegrin and metalloproteinase
domain 7
EBV-induced G protein-coupled
receptor 2
POU transcription factor
Chemokine (C-X-C motif) ligand 5
precursor
UDP glucuronosyltransferase 2 family,
polypeptide A3
Paternally expressed 3

-61.728
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Accession
Gene Product
No.
Up-Regulated Gene Products
N-acetylated alpha-linked acidic
dipeptidase 2
AJ012370
Tripartite motif-containing 58
AL080170
Sidekick homolog 1

Foldchange

10.5
10.49

Accession
Gene Product
No.
Down-Regulated Gene Products
C-K-ras2 protein isoform b; c-K-ras2
protein isoform a
NM_004985
Tubulin, beta 8
AI433261
Calcium channel, voltage-dependent,
L type, alpha 1D subunit
BE550599
Myelin-associated oligodendrocyte
basic protein
D28114
Transporter 2, ATP-binding cassette,
sub-family B isoform 1&2
NM_018833
Plasma kallikrein B1 precursor
NM_000892
Aspartate beta-hydroxylase isoform ANM_020164
D
Phenylalanine hydroxylase
BG433489
RAB27B, member RAS oncogene
family
NM_004163

Foldchange

NM_014111

-15.267

NM_003950

-15.083

AW969675

-15.06

U34877

-15.015

-19.493
-17.361

R38712

10.46

Epsilon globin

NM_005330

10.27

Karyopherin alpha 1
Ubiquitin-conjugating enzyme E2O

BF575685
NM_022066

10.11
10.06

Glutathione synthetase
Calcitonin receptor
ATM/ATR-Substrate Chk2-Interacting
Zn2+-finger protein
Sodium potassium chloride
cotransporter 2
Phosphoinositide-3-kinase, regulatory
subunit 4, p150

NM_000178
AB022177

9.923
9.763

AI744148

9.578

AI632015

9.537

AK025026

9.411

Transferrin
Coagulation factor II (thrombin)
receptor-like 3 precursor

AK000244

9.164

Triadin

NM_000366

9.058

Biliverdin reductase A

NM_001244
BF510692

8.981
8.968

Solute carrier family 25 (mitochondrial
carrier; adenine nucleotide
translocator), member 31
PDZ and LIM domain 3

NM_031291
BC001017

-14.771
-14.347

Z00008

8.908

Fibroblast growth factor 18 precursor

AB007422

-14.327

Similar to FERM domain-containing
protein 4B (GRP1-binding protein
GRSP1) isoform 1
Tropomyosin 1 alpha chain isoform 17
Tumor necrosis factor (ligand)
superfamily, member 8
Paired box 5
Similar to Ig kappa chain V-I region
Walker precursor

-17.182
-17.094
-16.949
-16.779
-16.502
-15.748
-15.649
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Table 3.1b. Highly differentially expressed functional HMEC-1 transcriptomes, one hour after B. bacilliformis infection.
GeneSpring analysis of microarray data from uninfected control HMEC-1 cells, compared with data of B. bacilliformis-infected
HMEC-1 cells was performed to determine the fold-change of the highly differentially expressed HMEC-1 genes. Up-regulated and
down-regulated genes referred in text are highlighted in red and blue, respectively.
Accession
Gene Product
No.
Up-Regulated Gene Products
Solute carrier family 4, sodium
AF011390
bicarbonate cotransporter, member 4
Ubiquitin specific protease 49
Spectrin repeat containing, nuclear
envelope 2 isoform A,B,C,D&E
Resistin
Rab3 GTPase-activating protein, noncatalytic subunit
ATPase, aminophospholipid
transporter (APLT), class I, type 8A,
member 1
RAS p21 protein activator 3
CD1E antigen isoform b precursor
Phosphodiesterase 4D interacting
protein isoform 1,2,3,4&5
IQ motif containing GTPase activating
protein 2
Small inducible cytokine A18
precursor
CD69 antigen (p60, early T-cell
activation antigen)
Chromosome 22 open reading frame
16

Foldchange

Accession
Gene Product
No.
Down-Regulated Gene Products

Foldchange

20.92

Transcription factor EC isoform A&B

AI830469

-58.480

NM_018540

15.95

Itchy homolog E3 ubiquitin protein
ligase

AI732502

-36.364

AW965040

15.61

AU158643

-32.895

NM_020415

15.35

AI469884

-30.488

AK021928

15.15

AA017045

-29.851

AB013452

14.38

AA873021

-28.986

NM_007368

14.04

AI742190

-28.329

AA309511

12.34

AA769450

-26.385

AU157078

11.43

H15396

-26.247

NM_006633

11.06

AA404231

-24.038

Y13710

11.05

AI743727

-23.474

BF439675

10.74

NM_012069

-23.364

AI814909

10.57

AW130096

-22.371

ADAM metallopeptidase domain 12
isoform 1&2 preproprotein
Carboxypeptidase M precursor
Potassium voltage-gated channel,
Shab-related subfamily, member 2
Similar to SMC hinge domain
containing 1
Hypothetical protein LOC167691
Mitogen-activated protein kinase
kinase kinase 7 interacting protein 2
Phosphatidic acid phosphatase type 2
domain containing 2
Tudor domain containing 6
Transforming growth factor, beta
receptor I precursor
ATPase, (Na+)/K+ transporting, beta 4
polypeptide
Zinc finger protein 585B
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Accession
Gene Product
No.
Up-Regulated Gene Products
Serine (or cysteine) proteinase
BC005224
inhibitor, clade B (ovalbumin),
member 3
Protease, serine, 16

Foldchange

10.25

Accession
Gene Product
No.
Down-Regulated Gene Products
Ring finger and WD repeat domain 2
BF725688
isoform d24; ring finger and WD
repeat domain 2 isoform a

Foldchange

Methionyl Aminopeptidase 2

AI733395

-21.459

AK021887

-21.231

AW470799

-21.186

-21.552

NM_005865

10.17

AK022454

10.06

AK025118

9.969

U80736

9.946

Phospholipid scramblase 1

BE066040

-20.833

AF094518

9.943

Nance-Horan syndrome protein

AI680913

-20.704

NM_024781

9.896

Zinc finger protein 407

NM_017757

-20.534

RAN binding protein 9

AI476722

9.701

GPI deacylase

AW084937

-19.685

Two AAA domain containing protein

AI656807

9.697

Protein kinase D3

AW008270

-19.380

Sine oculis homeobox homolog 1

N79004

9.673

AI346849

-18.587

Mitogen-activated protein kinase
kinase 7

AI090153

9.405

AI003579

-18.182

Zinc finger protein 496

AA191336

9.295

MORF-related gene X

BE886165

-17.391

Kinesin family member 13A

AJ291579

-17.094

Collagen, type XXIV, alpha 1

AI631241

-17.065

Epsin 1
RUN and FYVE domain-containing 1
isoform b
Similar to trinucleotide repeat
containing 9 isoform 1
Estrogen-related receptor gamma
isoform 1; estrogen-related receptor
gamma isoform 2
Coiled-coil domain containing 102B

Sprouty-related protein 1 with EVH-1
domain
Iron-responsive element binding
protein 2

SEC15-like 1 isoform b; SEC15-like 1
isoform a
Solute carrier family 6
(neurotransmitter transporter, GABA),
member 1
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Table 3.1c. Highly differentially expressed functional HMEC-1 transcriptomes, three hours after B. bacilliformis infection.
GeneSpring analysis of microarray data from uninfected control HMEC-1 cells, compared with data of B. bacilliformis-infected
HMEC-1 cells was performed to determine the fold-change of the highly differentially expressed HMEC-1 genes. Up-regulated and
down-regulated genes referred in text are highlighted in red and blue, respectively.
Accession
Gene Product
No.
Up-Regulated Gene Products

Foldchange

Sciellin isoform a; sciellin isoform b

AW470178

24.9

Olfactory receptor, family 51,
subfamily E, member 2

AF311306

21.13

Accession
Gene Product
No.
Down-Regulated Gene Products
ATPase, (Na+)/K+ transporting, beta 4
NM_012069
polypeptide

Foldchange

Syntrophin, gamma 1

AI939541

-21.598

AW665138

-21.142

NM_017757

-20.534

H57111

-20.243

AU146874

-18.692

AI003579

-18.182

-23.364

Solute carrier family 4, sodium
bicarbonate cotransporter, member 4
Zinc finger protein 218

AF011390

20.92

AW953679

19.55

Pleckstrin homology domain
containing, family K member 1
Zinc finger protein 407

Holocarboxylase synthetase

AJ001863

18.15

Zinc finger protein 518

Sestrin 3

BF685808

17.49

Cadherin 2, type 1 preproprotein

AW450381

17.43

Ubiquitin specific protease 49

NM_018540

15.95

Phosphatase and tensin homolog

AK021487

-18.116

Checkpoint suppressor 1

AF138861

15.85

Ubiquitin specific protease 3

AU148154

-16.722

Tachykinin receptor 1 isoform long

AI492860

15.61

Pancreatic lipase precursor

NM_000936

-16.313

NM_020415

15.35

NM_000867

-16.287

AK021928

15.15

AI204212

-15.267

Resistin
Rab3 GTPase-activating protein, noncatalytic subunit

Neurexin 1 isoform alpha & beta
precursor
Solute carrier family 6
(neurotransmitter transporter, GABA),
member 1

5-hydroxytryptamine (serotonin)
receptor 2B
Developmental pluripotency
associated 2
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Accession
Gene Product
No.
Up-Regulated Gene Products
ATPase, aminophospholipid
AB013452
transporter (APLT), class I, type 8A,
member 1
Tyrosyl-DNA phosphodiesterase 1

Foldchange
14.38

Accession
Gene Product
No.
Down-Regulated Gene Products
Numb homolog isoform 1,2,3&4
Eukaryotic translation initiation factor
3, subunit 9 eta, 116kda
Nuclear factor of kappa light
polypeptide gene enhancer in B-cells
inhibitor, zeta isoform a&b

Foldchange

AW167424

-14.641

AA628539

-14.514

AB037925

-13.928

BF940025

-13.755

BF003018

-13.736

AI214464

-13.717

BE222041

14.24

NM_007368

14.04

Transketolase-like 2

AL136779

13.95

Zinc finger protein 407

AA012924

13.85

BE219628

13.82

AL035992

12.95

Contactin 3

BE221817

-13.569

AA609053

12.79

PEST-containing nuclear protein

BE465316

-13.495

AW300488

12.52

Filensin

NM_001195

-13.333

CD1E antigen isoform b precursor

AA309511

12.34

AW967956

-13.280

Rearranged L-myc fusion sequence

AI742686

12.25

BF966183

-12.920

Solute carrier family 16, member 11

AI802877

12.19

Similar to Ubinuclein (Ubiquitously
expressed nuclear protein) (VT4)
Gamma-aminobutyric acid (GABA) A
receptor, alpha 5 precursor
Gp130-like monocyte receptor

AI123586

-12.920

Similar to zinc finger protein 91

AI092709

12.12

Zinc finger RNA binding protein

AA629668

-12.920

Periostin, osteoblast specific factor

AW137148

-12.788

Myelodysplasia syndrome protein 1

AW452823

-12.642

RAS p21 protein activator 3

Glutamate receptor, ionotropic, AMPA
2
Spectrin repeat containing, nuclear
envelope 2 isoform A,B,C,D&E
Ectonucleotide
pyrophosphatase/phosphodiesterase
5 (putative function)
ATP-binding cassette, sub-family C,
member 6

Choline phosphotransferase 1
Heterogeneous nuclear
ribonucleoprotein M isoform A&B
TRAF3-interacting JNK-activating
modulator
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Accession
Gene Product
No.
Up-Regulated Gene Products

Foldchange

Accession
Gene Product
No.
Down-Regulated Gene Products
Fibroblast growth factor receptor
substrate 2
Transient receptor potential cation
channel, subfamily M, member 1

Foldchange

NM_006654

-12.484

AI277662

-12.453
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Table 3.1d. Highly differentially expressed functional HMEC-1 transcriptomes, six hours after B. bacilliformis infection.
GeneSpring analysis of microarray data from uninfected control HMEC-1 cells, compared with data of B. bacilliformis-infected
HMEC-1 cells was performed to determine the fold-change of the highly differentially expressed HMEC-1 genes. Up-regulated and
down-regulated genes referred in text are highlighted in red and blue, respectively.
Accession
Gene Product
No.
Up-Regulated Gene Products
SET and MYND domain containing 3
AW074336

Foldchange
16.04

Accession
Gene Product
No.
Down-Regulated Gene Products
Interleukin 17
Z58820

Foldchange
-19.76

Polycystic kidney disease 2-like 2

AF182034

14.69

RAD23 homolog B

T93562

14.26

F-box only protein 3
Basic helix-loop-helix domain
containing, class B, 3

AL162053

13.68

R93946

13.65

InaD-like protein
Glutamate receptor, ionotropic,
AMPA1

AB044807

11.47

Potassium inwardly-rectifying channel,
subfamily J, member 15
RAP2B, member of RAS oncogene
family
Cardiomyopathy associated 4 isoform
2
Myeloid/lymphoid or mixed-lineage
leukemia translocated to 10
N-methyl-D-aspartate receptor subunit
2A precursor

AF007137

11.19

Mitochondrial ribosomal protein S31

CD24 molecule

BG327863

11.03

Hepatocyte nuclear factor 4, gamma

AI916600

-10.59

AW173151

-10.19

AI963104

-10.17

BG542347

-14.53

NM_002886

-12.89

AI800785

-12.84

N64035

-12.84

T65537

-11.20

AW007410

-10.63

Regulator of G-protein signaling 1
Cerebellar degeneration-related
protein 1

NM_002922

10.88

NM_004065

10.67

Ras homolog gene family, member A
Nuclear distribution gene E homolog
like 1

mutS homolog 6

D89646

10.05

Replication protein A3, 14kDa

AI022132

-9.90

Mohawk homeobox
Golgi autoantigen, golgin subfamily a,
8A

R59304

10.04

Jun D proto-oncogene

AI339541

-9.52

AI829170

9.98

CDC42 small effector 2

AL122039

-9.35
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Accession
Gene Product
No.
Up-Regulated Gene Products
Cholinergic receptor, nicotinic, beta 4
NM_000750
Actin related protein 2/3 complex,
subunit 1A, 41kDa
AF070647
Neuropeptide Y receptor Y2
U32500
Catalase
Alpha 1 type XI collagen isoform A
preproprotein
RAS-like, estrogen-regulated, growth
inhibitor
Protocadherin beta 14 precursor
Interleukin 6 receptor isoform 1
precursor

AU147084

Foldchange
9.63
9.28
9.22
10.5

Accession
Gene Product
No.
Down-Regulated Gene Products
Protocadherin gamma subfamily A, 3
AF152509
Adaptor-related protein complex 1
sigma 2 subunit
N74507
Polymerase (DNA directed), beta
S69873

Foldchange
-9.26
-9.26
-9.01

Epidermal retinal dehydrogenase 2

AI440266

-8.85

BG028597

8.967

Retinoic acid receptor, beta

NM_015854

-8.70

AW668616
NM_018934

8.679
8.332

Interleukin 26
Interleukin 24

NM_018402
NM_006850

-8.55
-7.092

AV700030

6.469

AI653981

-6.494

Harakiri, BCL2 interacting protein

NM_003806

6.339

L1 cell adhesion molecule
ras-related GTP-binding protein
RAB10

AU146686

-6.173

Fibroblast growth factor receptor 4

NM_002011

6.283
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Fold-change analysis of integrin and integrin-signaling pathway-related gene
transcripts
The fold-change ratios of integrins and integrin-signaling pathway-related genes
were computed from the signal intensity data derived from RNA hybridized cDNA chips.
The gene expression values depict the changes in the B. bacilliformis-infected HMEC-1
cells compared with mock infected cells during a total infection period of six hours.
Many integrin subunit genes are positively induced at 30 minutes and one hour post
infection (Table 3.2). Transcript levels decrease after that time with 57% and 42% of the
subunits exhibiting significantly lower expression as compared with the mock infected
culture by three and six hours, respectively. Genes encoding proteins that are affected by
integrin ligation also show an up-regulation at 30 minutes. These include those coding
for cytoskeletal proteins like tenesin 1, which have a 4.081-fold-change, and for members
of the small GTPase pathway, such as Cdc42 and p21-activating kinase (PAK), which are
increased by more than two-fold at 30 minutes and one hour post infection. Several small
GTPase genes such as cofilin1, Rac, Cdc42, and PAK exhibit a modest increase at 30
minutes after which their relative level of expression steadily decreases. Certain kinase
genes show significant up-regulation at 30 minutes post infection. Focal adhesion kinase
is an integral part of integrin signaling, and its expression is enhanced by fivefold and
twofold at 30 minutes and three hours, respectively. In contrast, some dual-specificity
kinases that regulate MAPKs (such as dual-specificity kinase 1) are down-regulated,
whereas two MAPKs (e.g. MAPK-9 and MAPK-14) show the reverse pattern at the same
time points. Anti-apoptotic genes, such as the Bcl2 antagonist of death (BAD), insulinlike growth factors (IGFs), and survivin (BRIC5) show a positive change at various time
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points; at the same time, some pro-apoptotic factors and caspases 3 and 9 are also upregulated.
Other cell surface receptors, including Toll-like receptors 2 and 4, PECAM
(platelet/endothelial cell association molecules), CEACAM (carcioembryonic antigenrelated cell adhesion molecule), Selectin E, and ICAM1 (intracellular adhesion molecule
1), which may play an important roles in the inflammatory response, also were included
in this study. Selectin E, a cell adhesion protein expressed on cytokine-activated cells
that mediates leukocyte adhesion shows the most dramatic variation. It is maximally
down-regulated (-4.167) at 30 minutes, with down-regulation continuing until three hours
post infection, after which it is up-regulated almost fourfold. With its multiple functions,
CEACAM experiences a twofold increase at 30 minutes and six hours. A few genes that
regulate angiogenesis are positively expressed: angiopoietin 1 at three hours and
angiopoietin 2 at six hours (after showing a negative fold-change at 30 minutes), and
vascular endothelial growth factor (VEGF), which exhibits two-fold or greater upregulation at one and six hours.
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Table 3.2. Integrin subunits and integrin signaling component HMEC-1 transcriptomes.
GeneSpring analysis of microarray data from uninfected control HMEC-1 cells,
compared with data of B. bacilliformis-infected HMEC-1 cells, performed to determine
the fold-change at various times points of differentially expressed HMEC-1 genes.
Genes exceeding the two-fold cutoff for up-and down-regulation are highlighted in red
and blue, respectively.
Gene Name

Accession No.
30mins

Integrin receptor subunits
Integrin alpha 2
Integrin alpha IIB
Integrin alpha 3
Integrin alpha 4
Integrin alpha 5
Integrin alpha 6
Integrin alpha 7
Integrin alpha 8
Integrin alpha 9
Integrin alpha 10
Integrin alpha11
Integrin alpha V
Integrin beta 1
Integrin beta 2
Integrin beta 4
Integrin beta 5
Integrin beta 6
Integrin beta 7
Integrin beta 8
Cytoskeletal associated
proteins
Myosin light chain 9
Actin related protein complex
subunit1A
Actin, alpha 1
Paxillin
Vinculin
Zyxin
Talin
Tensin 1
Small GTPase pathway
Cofilin 1
Ras-related C3 botulinum toxin
substrate 1
Cell division cycle 42
p21 activated kinase
ADP-ribosylation factorinteracting protein 2

Fold-change at Times
1hour
3hour

6hour

AI733222
NM_000419
NM_002204
NM_000885
NM_002205
NM_000210
AF072132
BF939224
BF510694
AF112345
AF109681
AI093579
AA215854
NM_000211
AA808063
AL048423
NM_000888
NM_000889
NM_002214

2.454
2.832
1.646
2.898
1.724
1.517
-2.865
2.311
2.299
1.139
1.149
1.635
1.898
-1.125
1.000
3.873
5.671
1.678
1.735

1.430
3.317
1.180
-1.845
1.130
1.305
1.006
1.957
-1.441
-1.117
1.528
1.046
-1.264
1.661
1.091
1.083
-2.882
-1.529
3.165

-1.227
2.929
-1.517
1.261
1.051
-1.297
-1.071
-3.356
-1.032
-1.475
1.005
-1.193
-1.451
2.248
-2.976
-1.305
11.010
1.701
-1.733

-1.127
1.070
1.359
1.339
1.473
-1.151
1.281
3.934
-1.119
1.444
-1.168
1.112
-1.325
-1.715
-1.178
1.247
1.413
-1.471
1.859

NM_006097

1.276

1.249

-1.010

-1.040

NM_006409
NM_001100
NM_002859
NM_014000
NM_003461
AI345601
AF116610

1.329
1.130
1.339
1.793
1.677
1.130
4.081

1.120
1.853
1.162
1.028
1.634
-1.859
-1.572

-1.183
1.130
1.066
1.033
1.173
1.892
1.454

-1.110
-1.433
1.153
-1.001
1.002
3.405
1.098

NM_005507

1.484

1.165

-1.033

1.115

BG292367
BC002711
U51120

1.724
2.456
2.215

1.114
1.507
1.551

-1.002
-2.119
-1.004

1.149
-1.397
2.079

NM_012402

2.075

1.136

1.134

-1.183
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Gene Name

Accession No.
30mins

Fold-change at Times
1hour
3hour

6hour

Ras homolog gene family,
member A (RhoA)

AA011598

-1.001

-2.347

1.377

-1.346

Integrin-related cell
signaling kinases
Focal adhesion kinase
Integrin linked kinase

AA912743
BE617348

5.11
1.123

1.933
3.140

2.066
-1.692

-1.572
-1.041

MAPK signaling
Mitogen activated kinase 1
Mitogen activated kinase 2
Mitogen activated kinase 8
Mitogen activated kinase 9
Mitogen activated kinase 14
Dual Specificity kinase 1
Dual Specificity kinase 5
Dual Specificity kinase14
Dual Specificity kinase 3

AA195999
X60188
AI379407
W37431
AF100544
AW024420
U16996
NM_007026
NM_004090

1.350
1.885
1.736
2.456
2.687
-6.329
2.579
2.015
-1.239

1.124
-1.451
1.244
-1.280
1.106
-5.263
-1.224
-1.171
-1.508

-1.147
1.398
-1.205
1.180
-1.048
-1.057
-1.013
1.028
1.184

1.034
1.076
1.060
1.035
-1.280
-2.681
1.111
-1.147
-1.508

AA767763

2.394

2.268

-2.155

-1.157

AA018968
U66879
NM_004346
AB015653

2.479
3.624
3.360
5.161

3.780
-1.037
-1.208
-1.156

-1.033
-1.416
-1.300
1.130

1.671
1.046
-1.152
1.202

NM_005163
M37484
AA648913

2.318
1.858
1.839

1.299
4.893
1.932

1.228
2.548
-1.522

1.030
-1.776
-1.107

BE786164

3.483

1.082

-1.110

-1.192

AI655737

3.774

-1.037

-1.412

-1.890

BC002646

3.819

1.054

-1.323

-1.045

NM_002467

1.480

-1.473

-1.323

-1.041

M55643
NM_005229
BC002646

1.056
1.091
3.819

-1.458
1.133
1.054

1.018
-1.022
-1.323

1.184
-1.305
-1.045

PI3K/Akt signaling pathway
Phosphinositide 3-kinase,
catalytic subunit
Phosphinositide 3-kinase,
regulatory subunit
Bcl2 antagonist of cell death
Caspase 3
Caspase 9
v-akt murine thymoma viral
oncogene homolog 1
Insulin like growth factor1
Survivin
Transcriptional factors
Activating transcription factor 2
cAMP responsive element
binding protein 1
vian sarcoma virus 17
oncogene homolog
v-myc myelocytomatosis viral
oncogene homolog (avian)
Nuclear factor of kappa light
polypeptide gene enhancer in
B cells
Elk1
c-Jun
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Gene Name

Accession No.
30mins

Other receptors
Toll like receptor 2
Toll like receptor 4
Lymphocyte antigen 96
Platelet/endothelial cell
adhesion molecule
CD98
Carcinoembryonic antigenrelated cell adhesion molecule
1
Selectin E
Intercellular adhesion molecule
1

Fold-change at Times
1hour
3hour

6hour

NM_003264
NM_003266
NM_015364

-1.297
1.226
1.295

1.014
1.251
1.106

-4.219
-1.395
1.052

1.260
-1.149
-1.479

M37780
NM_002394

3.069
2.662

1.221
-1.175

-1.181
-1.742

-1.054
-1.044

NM_001712
NM_000450

2.633
-4.167

-1.272
-2.591

1.061
-2.660

2.106
3.997

NM_000201

2.591

2.631

1.074

1.113

U19599
NM_001146
NM_001147
NM_003377

4.368
-1.183
-1.092
1.388

-1.261
-1.587
3.391
2.610

-1.328
1.157
1.313
-1.101

-1.142
1.306
2.292
2.167

Apoptosis

Bcl2 associated X protein
(BAX)
ANGPT1
ANGPT2
VEGF
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Real Time PCR validation of microarray data
GeneSpring analysis of the gene expression in B. bacilliformis cells gave the foldchange ratio between the experimental and control samples. The mRNA sample used for
microarray hybridization was also used in real time RT-PCR experiments that were
designed to analyze the expression of selected genes. The fold-change ratio from the
relative quantification values derived from RT-PCR studies was determined and
compared with the values obtained from the microarray analysis (Table 3.3). The
correlation between the seven genes compared at defined time points is variable. The
degree of integrin α5 gene expression is the same in RT-PCR and microarray studies at all
times points, except at six hours post infection. In contrast integrin β1 fold-change data
from microarray analysis correlates with the RT-PCR data only at 30 minutes. Integrin
αv fold-change is similar in both sets of experiments at 30 minutes and three hours and
integrin β3 at one, three and six hours. The three MAPKs fall within the defined range of
a 2.5-fold of each other at 30 minutes. At one hour only MAPK1 and MAPK3 show a
similar gene expression. According to the results from microarray analysis, MAPK1 and
MAPK8 have a negative fold-change at three hours, whereas the RT-PCR data suggests
their up-regulation. Lastly at six hours only MAPK8 fold-change was in agreement,
while discordance was noted with MAPK1 and MAPK3 gene expression.
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Table 3.3. Validation of gene expression data obtained from microarray studies.
The fold-change data of the gene expression obtained by GeneSpring analysis was compared to the fold-change data obtained by real
time PCR. The data from the two experiments correlate when the difference between two readings is within ±2.5 fold-change. The
data that does not correlate is indicated by (*).
Time

30'

1hr

3hr

6hr

Gene Name

Accession
no.

RT-PCR
foldchange

Microarray
foldchange

RTPCR
foldchange

Integrin alpha 5

NM_002205

2.18

1.72

1.39

1.13

1.11

1.05

-1.99

1.47

Integrin beta 1

AA215854

1.80

1.90

1.33

-1.26

1.11

-1.45

1.09

-1.33

Integrin alpha V

AI093579

1.49

1.64

-1.22

1.05

-2.02

-1.19

-1.56

1.11

Integrin beta 3
Mitogen
activated protein
kinase 1
Mitogen
activated protein
kinase 3
Mitogen
activated protein
kinase 8

NM_000212

1.79

-1.44

-2.04

-2.3

-2.05

-1.52

-1.56

-1.3

AA195999

1.10

1.35

1.32

1.12

1.28

-1.15

-1.09

1.03

X60188

1.11

1.89

-1.47

-1.45

1.17

1.40

-1.28

1.08

AI379407

1.62

1.74

-1.00

1.24

1.16

-1.21

1.19

1.06

Microarray
foldchange

RTPCR
foldchange

Microarray
foldchange

RTPCR
foldchange

Microarray
foldchange
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Discussion
With the advent of cDNA microarray technology, it is now possible to
characterize the global transcriptional responses in host cells infected with pathogens. In
this study, we profiled the endothelial cell genes involved in B. bacilliformis invasion.
Microvascular endothelial cells line the blood vessels of the body and provide a selective
barrier to the translocation of various molecules into the surrounding tissues. These cells
are the primary targets for B. bacilliformis, and undergo proliferation following infection,
both in vivo and in vitro (Garcia, F. U. et al., 1992). The presence of B. bacilliformis also
induces pro-angiogenic signals and forces the infected endothelial cells to form
angiogenic blood vessels that culminate in the formation of blood-filled nodules,
described as verruga peruana. In previous chapters, we have demonstrated the function
of integrins and their ligands for establishing B. bacilliformis infection. Of the integrins
studied, the fibronectin receptor α5β1 reveals the most significant effect on bacterial
uptake. Integrin activation by extracellular signals results in hierarchical protein
interactions that affect cytoskeletal reorganization, the activation of signaling pathways,
and eventually the regulation of gene expression. An important component of integrin
signaling is the mitogen-activated protein kinase (MAPK) pathway, components of which
also regulate transcription. In our experiments with MAPK inhibitors, we found that
MEK1/2, JNK, and p38 kinase are involved in B. bacilliformis invasion. In addition to
MAPKs, the lipid kinase PI3K plays a critical role in bacterial uptake and cell survival.
In this section, we analyze some of the gene transcripts that are part of the integrinsignaling pathway, linking events that may occur in endothelial cells after B. bacilliformis
infection.
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Total RNA isolated from B. bacilliformis-infected and mock infected
microvascular endothelial cells was hybridized onto Affymetrix GeneChips, which have
human gene transcript oligomers spotted on two sets of chips. The analyses of
hybrization intensity signals were processed by GCOS and then by GeneSpring (Agilent)
as a means to determine the changes in the gene transcriptosomes from infected cells in
comparison with control cells.
Highly differentially expressed transcripts
GeneSpring analyses of the raw microarray data indicated which genes have the
highest and lowest fold-change ratios at various time points. All these genes could play
significant roles in determining the fate of B. bacilliformis-infected endothelial cells.
Discussion of all of these genes is beyond the scope of this study, but a few genes were
selected for discussion to provide a better understanding of some of the cellular changes
that occur during B. bacilliformis infection.
One gene that is significantly up-regulated by 30 minutes post infection codes for
the toll-like receptor (TLR7). TLR7 traditionally is responsive to small synthetic
compounds and single-stranded RNA. However, it also functions in bacterial infections;
for instance, dendritic cells exhibit increased TLR7 expression after exposure to
lipopolysaccaride (LPS), a primary component of the outer membrane of Gram negative
bacteria (Severa et al., 2007). Haemophilus influenzae also stimulates epithelial cell
TLR7 expression through a NFκB-dependent pathway, which enhances the host cell’s
antiviral response (Sakai et al., 2007). Although the implications of the TLR7 upregulation are unknown, it could lead to TLR7-specific responses, such as NFκB
activation and cytokine secretion.
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The Jun D proto-oncogene, which shows more than a 23-fold positive change at
30 minutes, is a member of the Jun family and a component of the Activation Protein 1
(AP1) factor complex. Its induction is significant because Jun D protects cells from p53dependent apoptosis brought on by stress signals and the cytotoxic effects of TNFα
(Weitzman et al., 2000).
Another factor that contributes to anti-apoptotic signals is phosphoinositide 3
kinase (PI3K). The regulatory component of this complex, p150, shows a 9.4-fold
positive change over the controls. Because B. bacilliformis is an intracellular pathogen, it
can benefit from the activation of cell survival genes early during the infection, which
enables it to establish the infection. Furthermore, the inflammatory cytokine CXC5
precursor is strongly suppressed. This cytokine is a potent activator of neutrophils which,
if recruited, could prevent B. bacilliformis from colonizing the endothelial cells. Thus the
down-regulation of CXC5 would be expected to be beneficial to the infecting bacteria
(Strieter et al., 1992).
At one hour post infection, the expression of two genes, one coding for the A
disintegrin and metalloprotease (ADAM12), and one coding for the TGF beta growth
factor, is reduced. ADAM12 and TGF-beta growth factor regulate cell spreading and
growth, respectively. The Ras p21 protein activator a negative regulator of the RasMAPK pathway required for growth, differentiation, and proliferation in response to
receptor tyrosine kinase-mediated stimuli reveals significantly enhanced expression
(Gibbs et al., 1990). Together, these signals would repress cell proliferation, which could
be a protective measure mounted by the host to balance the mitogenic signals from B.
bacilliformis. One such bacterial mediated mitogenic stimulus could be MAPK7 ( also
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called ERK5), which is activated at the one hour time point. This kinase is required for
endothelial cell survival and functions by decreasing caspase 3 activity (Pi et al., 2004).
The proliferative effects of growth factors, epidermal growth factors, and granulocyte
colony-stimulating factors, as well as the oncogenic effect of Ras, are all mediated by
ERK5 (English et al., 1999; Kato et al., 1998). In addition, ERK5 is required for VEGFand FGF-induced angiogensis (Hayashi et al., 2005). These contradictory signal
responses to B. bacilliformis appear unique and require detailed exploration to understand
how the host cell machinery provokes proliferation while also battling simultaneous
apoptotic signals.
The positive expression of some of the pro-angiogenic genes occurs at three hours
as well. One of them, cadherin 2, or N-cadherin, is involved in cell–cell contact, and in
endothelial cells it regulates angiogenesis by controlling VE-cadherin expression (Luo et
al., 2005). The transcription of the NFκB inhibitor zeta (IKBζ) isoform is reduced. This
protein has latent transcriptional activity required to inhibit NFκB (Yamazaki et al.,
2001). Down-regulation of IKBζ could activate NFκB, and thus mediate proliferative
effects and regulate inflammatory responses. Another gene worth mentioning is the
TRAF3-interacting JNK-activating modulator, which is down-regulated at three hours.
This protein interacts specifically with TRAF3 to activate JNK (Dadgostar et al., 2003).
Thus, JNK regulation in B. bacilliformis could be a TRAF-dependent event.
At six hours post infection, a pro-apoptosis gene, harakiri Bcl2-interacting protein
(HRK), shows a six-fold increase in expression. The HRK gene product physically
interacts selectively with Bcl2 and BAX to activate the cell death cycle (Inohara et al.,
1997). Interestingly, the JunD proto-oncogene, which displays a dramatic increase in
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expression at 30 minutes, shows a nine-fold decrease in expression by six hours post
infection. As mentioned previously, JunD is anti-apoptotic, and its down-regulation,
together with an increase in HRK expression, could favor cell death at this time point.
However, apoptosis is a complex process with multiple protein interactions that must be
taken into consideration before drawing any final conclusions. The fibroblast growth
factor receptor 4 (FGFR4), which recognizes FGF19, is up-regulated. The receptor may
be involved in cell proliferation, differentiation, and angiogenesis. Because B.
bacilliformis-infected cells eventually undergo angiogenesis, the high expression of genes
that contribute to cell growth and blood vessel formation may be advantageous.
Integrins
B. bacilliformis is internalized by endothelial cells within the first hour of
coincubation, and endothelial proliferation requires as little as 30 minutes of infection
(Garcia et al., 1990). These observations suggest that the function of B. bacilliformisinfected cell components changes within a short period after of bacterial incubation. B.
bacilliformis aggregates also can be found on cell membranes, and integrins have been
identified as potential receptors. The inhibition of α5β1 receptor leads to a maximum
decrease in invasion, and RT-PCR analyses of the individual subunits show an increase in
their gene expression. Microarray data are consistent with these findings (Table 3.3).
Furthermore, other alpha and beta subunits are up-regulated at early times after infection.
Enhanced integrin gene expression over the course of the infection could ensure efficient
and continuous B. bacilliformis internalization. The subunit β6 has the highest foldchange among the β subunits at both 30 minutes and three hours. In addition, β6 can pair
with α5 subunits that recognize both fibronectin and vitronectin (Huang et al., 1995).
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This integrin subunit pairing also serves as a receptor for foot-and-mouth disease virus
and coxsackievirus A9 (Jackson et al., 2000; Williams et al., 2004). Fibronectin-bound
B. bacilliformis are internalized more efficiently than uncoated bacteria and can use αvβ6,
along with other fibronectin integrins for adherence. Some integrin genes exhibit
decreased expression after three hours post infection, which could suggest a host defense
mechanism against the uptake of surface-bound bacteria.
The differential regulation of selected genes, such as those involved with integrin
binding was also investigated by real-time RT-PCR. To be considered comparable, the
RT-PCR and microarray data must have a minimum 80% correlation, with no more than
a 2.5-fold-change difference between the sets of data (Draghici, 2002; Gao et al., 2004).
With regard to integrin expression, our RT-PCR fold-change data provided a general
validation of the data from the microarray experiments with most time points showing
similar degrees of up- or down-regulation. However, less consistent results were
obtained with other genes such as the MAP kinases. Differences in the immobilized
array oligonucleotide and RT-PCR primer binding sites for the specific gene being
measured could account for the fold-change variations between the two methods. The
fold-change in microarray experiments also is a measure of the hybridization intensity
levels, as analyzed by the GCOS software. These signals were normalized as much as
possible, yet the fold-change data are extremely sensitive to the computational accuracy
of the software. Our microarray data for some of the genes selected does not correlate
very well with the RT-PCR data, but we cannot rule out the significance of the
microarray data.
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Integrin interaction with its ligand leads to conformational changes, resulting in
clustering or cross-linking, which constitutes the active form of the integrins and
promotes the formation of cell structures, called focal adhesions, at the base of the
cytosolic region of the integrins. Focal adhesions or contacts entail a complex of various
proteins through which integrins integrate into the outside matrix to the cytoskeleton.
The proteins concentrated within focal contacts are tyrosine phosphorylating kinases,
signaling kinases, and cytoskeleton components. Actin-binding components in the focal
plaques include talin, tensilin, vinculin, paxillin, and zyxin, and some of the protein
kinases are focal adhesion kinase (FAK), integrin-linked kinase (ILK), and protein kinase
C. Focal plaques can be detected in B. bacilliformis-infected cells as well, though the
receptors associated with the focal contacts detected in B. bacilliformis-infected cells
have not been studied (Verma et al., 2001). An integrin-mediated event seems highly
likely, as supported by two observations: B. bacilliformis interaction with endothelial
cells is an integrin-mediated event, and focal contact formation is always associated with
the beta integrin subunit.
Focal adhesion kinase (FAK)
Integrins lack intrinsic enzyme activity and depend on adaptor proteins for their
downstream signal propagation. As a critical adaptor protein for the mediation of
integrin signaling, the FAK protein tyrosine kinase is evolutionarily conserved and
activated upon integrin activation. The major phosphorylation site is the tyrosine residue
at position 397, which can be autophosphorylated (Eide et al., 1995). Furthermore, FAK
activity relies on direct or indirect interaction (via talin) with the beta subunit of the
integrin complex (Schaller et al., 1995). The ability of FAK to associate with structural
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and signaling proteins is essential for the regulation of cell motility and control of
apoptosis. The importance of tyrosine phosphorylation in B. bacilliformis infection of
host cells also has been demonstrated. Initial evidence was obtained when protein
tyrosine kinase inhibitors reduced B. bacilliformis uptake into epithelial cells (WilliamsBouyer et al., 1999). In the same study, phosphorylated tyrosine kinases were detected
after one hour of epithelial cell infection. A band of approximately 110kDa appeared in
infected cells, which could be the similarly sized FAK protein. A time-dependent
increase in FAK activity was noted in endothelial cells as well (Verma et al., 2001). B.
bacilliformis endothelial cells undergo morphological changes due to the formation of
stress fibers; at 24 hours, prominent focal contacts occur at the distal ends of these fibers.
These focal plaques are rich in FAK, paxillin, and phosphorylated tyrosine kinases. At
30 minutes, FAK is up-regulated by five fold, a change in expression that coincides with
the increased integrin gene transcription. In addition to integrin-mediated activation,
FAK induction can occur by bFGF- (basic fibroblastic growth factor) or VEGF- (vascular
endothelial growth factor) mediated receptor phosphorylation (Abedi et al., 1997). The
VEGF mRNA up-regulation has been reported in vitro and occurs in our microarray
studies; however, the protein has not been detected in culture (Verma et al., 2001). In
situ, though, VEGF of epithelial origin has been detected in verruga lesions and is
believed to be synthesized in the presence of intracellular and/or extracellular B.
bacilliformis (Cerimele et al., 2003). Elucidation of the receptors involved in the
stimulation of FAK and examination of its activity during the course of B. bacilliformis
infection thus would represent important advances in the understanding of B.
bacilliformis pathogenesis.
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Actin-binding components
The focal plaques previously described are rich in talin, tensilin, vinculin,
paxillin, and zyxin, all of which associate with actin and modulate the cytoskeletal
network. Talin may recruit FAK to activate integrins by binding the carboxy terminal of
FAK; it also interacts with vinculin and paxillin (Chen et al., 1995). The FAK interaction
with talin, and thus integrin, then causes a conformational change, a prerequisite for its
autophosphorylation. The cytoskeletal protein substrates for activated FAK are paxillin
and tensin, which together form an active focal adhesion complex, as required for
downstream signaling. The expression of talin, vinculin, tensin, and another cytoskeletal
protein, zyxin, are enhanced slightly in B. bacilliformis-infected HMEC-1 cells, and
tensin is increased over four-fold. This finding supports the possibility of focal plaque
formation early in infected cells.
Rho family GTPases and MAPKs
Rapid development of filopodia and lamellipodia occurs in cells plated on
extracellular matrix (ECM), which indicates mechanisms that involve integrins and small
GTPases Cdc42 and Rac. These protrusions contain cytoskeletal and signaling molecules
coupled with integrin clusters. Ligand-bound integrins trigger Rac and Cdc42 activation
by allowing GTP loading and membrane targeting of these molecules, which in turn leads
to the phosphorylation of the downstream effector kinase, or p21-activating kinase (del
Pozo et al., 2000). B. bacilliformis infection of endothelial cells elicits the same response
as ECM-mediated signaling. Filopodia formation occurs first at 30 minutes, followed by
lamellipodia production at one hour. These membrane alterations are synchronized with
their respective small GTPase proteins, Cdc42 and Rac (Verma et al., 2002b). The
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transcription analysis of Cdc42 and Rac genes in our microarray experiments shows a
slight increase in Rac and a significant increase in Cdc42 gene expression, suggesting
that B. bacilliformis infection affects these proteins at the genetic level as well. Increases
in Cdc42 and Rac gene expression occur up to one hour, followed by a subsequent
decrease. Enhanced gene expression should result in the production of more Rac and
Cdc42 molecules, which, when activated, increase membrane ruffling and augment B.
bacilliformis invasion. Activated Rac recruits high-affinity integrins to the leading
lamellipodia, which again would be expected to facilitate B. bacilliformis invasion, since
entry is an integrin-mediated event. The Rac in cells grown on fibronectin is induced by
α5β1, and the signals generated by activated Rac are mitogenic. Our invasion assays
demonstrate that B. bacilliformis can bind to α5β1 through fibronectin. Thus, in these
cells, Rac may be activated by α5β1 engagement with fibronectin-bound B. bacilliformis,
which then leads to host cell proliferation—a hallmark of B. bacilliformis infections.
The other small GTPase affected by integrins is RhoA, a component of the Rho
family proteins. RhoA promotes and maintains the formation of stress fibers.
Surprisingly, the RhoA activation in B. bacilliformis-infected endothelial cells is exactly
like the integrin-mediated RhoA activation pattern. The absence of activated Rho marks
the first 16 hours of infection (Verma et al., 2001). According to our data, the bacteria
suppress the transcription of Rho early in infection which could allow for membrane
modifications. Rho activity subsequently peaks with the assembly of stress fibers and
focal contacts (Verma et al., 2001). The initial decrease in RhoA is linked to the
activation of FAK in integrin-mediated events through a bidirectional regulation (Ren et
al., 2000). Even though a positive expression of this gene takes place at three hours,
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activated forms are not detected, so the mechanisms that repress RhoA activity may
prevent its phosphorylation in the cytosol.
The downstream substrate for activated small GTPase is p21-activating kinase
(PAK). Activated PAK and its genetic up-regulation appears in B. bacilliformis-infected
endothelial cells (Verma et al., 2002b). Moreover, activated PAK targets MAPK /ERK
indirectly through Raf1 and MEK1, as well as JNK (MAPK8) and p38 (MAPK14)
through intermediate kinases (Frost et al., 1997). Thus, PAK can contribute to B.
bacilliformis infection by acting on various cytoskeletal modulators and maintaining cell
survival via the MAPK pathway.
Bacterial attachment to cell surface receptors induces a variety of signaling
pathways. In the case of B. bacilliformis-infected endothelial cells, activated MAPKs
have been detected. Of the three MAPKs, the activated forms of JNK1/2 and p38 kinase
occur in infected endothelial cells, whereas ERK1/2 phosphorylation has not been studied
(Verma et al., 2002b). Our research with MAPK inhibitors demonstrates their necessity
for B. bacilliformis infection. Integrin engagement by B. bacilliformis likely causes
integrin aggregation, an event that leads to the activation of MEK1, ERK1/2, and
SAPK/JNK at differing times (Miyamoto et al., 1995). The analysis of MAPK gene
expression indicates a two-fold or higher up-regulation of MAPK, with JNK2 (MAPK9)
and p38 kinase (MAPK14) showing a twofold or greater increase after just 30 minutes of
B. bacilliformis incubation. At six hours, all the MAPKs with the exception of p38
kinase are positively regulated. The gene expression patterns of these MAPKs compare
well with the activation timeline reported in previous research (Verma et al., 2002b). B.
quintana-infected endothelial cells undergo apoptosis during the first six hours of
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infection. This may be mediated by JNK and p38 kinase, since their activation coincides
with increased cell death (Liberto et al., 2004). The effect of JNK up-regulation and
activation on B. bacilliformis-infected endothelial cell survival has not been examined,
and its role in apoptosis remains controversial because it functions in cell survival
processes as well (Salameh et al., 2005). Thus, the function of JNK as a pro- or antiapoptotic agent depends on the cell type, external stimuli, and other signaling pathways
(Yu et al., 2004). In turn, the effect of activated JNK and its up-regulation on B.
bacilliformis-infected apoptosis pathways requires further elucidation before any
conclusions about its role in cell survival are possible. However, JNK activation leads to
the stimulation of transcription factors such as AP1, which is composed of fos and c-Jun.
The gene expression of c-Jun is significantly enhanced at 30 minutes, and c-Jun continues
to be up-regulated at one hour. Along with an increase in c-Jun gene expression, the
protein itself is phosphorylated between one and 16 hours in B. bacilliformis-infected
cells (Verma et al., 2002b). The activity of these transcription factors is important for the
regulation of various cellular functions that may be required for the successful
establishment of a B. bacilliformis infection.
Integrin-mediated PI3K signaling
Phosphoinositide 3 kinase (PI3K) belongs to the phosphoinositide family of shortlived lipid kinases. An important downstream effector of integrin signaling, it can be
activated by FAK and integrin-linked kinase (ILK). The role of FAK has been discussed
in detail, whereas the function of ILK, the other kinase involved in PI3K signaling, has
not been studied in relation to B. bacilliformis infection. Increased expression of the ILK
transcript is observed in endothelial cells at one hour post infection. Initial up-regulation
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would enhance B. bacilliformis invasion because ILK can recruit adaptor proteins for
actin modulation. Integrin-dependent invasion of Staphylococcus aureus and Yersinia
pseudotuberculosis also requires proper ILK expression (Wang et al., 2006). It appears
that ILK activation should lead to PI3K activation, which also plays a role in bacterial
invasion by activating small GTPases and pseudopod formation (Qian et al., 2005).
The phosphorylation state of PI3K kinase in B. bacilliformis remains
undetermined, but invasion appears impaired in the presence of PI3K inhibitors. The
PI3K enzyme consists of both regulatory and catalytic units, whose genes expressions are
positively regulated up to one hour post infection. PI3K regulates certain aspects of
phagocytosis including pseudopod extension and phagosome closure and actin
polymerization (Allen et al., 2005; Cox, Dianne et al., 1999). Therefore, PI3K can act at
multiple steps that are involved in B. bacilliformis uptake. Additionally, PI3K-dependent
pathways are crucial for cell survival, and the survival of B. bacilliformis-infected cells
also depends on PI3K, as determined by the effects of the PI3K inhibitor, LY294002.
The viability of infected cells decreases dramatically in the presence of this inhibitor: by
24 hours post infection, no live cells are present. Protein kinase B (PKB) and v-akt
murine thymoma viral oncogene homolog 1 (Akt) depend on PI3K for activation, after
which they arrest the apoptotic cycle. Endothelial cells have high Akt-1 expression,
which inhibits the pro-apoptotic molecule Bcl2, an antagonist of cell death, the Bcl2associated X protein (BAX), and caspase 9. Akt-1 also stimulates the expression of
survivin, an anti-apoptotic protein. By profiling these genes, our studies show that
apoptogenic genes BAD, CASP9, and the anti-apoptotic gene BRIC5 are all up-regulated
at 30 minutes. Other anti-apoptotic genes that are part of the PI3K signaling pathway
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showing a sustained up-regulation include the insulin-like growth factor 1 (IGF1), which
induces cell survival by activating Akt1/2, and the gene for B cell lymphoma 2 (Bcl2),
which inhibits caspase activity. These mixed signals are not surprising, because one of
the first lines of defense against bacterial infection is apoptosis. However, B.
bacilliformis coincubation with endothelial cells has a mitogenic effect within just 30
minutes (Garcia, F. U. et al., 1992), which means that as the cells sense invading bacteria,
they “turn on” the apoptotic genes and proteins, while B. bacilliformis simultaneously
manipulates the signaling pathways to express anti-apoptotic factors.
Induction of the gene coding for the angiogenic factor, Angiopoetin-2 has been
recorded in B. bacilliformis-infected endothelium has been recorded both in vivo and in
vitro (Cerimele et al., 2003). The work of Cerimele et al (2003) also reveals that the
VEGF in verruga lesions has an epidermal source, and that the angiogenic endothelial
cells express high levels of VEGF receptors. Our microarray analysis confirms the upregulation of angiopoetin-2. Ligation of angiopoetin and VEGF receptors activates the
PI3K signal cascade; such activation gets greatly amplified when the integrin couples
with its ligands (Gerber et al., 1998; Kim et al., 2000). A likely scenario in B.
bacilliformis-infected cells thus depicts bacterial attachment to integrins, with additional
signals from VEGFR and angiopoetin receptors triggering the activation of PI3K, which
then suppresses the apoptotic proteins and maintains cell survival. These signals, coupled
with other mitogenic and angiogenic signals, eventually propel the cell cycle toward cell
proliferation, followed by angiogenesis. Additional studies involving the elucidation of
receptors that induce PI3K activation and PI3K pathway-associated proteins could shed
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more light on the mechanisms that lead to cell proliferation and angiogenesis in B.
bacilliformis endothelial cells.
The microarray analysis of gene transcripts from B. bacilliformis infected
endothelial cells performed here offers the first glimpse into cellular changes inflicted by
these bacteria. Although all of the data could not be analyzed in this study, the alterations
in gene expression levels provides us with a foundation for future research to understand
the complex cellular reactions that occur during B. bacilliformis infection.
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Summary and conclusions
B. bacilliformis can attach to and invade vascular endothelial cells; according to
our observations and these interactions depend on cell surface integrins. The integrin
with the most significant role in endothelial cell infection is α5β1, an integrin known to be
essential for cell adhesion to the extracellular matrix as well as cell proliferation,
spreading, and survival. Functional blocking of α5β1 inhibits internalization of bacteria
by 80% and severely decreases B. bacilliformis attachment. Expression of the α5 and β1
genes increases after infection for up to six and one hour, respectively, and this increased
expression would be expected to enhance the efficiency of B. bacilliformis uptake. The
other integrins possibly involved are αVβ3 and integrins containing β1, since antibodies
against these molecules also decrease the invasion by 30% on average. Pathogenic
engagement of integrins could be direct or through their ligands. The extracellular matrix
proteins fibronectin and vitronectin are the natural ligands for α5β1 and αVβ3, respectively.
These proteins are present in a soluble plasma form and an insoluble cellular form as a
part of the extracellular matrix. According to our data, plasma and cellular protein
association with B. bacilliformis enhances internalization, but endothelial cell infection
can occur even in its absence (Figure 3.2a)
Loading of integrins leads to their clustering and transforms them into an
activated conformation, which results in cytoplasmic signal transduction that regulates
various cellular processes. We propose a hypothetical working model that describes the
integrin-mediated cell signaling events that may take place after B. bacilliformis infection
(Figure 3.2b). According to this model, integrin clustering gives way to the formation of
a focal adhesion plaque, which consists of a group of proteins that interact to facilitate
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signal transduction. In this respect, phosphorylated tyrosine kinases (PTKs) play central
roles, because integrins lack intrinsic enzymatic activity. All integrins with β1 and αv
phosphorylate focal adhesion kinase, a PTK, which is followed by the formation of stress
fibers and focal adhesion plaques at the base of the cytoplasmic domain of integrins. B.
bacilliformis infection of endothelial cells results in the formation of stress fibers of Factin bundles (Verma et al., 2001). Focal adhesion structures, which appear at the base
of these stress fibers, consist of paxillin, FAK, and PTKs, and the non-specific inhibition
of PTKs decreases B. bacilliformis invasion (Williams-Bouyer et al., 1999). Based on
our microarray data and studies by Verma et al (2000), we propose that B. bacilliformis
binding to integrins induces the formation of actin polymerization and focal adhesion
complexes upon binding. The activated kinases of the focal plaque could trigger the
downstream activation of various kinases, including p21-activating kinase (PAK), Ras,
and PI3K. Phosphorylated PI3K and Ras then could mediate the stimulation of small
GTPases, Rac1, and Cdc42, as seen in B. bacilliformis infected cells as early as 30
minutes post infection until as late as eight hours into the infection (Verma et al., 2002b).
The membrane alterations brought on by activated Rac1 and Cdc42 thus are proposed as
the leading cause of B. bacilliformis internalization.
The next step of the cascade involves the stimulation of PAK, a substrate for both
FAK and Rac1. The activated form of PAK and PAK gene up-regulation can be detected
in B. bacilliformis-infected cells at two hours after infection (Verma et al., 2002b).
Phosphorylated PAK is an upstream modulator of MAPKs, ERK1/2, JNK, and p38.
Phosphorylated ERK1/2 proteins are involved in cell structure remodeling, and the stressactivated kinase JNK is known to induce transcription factors, which promote cell
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survival and actin rearrangements. Lastly, p38 can also be activated by PAK and is
involved in C. jejuni and S.typhi invasion of epithelial cells. Therefore, on the basis of
previous studies that detect activated JNK and p38, as well as our microarray data and
inhibitor studies, we can assume that the initial entry of B. bacilliformis is a MAPKdependent event. The fold-change analysis of FAK, PAK, Rac1, and Cdc42 shows that
their gene expression is down-regulated three hours post-infection, although the downregulation is not significant.

Proteomic studies would be required to confirm their

suppression at the protein level, but it seems likely that these proteins would be
inactivated by the host cell machinery to inhibit parasitization. B. bacilliformis invasion
is a continuous process, and the up-regulation of FAK and PAK at three and six hours,
respectively, suggests that B. bacilliformis has the potential to overcome the host cell
defenses and induced conditions that could favor its uptake.
Like all intracellular pathogens, B. bacilliformis depends on host cell survival to
propagate its intracellular lifestyle.

Our model proposes the integrin-dependent

activation of PI3K, a kinase with multiple functions including cytoskeletal rearrangement
and suppression of apoptogenic proteins. The inhibitors of PI3K kinase prevent the
internalization of B. bacilliformis and induce apoptosis within two hours of infection.
Therefore, PI3K could play an important role throughout the course of the infection by
sustaining cell survival and abetting B. bacilliformis invasion.
In conclusion, this study, the first to demonstrate the role of endothelial cell
integrins as B. bacilliformis receptors, also clarifies the role of ECM proteins in B.
bacilliformis infection. Furthermore, our invasion assay data suggest that both plasma
and cellular ECM proteins assist B. bacilliformis invasion. Cellular signaling pathway
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activation is required for cytoskeletal remodeling, proliferation, and the prevention of
apoptosis.

Although B. bacilliformis invasion is not completely dependent on one

particular kinase, we note the requirement of MEK1/2, JNK, and p38 kinases. Finally,
experiments with PI3K inhibitors strongly support the hypothesis that B. bacilliformisinfected endothelial cells transduce anti-apoptotic signals through the PI3K-Pkb/Akt
pathway. We have not determined the effect of integrin blocking on the various members
of the integrin signaling pathway, yet we provide necessary data for further research into
this aspect of B. bacilliformis pathogenesis. With further studies on the role of integrin
signaling during B. bacilliformis infection, it should be possible to compare the gene
expression pattern and the protein activation states of infected wild type cells with
infected integrin negative cell lines. This study would definitively establish the role of
these proteins in the infection process.
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Figure 3.2a. Bartonella bacilliformis binding to integrins.
B. bacilliformis attachment to integrins can be a direct event (A) or the bacteria can
interact with integrin ligands that bridge bacterial binding to integrins (B). The integrin
ligands fibronectin and/or vitronectin can be of the plasma or cellular origin. B.
bacilliformis binding to integrins then leads to their clustering, a conformational change
resulting in integrin activation.
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Figure 3.2b. Integrin mediated signaling events occurring after B. bacilliformis
attachment to integrins.
B. bacilliformis binding to integrins triggers a signaling cascade involving the protein
tyrosine kinase focal adhesion kinase (FAK) that forms a focal adhesion plaque with
paxillin (PAX) and talin (TAL). Activated FAK then activates Ras, p21 activating kinase
(PAK) and phosphotidylinsotol 3 kinase (PI3K), which eventually results in the
phosphorylation of mitogen activated kinases (MAPKs): extracellular receptor kinase 1/2
(ERK1/2), Jun N-terminal kinase (JNK) and p38 kinase. These MAPKs regulate cellular
transcriptional events that account for the changes that occur in response to B.
bacilliformis infections. Activation of the small GTPases, Rac, Cdc42 and Rho by PI3K
results in alterations of the actin network symbolized by formation of lamellipodia and
filopodia that aide B. bacilliformis internalization. The activation of protein kinase B
(PKB) and v-akt murine thymoma viral oncogene homolog 1 (Akt) by PI3K is proposed
to be involved in generation of anti-apoptotic signals that allow the B. bacilliformis
infected cell to survive.
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